ABBOTT LABORATORIES 002824100 US0028241000 04/24/2026 Election of 12 Directors: N. Ahuja DIRECTOR ELECTIONS ISSUER 17200 0 FOR 17200 FOR ABBOTT LABORATORIES 002824100 US0028241000 04/24/2026 Election of 12 Directors: C. Babineaux-Fontenot DIRECTOR ELECTIONS ISSUER 17200 0 FOR 17200 FOR ABBOTT LABORATORIES 002824100 US0028241000 04/24/2026 Election of 12 Directors: S. E. Blount DIRECTOR ELECTIONS ISSUER 17200 0 FOR 17200 FOR ABBOTT LABORATORIES 002824100 US0028241000 04/24/2026 Election of 12 Directors: R. B. Ford DIRECTOR ELECTIONS ISSUER 17200 0 FOR 17200 FOR ABBOTT LABORATORIES 002824100 US0028241000 04/24/2026 Election of 12 Directors: P. Gonzalez DIRECTOR ELECTIONS ISSUER 17200 0 FOR 17200 FOR ABBOTT LABORATORIES 002824100 US0028241000 04/24/2026 Election of 12 Directors: M. A. Kumbier DIRECTOR ELECTIONS ISSUER 17200 0 FOR 17200 FOR ABBOTT LABORATORIES 002824100 US0028241000 04/24/2026 Election of 12 Directors: D. W. McDew DIRECTOR ELECTIONS ISSUER 17200 0 FOR 17200 FOR ABBOTT LABORATORIES 002824100 US0028241000 04/24/2026 Election of 12 Directors: N. McKinstry DIRECTOR ELECTIONS ISSUER 17200 0 FOR 17200 FOR ABBOTT LABORATORIES 002824100 US0028241000 04/24/2026 Election of 12 Directors: M. G. O'Grady DIRECTOR ELECTIONS ISSUER 17200 0 FOR 17200 FOR ABBOTT LABORATORIES 002824100 US0028241000 04/24/2026 Election of 12 Directors: M. F. Roman DIRECTOR ELECTIONS ISSUER 17200 0 FOR 17200 FOR ABBOTT LABORATORIES 002824100 US0028241000 04/24/2026 Election of 12 Directors: D. J. Starks DIRECTOR ELECTIONS ISSUER 17200 0 FOR 17200 FOR ABBOTT LABORATORIES 002824100 US0028241000 04/24/2026 Election of 12 Directors: J. G. Stratton DIRECTOR ELECTIONS ISSUER 17200 0 FOR 17200 FOR ABBOTT LABORATORIES 002824100 US0028241000 04/24/2026 Ratification of Ernst & Young LLP As Auditors AUDIT-RELATED ISSUER 17200 0 FOR 17200 FOR ABBOTT LABORATORIES 002824100 US0028241000 04/24/2026 Say on Pay - An Advisory Vote on the Approval of Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 17200 0 FOR 17200 FOR ABBOTT LABORATORIES 002824100 US0028241000 04/24/2026 Approval of the Abbott Laboratories 2026 Incentive Stock Program COMPENSATION ISSUER 17200 0 FOR 17200 FOR ABBOTT LABORATORIES 002824100 US0028241000 04/24/2026 Approval of the Abbott Laboratories 2026 Employee Stock Purchase Plan for Non-U.S. Employees CAPITAL STRUCTURE ISSUER 17200 0 FOR 17200 FOR ABBVIE INC. 00287Y109 US00287Y1091 05/08/2026 Election of Class II Directors Jennifer L. Davis DIRECTOR ELECTIONS ISSUER 23900 0 FOR 23900 FOR ABBVIE INC. 00287Y109 US00287Y1091 05/08/2026 Election of Class II Directors Melody B. Meyer DIRECTOR ELECTIONS ISSUER 23900 0 FOR 23900 FOR ABBVIE INC. 00287Y109 US00287Y1091 05/08/2026 Election of Class II Directors Robert A. Michael DIRECTOR ELECTIONS ISSUER 23900 0 FOR 23900 FOR ABBVIE INC. 00287Y109 US00287Y1091 05/08/2026 Election of Class II Directors Frederick H. Waddell DIRECTOR ELECTIONS ISSUER 23900 0 FOR 23900 FOR ABBVIE INC. 00287Y109 US00287Y1091 05/08/2026 Ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2026 AUDIT-RELATED ISSUER 23900 0 FOR 23900 FOR ABBVIE INC. 00287Y109 US00287Y1091 05/08/2026 Say on Pay - An advisory vote on the approval of executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 23900 0 FOR 23900 FOR ABBVIE INC. 00287Y109 US00287Y1091 05/08/2026 Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting CORPORATE GOVERNANCE ISSUER 23900 0 FOR 23900 FOR ABBVIE INC. 00287Y109 US00287Y1091 05/08/2026 Stockholder Proposal - to Adopt a Policy to Require an Independent Chair CORPORATE GOVERNANCE SECURITY HOLDER 23900 0 AGAINST 23900 FOR ABIVAX SA 00370M103 US00370M1036 05/11/2026 Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda items. OTHER ISSUER 6500 0 ABSTAIN 6500 AGAINST ABIVAX SA 00370M103 US00370M1036 05/11/2026 Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda items. OTHER ISSUER 6500 0 ABSTAIN 6500 AGAINST ABIVAX SA 00370M103 US00370M1036 05/11/2026 Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda items. CAPITAL STRUCTURE ISSUER 6500 0 ABSTAIN 6500 AGAINST ABIVAX SA 00370M103 US00370M1036 05/11/2026 Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda items. OTHER ISSUER 6500 0 ABSTAIN 6500 AGAINST ABIVAX SA 00370M103 US00370M1036 05/11/2026 Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda items. DIRECTOR ELECTIONS ISSUER 6500 0 ABSTAIN 6500 AGAINST ABIVAX SA 00370M103 US00370M1036 05/11/2026 Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda items. DIRECTOR ELECTIONS ISSUER 6500 0 ABSTAIN 6500 AGAINST ABIVAX SA 00370M103 US00370M1036 05/11/2026 Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda items. DIRECTOR ELECTIONS ISSUER 6500 0 ABSTAIN 6500 AGAINST ABIVAX SA 00370M103 US00370M1036 05/11/2026 Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda items. COMPENSATION ISSUER 6500 0 ABSTAIN 6500 AGAINST ABIVAX SA 00370M103 US00370M1036 05/11/2026 Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda items. SECTION 14A SAY-ON-PAY VOTES ISSUER 6500 0 ABSTAIN 6500 AGAINST ABIVAX SA 00370M103 US00370M1036 05/11/2026 Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda items. SECTION 14A SAY-ON-PAY VOTES ISSUER 6500 0 ABSTAIN 6500 AGAINST ABIVAX SA 00370M103 US00370M1036 05/11/2026 Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda items. COMPENSATION ISSUER 6500 0 ABSTAIN 6500 AGAINST ABIVAX SA 00370M103 US00370M1036 05/11/2026 Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda items. COMPENSATION ISSUER 6500 0 ABSTAIN 6500 AGAINST ABIVAX SA 00370M103 US00370M1036 05/11/2026 Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda items. COMPENSATION ISSUER 6500 0 ABSTAIN 6500 AGAINST ABIVAX SA 00370M103 US00370M1036 05/11/2026 Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda items. COMPENSATION ISSUER 6500 0 ABSTAIN 6500 AGAINST ABIVAX SA 00370M103 US00370M1036 05/11/2026 Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda items. CAPITAL STRUCTURE ISSUER 6500 0 ABSTAIN 6500 AGAINST ABIVAX SA 00370M103 US00370M1036 05/11/2026 Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda items. CAPITAL STRUCTURE ISSUER 6500 0 ABSTAIN 6500 AGAINST ABIVAX SA 00370M103 US00370M1036 05/11/2026 Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda items. CAPITAL STRUCTURE ISSUER 6500 0 ABSTAIN 6500 AGAINST ABIVAX SA 00370M103 US00370M1036 05/11/2026 Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda items. CAPITAL STRUCTURE ISSUER 6500 0 ABSTAIN 6500 AGAINST ABIVAX SA 00370M103 US00370M1036 05/11/2026 Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda items. CAPITAL STRUCTURE ISSUER 6500 0 ABSTAIN 6500 AGAINST ABIVAX SA 00370M103 US00370M1036 05/11/2026 Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda items. CAPITAL STRUCTURE ISSUER 6500 0 ABSTAIN 6500 AGAINST ABIVAX SA 00370M103 US00370M1036 05/11/2026 Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda items. CAPITAL STRUCTURE ISSUER 6500 0 ABSTAIN 6500 AGAINST ABIVAX SA 00370M103 US00370M1036 05/11/2026 Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda items. CAPITAL STRUCTURE ISSUER 6500 0 ABSTAIN 6500 AGAINST ABIVAX SA 00370M103 US00370M1036 05/11/2026 Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda items. CAPITAL STRUCTURE ISSUER 6500 0 ABSTAIN 6500 AGAINST ABIVAX SA 00370M103 US00370M1036 05/11/2026 Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda items. CAPITAL STRUCTURE ISSUER 6500 0 ABSTAIN 6500 AGAINST ABIVAX SA 00370M103 US00370M1036 05/11/2026 Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda items. CAPITAL STRUCTURE ISSUER 6500 0 ABSTAIN 6500 AGAINST ABIVAX SA 00370M103 US00370M1036 05/11/2026 Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda items. CAPITAL STRUCTURE ISSUER 6500 0 ABSTAIN 6500 AGAINST ABIVAX SA 00370M103 US00370M1036 05/11/2026 Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda items. CAPITAL STRUCTURE ISSUER 6500 0 ABSTAIN 6500 AGAINST ABIVAX SA 00370M103 US00370M1036 05/11/2026 Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda items. COMPENSATION ISSUER 6500 0 ABSTAIN 6500 AGAINST ABIVAX SA 00370M103 US00370M1036 05/11/2026 Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda items. COMPENSATION ISSUER 6500 0 ABSTAIN 6500 AGAINST ABIVAX SA 00370M103 US00370M1036 05/11/2026 Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda items. COMPENSATION ISSUER 6500 0 ABSTAIN 6500 AGAINST ABIVAX SA 00370M103 US00370M1036 05/11/2026 Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda items. CAPITAL STRUCTURE ISSUER 6500 0 ABSTAIN 6500 AGAINST ABIVAX SA 00370M103 US00370M1036 05/11/2026 Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda items. CAPITAL STRUCTURE ISSUER 6500 0 ABSTAIN 6500 AGAINST ABIVAX SA 00370M103 US00370M1036 05/11/2026 Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda items. OTHER ISSUER 6500 0 ABSTAIN 6500 AGAINST ABIVAX SA 00370M103 US00370M1036 05/11/2026 Such other business as may properly come before the meeting or any adjournment thereof. OTHER ISSUER 6500 0 ABSTAIN 6500 AGAINST AKERO THERAPEUTICS, INC 00973Y108 US00973Y1082 12/02/2025 To adopt the Agreement and Plan of Merger (as may be amended, modified or supplemented from time to time, the ''Merger Agreement''), dated October 9, 2025, by and among Akero Therapeutics, Inc., a Delaware corporation ("Akero"), Novo Nordisk A/S, a Danish aktieselskab (''Parent''), and NN Invest Sub, Inc, a Delaware corporation and a direct or indirect wholly owned subsidiary of Parent (''Merger Sub''), including the form of contingent value rights agreement (''CVR Agreement'') to be entered into at or immediately prior to the effective time of the Merger by a direct or indirect wholly owned subsidiary of Parent designated in the CVR Agreement, a rights agent selected by Parent and reasonably acceptable to Akero and, solely with respect to Section 6.11 of the CVR Agreement, Parent, subject to changes permitted by the Merger Agreement, pursuant to which Merger Sub will merge with and into Akero (the ''Merger''), and Akero will become a direct or indirect wholly owned subsidiary of Parent. CORPORATE GOVERNANCE ISSUER 4500 0 FOR 4500 FOR AKERO THERAPEUTICS, INC 00973Y108 US00973Y1082 12/02/2025 To approve, on an advisory, non-binding basis, the payment of certain compensation that may be paid or become payable by Akero to its named executive officers in connection with the Merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 4500 0 FOR 4500 FOR AKERO THERAPEUTICS, INC 00973Y108 US00973Y1082 12/02/2025 To approve the adjournment of the Special Meeting, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes in favor of the adoption of the Merger Agreement at the time of the Special Meeting. CORPORATE GOVERNANCE ISSUER 4500 0 FOR 4500 FOR ALIGN TECHNOLOGY, INC. 016255101 US0162551016 05/20/2026 ELECTION OF DIRECTORS: Kevin T. Conroy DIRECTOR ELECTIONS ISSUER 500 0 FOR 500 FOR ALIGN TECHNOLOGY, INC. 016255101 US0162551016 05/20/2026 ELECTION OF DIRECTORS: Kevin J. Dallas DIRECTOR ELECTIONS ISSUER 500 0 FOR 500 FOR ALIGN TECHNOLOGY, INC. 016255101 US0162551016 05/20/2026 ELECTION OF DIRECTORS: Joseph M. Hogan DIRECTOR ELECTIONS ISSUER 500 0 FOR 500 FOR ALIGN TECHNOLOGY, INC. 016255101 US0162551016 05/20/2026 ELECTION OF DIRECTORS: Joseph Lacob DIRECTOR ELECTIONS ISSUER 500 0 FOR 500 FOR ALIGN TECHNOLOGY, INC. 016255101 US0162551016 05/20/2026 ELECTION OF DIRECTORS: C. Raymond Larkin, Jr. DIRECTOR ELECTIONS ISSUER 500 0 FOR 500 FOR ALIGN TECHNOLOGY, INC. 016255101 US0162551016 05/20/2026 ELECTION OF DIRECTORS: Anne M. Myong DIRECTOR ELECTIONS ISSUER 500 0 FOR 500 FOR ALIGN TECHNOLOGY, INC. 016255101 US0162551016 05/20/2026 ELECTION OF DIRECTORS: Mojdeh Poul DIRECTOR ELECTIONS ISSUER 500 0 FOR 500 FOR ALIGN TECHNOLOGY, INC. 016255101 US0162551016 05/20/2026 ELECTION OF DIRECTORS: Andrea L. Saia DIRECTOR ELECTIONS ISSUER 500 0 FOR 500 FOR ALIGN TECHNOLOGY, INC. 016255101 US0162551016 05/20/2026 ELECTION OF DIRECTORS: Susan E. Siegel DIRECTOR ELECTIONS ISSUER 500 0 FOR 500 FOR ALIGN TECHNOLOGY, INC. 016255101 US0162551016 05/20/2026 ELECTION OF DIRECTORS: Britt Vitalone DIRECTOR ELECTIONS ISSUER 500 0 FOR 500 FOR ALIGN TECHNOLOGY, INC. 016255101 US0162551016 05/20/2026 Advisory Vote to Approve the Compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES ISSUER 500 0 FOR 500 FOR ALIGN TECHNOLOGY, INC. 016255101 US0162551016 05/20/2026 Ratification of Appointment of Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 500 0 FOR 500 FOR ALIGN TECHNOLOGY, INC. 016255101 US0162551016 05/20/2026 Ratification of Special Meeting Provision in our Bylaws CORPORATE GOVERNANCE ISSUER 500 0 FOR 500 FOR ALIGNMENT HEALTHCARE INC 01625V104 US01625V1044 06/04/2026 Election of Directors Jody Bilney DIRECTOR ELECTIONS ISSUER 25000 0 FOR 25000 FOR ALIGNMENT HEALTHCARE INC 01625V104 US01625V1044 06/04/2026 Election of Directors David Hodgson DIRECTOR ELECTIONS ISSUER 25000 0 FOR 25000 FOR ALIGNMENT HEALTHCARE INC 01625V104 US01625V1044 06/04/2026 Election of Directors Jacqueline Kosecoff DIRECTOR ELECTIONS ISSUER 25000 0 FOR 25000 FOR ALIGNMENT HEALTHCARE INC 01625V104 US01625V1044 06/04/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2026 AUDIT-RELATED ISSUER 25000 0 FOR 25000 FOR ALIGNMENT HEALTHCARE INC 01625V104 US01625V1044 06/04/2026 Approval, on a non-binding, advisory basis, of the compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES ISSUER 25000 0 FOR 25000 FOR AMGEN INC. 031162100 US0311621009 05/19/2026 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Wanda M. Austin DIRECTOR ELECTIONS ISSUER 7900 0 FOR 7900 FOR AMGEN INC. 031162100 US0311621009 05/19/2026 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Robert A. Bradway DIRECTOR ELECTIONS ISSUER 7900 0 FOR 7900 FOR AMGEN INC. 031162100 US0311621009 05/19/2026 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Michael V. Drake DIRECTOR ELECTIONS ISSUER 7900 0 FOR 7900 FOR AMGEN INC. 031162100 US0311621009 05/19/2026 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Brian J. Druker DIRECTOR ELECTIONS ISSUER 7900 0 FOR 7900 FOR AMGEN INC. 031162100 US0311621009 05/19/2026 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Robert A. Eckert DIRECTOR ELECTIONS ISSUER 7900 0 FOR 7900 FOR AMGEN INC. 031162100 US0311621009 05/19/2026 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Greg C. Garland DIRECTOR ELECTIONS ISSUER 7900 0 FOR 7900 FOR AMGEN INC. 031162100 US0311621009 05/19/2026 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Charles M. Holley, Jr. DIRECTOR ELECTIONS ISSUER 7900 0 FOR 7900 FOR AMGEN INC. 031162100 US0311621009 05/19/2026 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. S. Omar Ishrak DIRECTOR ELECTIONS ISSUER 7900 0 FOR 7900 FOR AMGEN INC. 031162100 US0311621009 05/19/2026 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Tyler Jacks DIRECTOR ELECTIONS ISSUER 7900 0 FOR 7900 FOR AMGEN INC. 031162100 US0311621009 05/19/2026 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Mary E. Klotman DIRECTOR ELECTIONS ISSUER 7900 0 FOR 7900 FOR AMGEN INC. 031162100 US0311621009 05/19/2026 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Ms. Ellen J. Kullman DIRECTOR ELECTIONS ISSUER 7900 0 FOR 7900 FOR AMGEN INC. 031162100 US0311621009 05/19/2026 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Ms. Amy E. Miles DIRECTOR ELECTIONS ISSUER 7900 0 FOR 7900 FOR AMGEN INC. 031162100 US0311621009 05/19/2026 Advisory vote to approve our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 7900 0 FOR 7900 FOR AMGEN INC. 031162100 US0311621009 05/19/2026 To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 7900 0 FOR 7900 FOR AMGEN INC. 031162100 US0311621009 05/19/2026 Stockholder proposal to require an independent board chairman. CORPORATE GOVERNANCE SECURITY HOLDER 7900 0 AGAINST 7900 FOR ANNEXON, INC. 03589W102 US03589W1027 06/11/2026 Election of Director: 1. Bettina M. Cockroft, MD DIRECTOR ELECTIONS ISSUER 1000 0 FOR 1000 FOR ANNEXON, INC. 03589W102 US03589W1027 06/11/2026 Election of Director: 2. Douglas Love, Esq. DIRECTOR ELECTIONS ISSUER 1000 0 FOR 1000 FOR ANNEXON, INC. 03589W102 US03589W1027 06/11/2026 To ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1000 0 FOR 1000 FOR ANNEXON, INC. 03589W102 US03589W1027 06/11/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1000 0 FOR 1000 FOR ANNEXON, INC. 03589W102 US03589W1027 06/11/2026 To approve an amendment to the Company's amended and restated Certificate of Incorporation to increase the number of authorized shares of common stock from 300,000,000 to 500,000,000. CAPITAL STRUCTURE ISSUER 1000 0 FOR 1000 FOR APOGEE THERAPEUTICS, INC. 03770N101 US03770N1019 06/09/2026 Election of Director: 1. Mark C. McKenna DIRECTOR ELECTIONS ISSUER 1500 0 FOR 1500 FOR APOGEE THERAPEUTICS, INC. 03770N101 US03770N1019 06/09/2026 Election of Director: 2. Jennifer Fox DIRECTOR ELECTIONS ISSUER 1500 0 FOR 1500 FOR APOGEE THERAPEUTICS, INC. 03770N101 US03770N1019 06/09/2026 Election of Director: 3. William (BJ) Jones, Jr. DIRECTOR ELECTIONS ISSUER 1500 0 FOR 1500 FOR APOGEE THERAPEUTICS, INC. 03770N101 US03770N1019 06/09/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1500 0 FOR 1500 FOR APOGEE THERAPEUTICS, INC. 03770N101 US03770N1019 06/09/2026 Approval, on a non-binding advisory basis, of the compensation of our named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1500 0 FOR 1500 FOR ARROWHEAD PHARMACEUTICALS, INC. 04280A100 US04280A1007 03/19/2026 Election of Directors Christopher Anzalone DIRECTOR ELECTIONS ISSUER 2500 0 FOR 2500 FOR ARROWHEAD PHARMACEUTICALS, INC. 04280A100 US04280A1007 03/19/2026 Election of Directors Mauro Ferrari DIRECTOR ELECTIONS ISSUER 2500 0 FOR 2500 FOR ARROWHEAD PHARMACEUTICALS, INC. 04280A100 US04280A1007 03/19/2026 Election of Directors Hongbo Lu DIRECTOR ELECTIONS ISSUER 2500 0 FOR 2500 FOR ARROWHEAD PHARMACEUTICALS, INC. 04280A100 US04280A1007 03/19/2026 Election of Directors Adeoye Olukotun DIRECTOR ELECTIONS ISSUER 2500 0 FOR 2500 FOR ARROWHEAD PHARMACEUTICALS, INC. 04280A100 US04280A1007 03/19/2026 Election of Directors Michael S. Perry DIRECTOR ELECTIONS ISSUER 2500 0 FOR 2500 FOR ARROWHEAD PHARMACEUTICALS, INC. 04280A100 US04280A1007 03/19/2026 Election of Directors Victoria Vakiener DIRECTOR ELECTIONS ISSUER 2500 0 FOR 2500 FOR ARROWHEAD PHARMACEUTICALS, INC. 04280A100 US04280A1007 03/19/2026 Election of Directors William Waddill DIRECTOR ELECTIONS ISSUER 2500 0 FOR 2500 FOR ARROWHEAD PHARMACEUTICALS, INC. 04280A100 US04280A1007 03/19/2026 Advisory Vote to Approve Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2500 0 FOR 2500 FOR ARROWHEAD PHARMACEUTICALS, INC. 04280A100 US04280A1007 03/19/2026 Approval of the Arrowhead Pharmaceuticals, Inc. Amended and Restated 2021 Incentive Plan. COMPENSATION ISSUER 2500 0 ABSTAIN 2500 AGAINST ARROWHEAD PHARMACEUTICALS, INC. 04280A100 US04280A1007 03/19/2026 Ratification of the selection of KPMG LLP as independent auditors of the Company for the fiscal year ending September 30, 2026. AUDIT-RELATED ISSUER 2500 0 FOR 2500 FOR ASTRAZENECA PLC 046353108 US0463531089 11/03/2025 To adopt the articles of association produced to the meeting (and for the purpose of identification signed by the Chair of the General Meeting) as the articles of association of the Company in substitution for and to the exclusion of the existing articles of association of the Company, with effect from the conclusion of the meeting. CORPORATE GOVERNANCE ISSUER 32300 0 FOR 32300 FOR ASTRAZENECA PLC G0593M107 GB0009895292 04/09/2026 To receive the Company's Accounts, the Reports of the Directors and Auditor and the Strategic Report for the year ended December 31, 2025 OTHER ISSUER 16600 0 FOR 16600 FOR ASTRAZENECA PLC G0593M107 GB0009895292 04/09/2026 To confirm the 2025 interim dividends CAPITAL STRUCTURE ISSUER 16600 0 FOR 16600 FOR ASTRAZENECA PLC G0593M107 GB0009895292 04/09/2026 To appoint KPMG LLP as Auditor AUDIT-RELATED ISSUER 16600 0 FOR 16600 FOR ASTRAZENECA PLC G0593M107 GB0009895292 04/09/2026 To authorize the Directors to agree the remuneration of the Auditor AUDIT-RELATED ISSUER 16600 0 FOR 16600 FOR ASTRAZENECA PLC G0593M107 GB0009895292 04/09/2026 Election of Director: Michel Demare DIRECTOR ELECTIONS ISSUER 16600 0 FOR 16600 FOR ASTRAZENECA PLC G0593M107 GB0009895292 04/09/2026 Election of Director: Pascal Soriot DIRECTOR ELECTIONS ISSUER 16600 0 FOR 16600 FOR ASTRAZENECA PLC G0593M107 GB0009895292 04/09/2026 Election of Director: Aradhana Sarin DIRECTOR ELECTIONS ISSUER 16600 0 FOR 16600 FOR ASTRAZENECA PLC G0593M107 GB0009895292 04/09/2026 Election of Director: Philip Broadley DIRECTOR ELECTIONS ISSUER 16600 0 FOR 16600 FOR ASTRAZENECA PLC G0593M107 GB0009895292 04/09/2026 Election of Director: Euan Ashley DIRECTOR ELECTIONS ISSUER 16600 0 FOR 16600 FOR ASTRAZENECA PLC G0593M107 GB0009895292 04/09/2026 Election of Director: Birgit Conix DIRECTOR ELECTIONS ISSUER 16600 0 FOR 16600 FOR ASTRAZENECA PLC G0593M107 GB0009895292 04/09/2026 Election of Director: Rene Haas DIRECTOR ELECTIONS ISSUER 16600 0 FOR 16600 FOR ASTRAZENECA PLC G0593M107 GB0009895292 04/09/2026 Election of Director: Karen Knudsen DIRECTOR ELECTIONS ISSUER 16600 0 FOR 16600 FOR ASTRAZENECA PLC G0593M107 GB0009895292 04/09/2026 Election of Director: Diana Layfield DIRECTOR ELECTIONS ISSUER 16600 0 FOR 16600 FOR ASTRAZENECA PLC G0593M107 GB0009895292 04/09/2026 Election of Director: Anna Manz DIRECTOR ELECTIONS ISSUER 16600 0 FOR 16600 FOR ASTRAZENECA PLC G0593M107 GB0009895292 04/09/2026 Election of Director: Sheri McCoy DIRECTOR ELECTIONS ISSUER 16600 0 FOR 16600 FOR ASTRAZENECA PLC G0593M107 GB0009895292 04/09/2026 Election of Director: Tony Mok DIRECTOR ELECTIONS ISSUER 16600 0 FOR 16600 FOR ASTRAZENECA PLC G0593M107 GB0009895292 04/09/2026 Election of Director: Marcus Wallenberg DIRECTOR ELECTIONS ISSUER 16600 0 FOR 16600 FOR ASTRAZENECA PLC G0593M107 GB0009895292 04/09/2026 To approve the annual statement of the Chair of the Remuneration Committee and the Annual Report on Remuneration for the year ended December 31, 2025 SECTION 14A SAY-ON-PAY VOTES ISSUER 16600 0 FOR 16600 FOR ASTRAZENECA PLC G0593M107 GB0009895292 04/09/2026 To renew the authorization to grant awards under the French Appendix 3 of the AstraZeneca Performance Share Plan 2020 COMPENSATION ISSUER 16600 0 FOR 16600 FOR ASTRAZENECA PLC G0593M107 GB0009895292 04/09/2026 To authorize limited political donations OTHER SOCIAL ISSUES ISSUER 16600 0 FOR 16600 FOR ASTRAZENECA PLC G0593M107 GB0009895292 04/09/2026 To authorize the Directors to allot shares CAPITAL STRUCTURE ISSUER 16600 0 FOR 16600 FOR ASTRAZENECA PLC G0593M107 GB0009895292 04/09/2026 To authorize the Directors to disapply pre-emption rights1 CAPITAL STRUCTURE ISSUER 16600 0 ABSTAIN 16600 AGAINST ASTRAZENECA PLC G0593M107 GB0009895292 04/09/2026 To authorize the Directors to further disapply pre-emption rights for acquisitions and specified capital investments1 CAPITAL STRUCTURE ISSUER 16600 0 FOR 16600 FOR ASTRAZENECA PLC G0593M107 GB0009895292 04/09/2026 To authorize the Company to purchase its own shares1 CAPITAL STRUCTURE ISSUER 16600 0 FOR 16600 FOR ASTRAZENECA PLC G0593M107 GB0009895292 04/09/2026 To reduce the notice period for general meetings1 CORPORATE GOVERNANCE ISSUER 16600 0 FOR 16600 FOR ATRICURE, INC. 04963C209 US04963C2098 05/18/2026 Election of Directors Michael H. Carrel DIRECTOR ELECTIONS ISSUER 2000 0 FOR 2000 FOR ATRICURE, INC. 04963C209 US04963C2098 05/18/2026 Election of Directors Regina E. Groves DIRECTOR ELECTIONS ISSUER 2000 0 FOR 2000 FOR ATRICURE, INC. 04963C209 US04963C2098 05/18/2026 Election of Directors B. Kristine Johnson DIRECTOR ELECTIONS ISSUER 2000 0 FOR 2000 FOR ATRICURE, INC. 04963C209 US04963C2098 05/18/2026 Election of Directors Shlomo Nachman DIRECTOR ELECTIONS ISSUER 2000 0 FOR 2000 FOR ATRICURE, INC. 04963C209 US04963C2098 05/18/2026 Election of Directors Karen N. Prange DIRECTOR ELECTIONS ISSUER 2000 0 FOR 2000 FOR ATRICURE, INC. 04963C209 US04963C2098 05/18/2026 Election of Directors Deborah H. Telman DIRECTOR ELECTIONS ISSUER 2000 0 FOR 2000 FOR ATRICURE, INC. 04963C209 US04963C2098 05/18/2026 Election of Directors Sven A. Wehrwein DIRECTOR ELECTIONS ISSUER 2000 0 FOR 2000 FOR ATRICURE, INC. 04963C209 US04963C2098 05/18/2026 Election of Directors Robert S. White DIRECTOR ELECTIONS ISSUER 2000 0 FOR 2000 FOR ATRICURE, INC. 04963C209 US04963C2098 05/18/2026 Election of Directors Maggie Yuen DIRECTOR ELECTIONS ISSUER 2000 0 FOR 2000 FOR ATRICURE, INC. 04963C209 US04963C2098 05/18/2026 Proposal to ratify the appointment of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2000 0 FOR 2000 FOR ATRICURE, INC. 04963C209 US04963C2098 05/18/2026 Proposal to approve an amendment to the AtriCure, Inc. 2023 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 1,500,000. COMPENSATION ISSUER 2000 0 ABSTAIN 2000 AGAINST ATRICURE, INC. 04963C209 US04963C2098 05/18/2026 Proposal to approve an amendment to the AtriCure, Inc. 2018 Employee Stock Purchase Plan to increase the number of shares of common stock authorized for issuance thereunder by 750,000. CAPITAL STRUCTURE ISSUER 2000 0 FOR 2000 FOR ATRICURE, INC. 04963C209 US04963C2098 05/18/2026 Advisory vote on the compensation of our named executive officers as disclosed in the proxy statement for the 2026 Annual Meeting. SECTION 14A SAY-ON-PAY VOTES ISSUER 2000 0 FOR 2000 FOR AVANTOR, INC. 05352A100 US05352A1007 05/07/2026 Election of Directors Simon Dingemans DIRECTOR ELECTIONS ISSUER 44000 0 FOR 44000 FOR AVANTOR, INC. 05352A100 US05352A1007 05/07/2026 Election of Directors Emmanuel Ligner DIRECTOR ELECTIONS ISSUER 44000 0 FOR 44000 FOR AVANTOR, INC. 05352A100 US05352A1007 05/07/2026 Election of Directors Gregory Lucier DIRECTOR ELECTIONS ISSUER 44000 0 FOR 44000 FOR AVANTOR, INC. 05352A100 US05352A1007 05/07/2026 Election of Directors Dame Louise Makin DIRECTOR ELECTIONS ISSUER 44000 0 FOR 44000 FOR AVANTOR, INC. 05352A100 US05352A1007 05/07/2026 Election of Directors Joseph Massaro DIRECTOR ELECTIONS ISSUER 44000 0 FOR 44000 FOR AVANTOR, INC. 05352A100 US05352A1007 05/07/2026 Election of Directors Sanjeev Mehra DIRECTOR ELECTIONS ISSUER 44000 0 FOR 44000 FOR AVANTOR, INC. 05352A100 US05352A1007 05/07/2026 Election of Directors Mala Murthy DIRECTOR ELECTIONS ISSUER 44000 0 FOR 44000 FOR AVANTOR, INC. 05352A100 US05352A1007 05/07/2026 Election of Directors Michael Severino DIRECTOR ELECTIONS ISSUER 44000 0 FOR 44000 FOR AVANTOR, INC. 05352A100 US05352A1007 05/07/2026 Election of Directors Gregory Summe DIRECTOR ELECTIONS ISSUER 44000 0 FOR 44000 FOR AVANTOR, INC. 05352A100 US05352A1007 05/07/2026 Advisory Approval of Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 44000 0 FOR 44000 FOR AVANTOR, INC. 05352A100 US05352A1007 05/07/2026 Advisory Vote on the Frequency of Future Advisory Votes on Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 44000 0 1 Year 44000 FOR AVANTOR, INC. 05352A100 US05352A1007 05/07/2026 Ratification of Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm for 2026 AUDIT-RELATED ISSUER 44000 0 FOR 44000 FOR AVITA MEDICAL, INC. 05380C102 US05380C1027 06/03/2026 To elect seven directors to serve for a one-year term or until their respective successors have been duly elected and qualified; Cary Vance DIRECTOR ELECTIONS ISSUER 15000 0 FOR 15000 FOR AVITA MEDICAL, INC. 05380C102 US05380C1027 06/03/2026 To elect seven directors to serve for a one-year term or until their respective successors have been duly elected and qualified; Professor Suzanne Crowe DIRECTOR ELECTIONS ISSUER 15000 0 FOR 15000 FOR AVITA MEDICAL, INC. 05380C102 US05380C1027 06/03/2026 To elect seven directors to serve for a one-year term or until their respective successors have been duly elected and qualified; Jeremy Curnock Cook DIRECTOR ELECTIONS ISSUER 15000 0 FOR 15000 FOR AVITA MEDICAL, INC. 05380C102 US05380C1027 06/03/2026 To elect seven directors to serve for a one-year term or until their respective successors have been duly elected and qualified; Robert McNamara DIRECTOR ELECTIONS ISSUER 15000 0 FOR 15000 FOR AVITA MEDICAL, INC. 05380C102 US05380C1027 06/03/2026 To elect seven directors to serve for a one-year term or until their respective successors have been duly elected and qualified; Jan Stern Reed DIRECTOR ELECTIONS ISSUER 15000 0 FOR 15000 FOR AVITA MEDICAL, INC. 05380C102 US05380C1027 06/03/2026 To elect seven directors to serve for a one-year term or until their respective successors have been duly elected and qualified; Dr. Michael Tarnoff DIRECTOR ELECTIONS ISSUER 15000 0 FOR 15000 FOR AVITA MEDICAL, INC. 05380C102 US05380C1027 06/03/2026 To elect seven directors to serve for a one-year term or until their respective successors have been duly elected and qualified; Joseph Woody DIRECTOR ELECTIONS ISSUER 15000 0 FOR 15000 FOR AVITA MEDICAL, INC. 05380C102 US05380C1027 06/03/2026 To ratify the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026; AUDIT-RELATED ISSUER 15000 0 FOR 15000 FOR AVITA MEDICAL, INC. 05380C102 US05380C1027 06/03/2026 To approve, for the purposes of ASX Listing Rule 10.17 and the Company's Amended and Restated Bylaws and for all other purposes, that the maximum aggregate annual cash fee pool from which the non-executive Directors of the Company may be paid for their services on the Board be increased from US$750,000 per annum to US$900,000 per annum; COMPENSATION ISSUER 15000 0 FOR 15000 FOR AVITA MEDICAL, INC. 05380C102 US05380C1027 06/03/2026 To approve the grant of 22,214 restricted stock units to acquire shares of the Company's Common Stock and the grant of 16,133 options to acquire shares of Common Stock to Professor Suzanne Crowe on the terms and conditions set out in this Proxy Statement, pursuant to and for the purposes of ASX Listing Rule 10.11; CAPITAL STRUCTURE ISSUER 15000 0 FOR 15000 FOR AVITA MEDICAL, INC. 05380C102 US05380C1027 06/03/2026 To approve the grant of 22,214 restricted stock units to acquire shares of Common Stock and the grant of 16,133 options to acquire shares of Common Stock to Jeremy Curnock Cook on the terms and conditions set out in this Proxy Statement, pursuant to and for the purposes of ASX Listing Rule 10.11; CAPITAL STRUCTURE ISSUER 15000 0 FOR 15000 FOR AVITA MEDICAL, INC. 05380C102 US05380C1027 06/03/2026 To approve the grant of 22,214 restricted stock units to acquire shares of Common Stock and the grant of 16,133 options to acquire shares of Common Stock to Robert McNamara on the terms and conditions set out in this Proxy Statement, pursuant to and for the purposes of ASX Listing Rule 10.11; CAPITAL STRUCTURE ISSUER 15000 0 FOR 15000 FOR AVITA MEDICAL, INC. 05380C102 US05380C1027 06/03/2026 To approve the grant of 22,214 restricted stock units to acquire shares of Common Stock and the grant of 16,133 options to acquire shares of Common Stock to Jan Stern Reed on the terms and conditions set out in this Proxy Statement, pursuant to and for the purposes of ASX Listing Rule 10.11; CAPITAL STRUCTURE ISSUER 15000 0 FOR 15000 FOR AVITA MEDICAL, INC. 05380C102 US05380C1027 06/03/2026 To approve the grant of 26,250 restricted stock units to acquire shares of the Common Stock and the grant of 19,063 options to acquire shares of Common Stock to Dr. Michael Tarnoff on the terms and conditions set out in this Proxy Statement, pursuant to and for the purposes of ASX Listing Rule 10.11, in recognition of Dr. Tarnoff being appointed as a new non-executive Director of the Board effective August 6, 2025; CAPITAL STRUCTURE ISSUER 15000 0 FOR 15000 FOR AVITA MEDICAL, INC. 05380C102 US05380C1027 06/03/2026 To approve the grant of 22,214 restricted stock units to acquire shares of Common Stock and the grant of 16,133 options to acquire shares of Common Stock to Dr. Michael Tarnoff on the terms and conditions set out in this Proxy Statement, pursuant to and for the purposes of ASX Listing Rule 10.11; CAPITAL STRUCTURE ISSUER 15000 0 FOR 15000 FOR AVITA MEDICAL, INC. 05380C102 US05380C1027 06/03/2026 To approve the grant of 40,547 restricted stock units to acquire shares of the Common Stock and the grant of 29,446 options to acquire shares of Common Stock to Joseph Woody on the terms and conditions set out in this Proxy Statement, pursuant to and for the purposes of ASX Listing Rule 10.11, in recognition of Mr. Woody being appointed as a new non-executive Director of the Board effective January 1, 2026; CAPITAL STRUCTURE ISSUER 15000 0 FOR 15000 FOR AVITA MEDICAL, INC. 05380C102 US05380C1027 06/03/2026 To approve the grant of 22,214 restricted stock units to acquire shares of Common Stock and the grant of 16,133 options to acquire shares of Common Stock to Joseph Woody on the terms and conditions set out in this Proxy Statement, pursuant to and for the purposes of ASX Listing Rule 10.11; CAPITAL STRUCTURE ISSUER 15000 0 FOR 15000 FOR AVITA MEDICAL, INC. 05380C102 US05380C1027 06/03/2026 To approve, on an advisory basis, the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 15000 0 FOR 15000 FOR AVITA MEDICAL, INC. 05380C102 US05380C1027 06/03/2026 To approve, on an advisory basis, the frequency of future advisory votes on executive compensation; SECTION 14A SAY-ON-PAY VOTES ISSUER 15000 0 1 Year 15000 FOR AVITA MEDICAL, INC. 05380C102 US05380C1027 06/03/2026 To approve, for the purpose of ASX Listing Rule 7.1 and all other purposes, the issuance of a warrant or warrants covering up to 650,000 shares of Common Stock, with a term of ten years, to Perceptive Credit Holdings V, LP, pursuant to the Credit Agreement between the Company and Perceptive, dated January 13, 2026, on the terms and conditions set forth in this Proxy Statement; and CAPITAL STRUCTURE ISSUER 15000 0 FOR 15000 FOR AVITA MEDICAL, INC. 05380C102 US05380C1027 06/03/2026 To approve, for the purpose of ASX Listing Rule 7.1A and all other purposes, the issue of Equity Securities (as defined in ASX Listing Rule 19.2) up to 10% of the issued capital (at the time of issuance) of the Company, calculated in accordance with ASX Listing Rule 7.1A.2, and on the terms and conditions set forth in this Proxy Statement. CAPITAL STRUCTURE ISSUER 15000 0 FOR 15000 FOR AXSOME THERAPEUTICS, INC. 05464T104 US05464T1043 06/05/2026 Election of Director: 1. Mark Saad DIRECTOR ELECTIONS ISSUER 1000 0 FOR 1000 FOR AXSOME THERAPEUTICS, INC. 05464T104 US05464T1043 06/05/2026 Election of Director: 2. Susan Mahony, PhD., MBA DIRECTOR ELECTIONS ISSUER 1000 0 FOR 1000 FOR AXSOME THERAPEUTICS, INC. 05464T104 US05464T1043 06/05/2026 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1000 0 FOR 1000 FOR AXSOME THERAPEUTICS, INC. 05464T104 US05464T1043 06/05/2026 To approve, by non-binding advisory vote, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1000 0 FOR 1000 FOR BAUSCH + LOMB CORPORATION 071705107 CA0717051076 05/20/2026 Election of Directors Eduardo Alfonso DIRECTOR ELECTIONS ISSUER 144000 0 FOR 144000 FOR BAUSCH + LOMB CORPORATION 071705107 CA0717051076 05/20/2026 Election of Directors Nathalie Bernier DIRECTOR ELECTIONS ISSUER 144000 0 FOR 144000 FOR BAUSCH + LOMB CORPORATION 071705107 CA0717051076 05/20/2026 Election of Directors Steven H. Collis DIRECTOR ELECTIONS ISSUER 144000 0 FOR 144000 FOR BAUSCH + LOMB CORPORATION 071705107 CA0717051076 05/20/2026 Election of Directors Sarah B. Kavanagh DIRECTOR ELECTIONS ISSUER 144000 0 FOR 144000 FOR BAUSCH + LOMB CORPORATION 071705107 CA0717051076 05/20/2026 Election of Directors Karen L. Ling DIRECTOR ELECTIONS ISSUER 144000 0 FOR 144000 FOR BAUSCH + LOMB CORPORATION 071705107 CA0717051076 05/20/2026 Election of Directors John A. Paulson DIRECTOR ELECTIONS ISSUER 144000 0 FOR 144000 FOR BAUSCH + LOMB CORPORATION 071705107 CA0717051076 05/20/2026 Election of Directors Russel C. Robertson DIRECTOR ELECTIONS ISSUER 144000 0 FOR 144000 FOR BAUSCH + LOMB CORPORATION 071705107 CA0717051076 05/20/2026 Election of Directors Thomas W. Ross, Sr. DIRECTOR ELECTIONS ISSUER 144000 0 FOR 144000 FOR BAUSCH + LOMB CORPORATION 071705107 CA0717051076 05/20/2026 Election of Directors Brenton L. Saunders DIRECTOR ELECTIONS ISSUER 144000 0 FOR 144000 FOR BAUSCH + LOMB CORPORATION 071705107 CA0717051076 05/20/2026 Election of Directors Andrew C. von Eschenbach DIRECTOR ELECTIONS ISSUER 144000 0 FOR 144000 FOR BAUSCH + LOMB CORPORATION 071705107 CA0717051076 05/20/2026 The approval, in an advisory vote, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 144000 0 FOR 144000 FOR BAUSCH + LOMB CORPORATION 071705107 CA0717051076 05/20/2026 The approval of an amendment and restatement of the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan to increase the number of common shares authorized for issuance thereunder. COMPENSATION ISSUER 144000 0 AGAINST 144000 AGAINST BAUSCH + LOMB CORPORATION 071705107 CA0717051076 05/20/2026 The appointment of PricewaterhouseCoopers LLP to serve as the Company's auditor until the close of the 2027 Annual Meeting of Shareholders and to authorize the Board to fix the auditor's remuneration. AUDIT-RELATED ISSUER 144000 0 FOR 144000 FOR BAUSCH HEALTH COMPANIES INC. 071734107 CA0717341071 10/07/2025 The approval of the ordinary resolution ratifying the adoption of the Rights Agreement. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 17500 0 AGAINST 17500 AGAINST BAUSCH HEALTH COMPANIES INC. 071734107 CA0717341071 05/19/2026 Election of Directors Thomas J. Appio DIRECTOR ELECTIONS ISSUER 17500 0 FOR 17500 FOR BAUSCH HEALTH COMPANIES INC. 071734107 CA0717341071 05/19/2026 Election of Directors Christian A. Garcia DIRECTOR ELECTIONS ISSUER 17500 0 FOR 17500 FOR BAUSCH HEALTH COMPANIES INC. 071734107 CA0717341071 05/19/2026 Election of Directors Michael Goettler DIRECTOR ELECTIONS ISSUER 17500 0 FOR 17500 FOR BAUSCH HEALTH COMPANIES INC. 071734107 CA0717341071 05/19/2026 Election of Directors Sarah B. Kavanagh DIRECTOR ELECTIONS ISSUER 17500 0 FOR 17500 FOR BAUSCH HEALTH COMPANIES INC. 071734107 CA0717341071 05/19/2026 Election of Directors Frank D. Lee DIRECTOR ELECTIONS ISSUER 17500 0 FOR 17500 FOR BAUSCH HEALTH COMPANIES INC. 071734107 CA0717341071 05/19/2026 Election of Directors Sandra Leung DIRECTOR ELECTIONS ISSUER 17500 0 FOR 17500 FOR BAUSCH HEALTH COMPANIES INC. 071734107 CA0717341071 05/19/2026 Election of Directors John A. Paulson DIRECTOR ELECTIONS ISSUER 17500 0 FOR 17500 FOR BAUSCH HEALTH COMPANIES INC. 071734107 CA0717341071 05/19/2026 Election of Directors Robert N. Power DIRECTOR ELECTIONS ISSUER 17500 0 FOR 17500 FOR BAUSCH HEALTH COMPANIES INC. 071734107 CA0717341071 05/19/2026 Election of Directors Eiry W. Roberts, M.D. DIRECTOR ELECTIONS ISSUER 17500 0 FOR 17500 FOR BAUSCH HEALTH COMPANIES INC. 071734107 CA0717341071 05/19/2026 Election of Directors Amy B. Wechsler, M.D. DIRECTOR ELECTIONS ISSUER 17500 0 FOR 17500 FOR BAUSCH HEALTH COMPANIES INC. 071734107 CA0717341071 05/19/2026 The approval, in an advisory vote, of the compensation of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 17500 0 FOR 17500 FOR BAUSCH HEALTH COMPANIES INC. 071734107 CA0717341071 05/19/2026 The appointment of PricewaterhouseCoopers LLP to serve as the Company's auditor until the close of the 2027 Annual Meeting of Shareholders and to authorize the Board to fix the auditor's remuneration. AUDIT-RELATED ISSUER 17500 0 FOR 17500 FOR BAXTER INTERNATIONAL INC. 071813109 US0718131099 05/05/2026 Election of Directors William A. Ampofo II DIRECTOR ELECTIONS ISSUER 23000 0 FOR 23000 FOR BAXTER INTERNATIONAL INC. 071813109 US0718131099 05/05/2026 Election of Directors Jeffrey A. Craig DIRECTOR ELECTIONS ISSUER 23000 0 FOR 23000 FOR BAXTER INTERNATIONAL INC. 071813109 US0718131099 05/05/2026 Election of Directors Andrew P. Hider DIRECTOR ELECTIONS ISSUER 23000 0 FOR 23000 FOR BAXTER INTERNATIONAL INC. 071813109 US0718131099 05/05/2026 Election of Directors Michael R. McDonnell DIRECTOR ELECTIONS ISSUER 23000 0 FOR 23000 FOR BAXTER INTERNATIONAL INC. 071813109 US0718131099 05/05/2026 Election of Directors Patricia B. Morrison DIRECTOR ELECTIONS ISSUER 23000 0 FOR 23000 FOR BAXTER INTERNATIONAL INC. 071813109 US0718131099 05/05/2026 Election of Directors Nancy M. Schlichting DIRECTOR ELECTIONS ISSUER 23000 0 FOR 23000 FOR BAXTER INTERNATIONAL INC. 071813109 US0718131099 05/05/2026 Election of Directors Brent Shafer DIRECTOR ELECTIONS ISSUER 23000 0 FOR 23000 FOR BAXTER INTERNATIONAL INC. 071813109 US0718131099 05/05/2026 Election of Directors Amy A. Wendell DIRECTOR ELECTIONS ISSUER 23000 0 FOR 23000 FOR BAXTER INTERNATIONAL INC. 071813109 US0718131099 05/05/2026 Election of Directors David S. Wilkes, M.D. DIRECTOR ELECTIONS ISSUER 23000 0 FOR 23000 FOR BAXTER INTERNATIONAL INC. 071813109 US0718131099 05/05/2026 Advisory Vote to Approve Named Executive Officer Compensation for 2025 SECTION 14A SAY-ON-PAY VOTES ISSUER 23000 0 FOR 23000 FOR BAXTER INTERNATIONAL INC. 071813109 US0718131099 05/05/2026 Ratification of Appointment of Independent Registered Public Accounting Firm for 2026 AUDIT-RELATED ISSUER 23000 0 FOR 23000 FOR BAXTER INTERNATIONAL INC. 071813109 US0718131099 05/05/2026 Approval of the Baxter International Inc. Second Amended and Restated 2021 Incentive Plan COMPENSATION ISSUER 23000 0 AGAINST 23000 AGAINST BAXTER INTERNATIONAL INC. 071813109 US0718131099 05/05/2026 Approval of Amendment to the Baxter International Inc. Amended and Restated Certificate of Incorporation to Amend Board Size AUDIT-RELATED ISSUER 23000 0 ABSTAIN 23000 AGAINST BECTON, DICKINSON AND COMPANY 075887109 US0758871091 01/27/2026 Election of Directors: William M. Brown DIRECTOR ELECTIONS ISSUER 8700 0 FOR 8700 FOR BECTON, DICKINSON AND COMPANY 075887109 US0758871091 01/27/2026 Election of Directors: Carrie L. Byington DIRECTOR ELECTIONS ISSUER 8700 0 FOR 8700 FOR BECTON, DICKINSON AND COMPANY 075887109 US0758871091 01/27/2026 Election of Directors: R. Andrew Eckert DIRECTOR ELECTIONS ISSUER 8700 0 FOR 8700 FOR BECTON, DICKINSON AND COMPANY 075887109 US0758871091 01/27/2026 Election of Directors: Claire M. Fraser DIRECTOR ELECTIONS ISSUER 8700 0 FOR 8700 FOR BECTON, DICKINSON AND COMPANY 075887109 US0758871091 01/27/2026 Election of Directors: Gregory J. Hayes DIRECTOR ELECTIONS ISSUER 8700 0 FOR 8700 FOR BECTON, DICKINSON AND COMPANY 075887109 US0758871091 01/27/2026 Election of Directors: Jeffrey W. Henderson DIRECTOR ELECTIONS ISSUER 8700 0 FOR 8700 FOR BECTON, DICKINSON AND COMPANY 075887109 US0758871091 01/27/2026 Election of Directors: Robert L. Huffines DIRECTOR ELECTIONS ISSUER 8700 0 FOR 8700 FOR BECTON, DICKINSON AND COMPANY 075887109 US0758871091 01/27/2026 Election of Directors: Christopher Jones DIRECTOR ELECTIONS ISSUER 8700 0 FOR 8700 FOR BECTON, DICKINSON AND COMPANY 075887109 US0758871091 01/27/2026 Election of Directors: Thomas E. Polen DIRECTOR ELECTIONS ISSUER 8700 0 FOR 8700 FOR BECTON, DICKINSON AND COMPANY 075887109 US0758871091 01/27/2026 Election of Directors: Timothy M. Ring DIRECTOR ELECTIONS ISSUER 8700 0 FOR 8700 FOR BECTON, DICKINSON AND COMPANY 075887109 US0758871091 01/27/2026 Election of Directors: Bertram L. Scott DIRECTOR ELECTIONS ISSUER 8700 0 FOR 8700 FOR BECTON, DICKINSON AND COMPANY 075887109 US0758871091 01/27/2026 Election of Directors: Joanne Waldstreicher DIRECTOR ELECTIONS ISSUER 8700 0 FOR 8700 FOR BECTON, DICKINSON AND COMPANY 075887109 US0758871091 01/27/2026 Election of Directors: Jacqueline Wright DIRECTOR ELECTIONS ISSUER 8700 0 FOR 8700 FOR BECTON, DICKINSON AND COMPANY 075887109 US0758871091 01/27/2026 Ratification of the selection of the independent registered public accounting firm AUDIT-RELATED ISSUER 8700 0 FOR 8700 FOR BECTON, DICKINSON AND COMPANY 075887109 US0758871091 01/27/2026 Advisory vote to approve named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 8700 0 FOR 8700 FOR BECTON, DICKINSON AND COMPANY 075887109 US0758871091 01/27/2026 Approval of an amendment to the 2004 Employee and Director Equity-Based Compensation Plan COMPENSATION ISSUER 8700 0 FOR 8700 FOR BELLRING BRANDS, INC. 07831C103 US07831C1036 01/28/2026 Election of Directors: Robert V. Vitale DIRECTOR ELECTIONS ISSUER 80000 0 FOR 80000 FOR BELLRING BRANDS, INC. 07831C103 US07831C1036 01/28/2026 Election of Directors: Darcy Horn Davenport DIRECTOR ELECTIONS ISSUER 80000 0 FOR 80000 FOR BELLRING BRANDS, INC. 07831C103 US07831C1036 01/28/2026 Election of Directors: David I. Finkelstein DIRECTOR ELECTIONS ISSUER 80000 0 FOR 80000 FOR BELLRING BRANDS, INC. 07831C103 US07831C1036 01/28/2026 Election of Directors: Chonda J. Nwamu DIRECTOR ELECTIONS ISSUER 80000 0 FOR 80000 FOR BELLRING BRANDS, INC. 07831C103 US07831C1036 01/28/2026 Election of Directors: Elliot H. Stein, Jr. DIRECTOR ELECTIONS ISSUER 80000 0 FOR 80000 FOR BELLRING BRANDS, INC. 07831C103 US07831C1036 01/28/2026 The ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending September 30, 2026. AUDIT-RELATED ISSUER 80000 0 FOR 80000 FOR BELLRING BRANDS, INC. 07831C103 US07831C1036 01/28/2026 To consider and vote, on an advisory basis, for the adoption of a resolution approving the compensation of our named executive officers, as such compensation is described under the "Compensation Discussion and Analysis" and "Executive Compensation" sections of this proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 80000 0 FOR 80000 FOR BICARA THERAPEUTICS INC. 055477103 US0554771032 06/09/2026 To elect two class II directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal. Christopher Bowden, M.D. DIRECTOR ELECTIONS ISSUER 650 0 FOR 650 FOR BICARA THERAPEUTICS INC. 055477103 US0554771032 06/09/2026 To elect two class II directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal. Carolyn Ng, Ph.D. DIRECTOR ELECTIONS ISSUER 650 0 FOR 650 FOR BICARA THERAPEUTICS INC. 055477103 US0554771032 06/09/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026; AUDIT-RELATED ISSUER 650 0 FOR 650 FOR BIO-RAD LABORATORIES, INC. 090572207 US0905722072 04/21/2026 Nominees: Melinda Litherland DIRECTOR ELECTIONS ISSUER 3900 0 FOR 3900 FOR BIO-RAD LABORATORIES, INC. 090572207 US0905722072 04/21/2026 Nominees: Arnold A. Pinkston DIRECTOR ELECTIONS ISSUER 3900 0 FOR 3900 FOR BIO-RAD LABORATORIES, INC. 090572207 US0905722072 04/21/2026 Proposal to ratify the selection of KPMG LLP to serve as the Company's independent auditors. AUDIT-RELATED ISSUER 3900 0 FOR 3900 FOR BIO-RAD LABORATORIES, INC. 090572207 US0905722072 04/21/2026 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 3900 0 FOR 3900 FOR BIO-RAD LABORATORIES, INC. 090572207 US0905722072 04/21/2026 Approval of the Amended Bio-Rad Laboratories, Inc. 2017 Incentive Award Plan. COMPENSATION ISSUER 3900 0 FOR 3900 FOR BIO-RAD LABORATORIES, INC. 090572207 US0905722072 04/21/2026 Stockholder proposal regarding dual class capital structure. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 3900 0 AGAINST 3900 FOR BOSTON SCIENTIFIC CORPORATION 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors. David C. Habiger DIRECTOR ELECTIONS ISSUER 6000 0 FOR 6000 FOR BOSTON SCIENTIFIC CORPORATION 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors. Edward J. Ludwig DIRECTOR ELECTIONS ISSUER 6000 0 FOR 6000 FOR BOSTON SCIENTIFIC CORPORATION 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors. Michael F. Mahoney DIRECTOR ELECTIONS ISSUER 6000 0 FOR 6000 FOR BOSTON SCIENTIFIC CORPORATION 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors. Jessica L. Mega DIRECTOR ELECTIONS ISSUER 6000 0 FOR 6000 FOR BOSTON SCIENTIFIC CORPORATION 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors. Susan E. Morano DIRECTOR ELECTIONS ISSUER 6000 0 FOR 6000 FOR BOSTON SCIENTIFIC CORPORATION 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors. Cheryl Pegus DIRECTOR ELECTIONS ISSUER 6000 0 FOR 6000 FOR BOSTON SCIENTIFIC CORPORATION 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors. Cathy R. Smith DIRECTOR ELECTIONS ISSUER 6000 0 FOR 6000 FOR BOSTON SCIENTIFIC CORPORATION 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors. Christophe P. Weber DIRECTOR ELECTIONS ISSUER 6000 0 FOR 6000 FOR BOSTON SCIENTIFIC CORPORATION 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors. David S. Wichmann DIRECTOR ELECTIONS ISSUER 6000 0 FOR 6000 FOR BOSTON SCIENTIFIC CORPORATION 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors. Ellen M. Zane DIRECTOR ELECTIONS ISSUER 6000 0 FOR 6000 FOR BOSTON SCIENTIFIC CORPORATION 101137107 US1011371077 04/30/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 6000 0 FOR 6000 FOR BOSTON SCIENTIFIC CORPORATION 101137107 US1011371077 04/30/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2026 fiscal year. AUDIT-RELATED ISSUER 6000 0 FOR 6000 FOR BOSTON SCIENTIFIC CORPORATION 101137107 US1011371077 04/30/2026 To amend our Employee Stock Purchase Plan to increase the number of shares reserved for issuance. CAPITAL STRUCTURE ISSUER 6000 0 FOR 6000 FOR BOSTON SCIENTIFIC CORPORATION 101137107 US1011371077 04/30/2026 To amend our Certificate of Incorporation to remove supermajority voting provisions. CORPORATE GOVERNANCE ISSUER 6000 0 FOR 6000 FOR BOSTON SCIENTIFIC CORPORATION 101137107 US1011371077 04/30/2026 To amend our Certificate of Incorporation to provide for exculpation of certain officers as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 6000 0 FOR 6000 FOR BOSTON SCIENTIFIC CORPORATION 101137107 US1011371077 04/30/2026 To amend our Certificate of Incorporation and By-Laws to permit stockholders holding 25% of our common stock to call a special meeting of stockholders. CORPORATE GOVERNANCE ISSUER 6000 0 FOR 6000 FOR BOSTON SCIENTIFIC CORPORATION 101137107 US1011371077 04/30/2026 Stockholder proposal titled "Give Shareholders the Ability to Call for a Special Shareholder Meeting." CORPORATE GOVERNANCE SECURITY HOLDER 6000 0 AGAINST 6000 FOR BRIDGEBIO PHARMA, INC. 10806X102 US10806X1028 06/22/2026 Election of Director: 1. James C. Momtazee DIRECTOR ELECTIONS ISSUER 51000 0 FOR 51000 FOR BRIDGEBIO PHARMA, INC. 10806X102 US10806X1028 06/22/2026 Election of Director: 2. Frank P. McCormick, PhD DIRECTOR ELECTIONS ISSUER 51000 0 FOR 51000 FOR BRIDGEBIO PHARMA, INC. 10806X102 US10806X1028 06/22/2026 Election of Director: 3. Hannah A. Valantine, MD DIRECTOR ELECTIONS ISSUER 51000 0 FOR 51000 FOR BRIDGEBIO PHARMA, INC. 10806X102 US10806X1028 06/22/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 51000 0 FOR 51000 FOR BRIDGEBIO PHARMA, INC. 10806X102 US10806X1028 06/22/2026 To conduct a non-binding advisory vote on the frequency of future non-binding advisory votes to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 51000 0 1 Year 51000 FOR BRIDGEBIO PHARMA, INC. 10806X102 US10806X1028 06/22/2026 To ratify the selection of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 51000 0 FOR 51000 FOR BRIDGEBIO PHARMA, INC. 10806X102 US10806X1028 06/22/2026 To approve an amendment and restatement of the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 2,000,000 shares. COMPENSATION ISSUER 51000 0 AGAINST 51000 AGAINST BRIGHTSPRING HEALTH SERVICES, INC. 10950A106 US10950A1060 05/21/2026 Election of Class II directors Olivia Kirtley DIRECTOR ELECTIONS ISSUER 11150 0 FOR 11150 FOR BRIGHTSPRING HEALTH SERVICES, INC. 10950A106 US10950A1060 05/21/2026 Election of Class II directors Max Lin DIRECTOR ELECTIONS ISSUER 11150 0 FOR 11150 FOR BRIGHTSPRING HEALTH SERVICES, INC. 10950A106 US10950A1060 05/21/2026 Election of Class II directors Steve Miller DIRECTOR ELECTIONS ISSUER 11150 0 FOR 11150 FOR BRIGHTSPRING HEALTH SERVICES, INC. 10950A106 US10950A1060 05/21/2026 Ratification of the appointment of KPMG LLP as the independent accounting firm for the year ending December 31, 2026 AUDIT-RELATED ISSUER 11150 0 FOR 11150 FOR BRIGHTSPRING HEALTH SERVICES, INC. 10950A106 US10950A1060 05/21/2026 Advisory vote on executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 11150 0 FOR 11150 FOR BRISTOL-MYERS SQUIBB COMPANY 110122108 US1101221083 05/05/2026 Election of Directors Peter J. Arduini DIRECTOR ELECTIONS ISSUER 45000 0 FOR 45000 FOR BRISTOL-MYERS SQUIBB COMPANY 110122108 US1101221083 05/05/2026 Election of Directors Deepak L. Bhatt, M.D., M.P.H., M.B.A. DIRECTOR ELECTIONS ISSUER 45000 0 FOR 45000 FOR BRISTOL-MYERS SQUIBB COMPANY 110122108 US1101221083 05/05/2026 Election of Directors Christopher S. Boerner, Ph.D. DIRECTOR ELECTIONS ISSUER 45000 0 FOR 45000 FOR BRISTOL-MYERS SQUIBB COMPANY 110122108 US1101221083 05/05/2026 Election of Directors Julia A. Haller, M.D. DIRECTOR ELECTIONS ISSUER 45000 0 FOR 45000 FOR BRISTOL-MYERS SQUIBB COMPANY 110122108 US1101221083 05/05/2026 Election of Directors Manuel Hidalgo Medina, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 45000 0 FOR 45000 FOR BRISTOL-MYERS SQUIBB COMPANY 110122108 US1101221083 05/05/2026 Election of Directors Michael R. McMullen DIRECTOR ELECTIONS ISSUER 45000 0 FOR 45000 FOR BRISTOL-MYERS SQUIBB COMPANY 110122108 US1101221083 05/05/2026 Election of Directors Paula A. Price DIRECTOR ELECTIONS ISSUER 45000 0 FOR 45000 FOR BRISTOL-MYERS SQUIBB COMPANY 110122108 US1101221083 05/05/2026 Election of Directors Derica W. Rice DIRECTOR ELECTIONS ISSUER 45000 0 FOR 45000 FOR BRISTOL-MYERS SQUIBB COMPANY 110122108 US1101221083 05/05/2026 Election of Directors Theodore R. Samuels DIRECTOR ELECTIONS ISSUER 45000 0 FOR 45000 FOR BRISTOL-MYERS SQUIBB COMPANY 110122108 US1101221083 05/05/2026 Election of Directors Karen H. Vousden, Ph.D. DIRECTOR ELECTIONS ISSUER 45000 0 FOR 45000 FOR BRISTOL-MYERS SQUIBB COMPANY 110122108 US1101221083 05/05/2026 Election of Directors Phyllis R. Yale DIRECTOR ELECTIONS ISSUER 45000 0 FOR 45000 FOR BRISTOL-MYERS SQUIBB COMPANY 110122108 US1101221083 05/05/2026 Advisory Vote to Approve the Compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES ISSUER 45000 0 FOR 45000 FOR BRISTOL-MYERS SQUIBB COMPANY 110122108 US1101221083 05/05/2026 Vote to Approve the Company's 2026 Stock Award and Incentive Plan COMPENSATION ISSUER 45000 0 FOR 45000 FOR BRISTOL-MYERS SQUIBB COMPANY 110122108 US1101221083 05/05/2026 Ratification of the Appointment of an Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 45000 0 FOR 45000 FOR BRISTOL-MYERS SQUIBB COMPANY 110122108 US1101221083 05/05/2026 Shareholder Proposal on the Adoption of a Board Policy that the Chairperson of the Board be an Independent Director CORPORATE GOVERNANCE SECURITY HOLDER 45000 0 AGAINST 45000 FOR BRUKER CORPORATION 116794108 US1167941087 05/21/2026 Election of Director: 1. John J. (Jack) Phillips DIRECTOR ELECTIONS ISSUER 2000 0 FOR 2000 FOR BRUKER CORPORATION 116794108 US1167941087 05/21/2026 Election of Director: 2. Hermann F. Requardt PhD DIRECTOR ELECTIONS ISSUER 2000 0 FOR 2000 FOR BRUKER CORPORATION 116794108 US1167941087 05/21/2026 Election of Director: 3. Laura A. Francis DIRECTOR ELECTIONS ISSUER 2000 0 FOR 2000 FOR BRUKER CORPORATION 116794108 US1167941087 05/21/2026 Approval on an advisory basis of the 2025 compensation of our named executive officers, as discussed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 2000 0 FOR 2000 FOR BRUKER CORPORATION 116794108 US1167941087 05/21/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as our Independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2000 0 FOR 2000 FOR CALAVO GROWERS, INC. 128246105 US1282461052 04/28/2026 The Merger Agreement Proposal - A proposal to approve the agreement and plan of merger, dated as of January 14, 2026 (the ''Merger Agreement''), by and among Calavo Growers, Inc., a California corporation (''Calavo''), Mission Produce, Inc., a Delaware corporation (''Mission Produce''), Cantaloupe Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of Mission Produce (''Merger Sub I''), and Cantaloupe Merger Sub II, LLC, a Delaware limited liability company and wholly owned subsidiary of Mission Produce, pursuant to which Merger Sub I will merge with and into Calavo (''First Merger''), with Calavo surviving the First Merger CORPORATE GOVERNANCE ISSUER 5000 0 FOR 5000 FOR CALAVO GROWERS, INC. 128246105 US1282461052 04/28/2026 The Merger-Related Compensation Proposal - A non-binding, advisory proposal to approve compensation that will or may become payable by Calavo to its named executive officers in connection with the transactions contemplated by the Merger Agreement. SECTION 14A SAY-ON-PAY VOTES ISSUER 5000 0 FOR 5000 FOR CALAVO GROWERS, INC. 128246105 US1282461052 04/28/2026 The Calavo Adjournment Proposal - A proposal to approve the adjournment of the special meeting of shareholders of Calavo from time to time to a later date or dates, if necessary or appropriate, to solicit additional proxies in favor of the Merger Agreement Proposal if there are insufficient votes at the time of such adjournment to approve the Merger Agreement Proposal. CORPORATE GOVERNANCE ISSUER 5000 0 FOR 5000 FOR CELCUITY INC. 15102K100 US15102K1007 05/14/2026 Election of Director: 1. Richard E. Buller DIRECTOR ELECTIONS ISSUER 1500 0 FOR 1500 FOR CELCUITY INC. 15102K100 US15102K1007 05/14/2026 Election of Director: 2. David F. Dalvey DIRECTOR ELECTIONS ISSUER 1500 0 FOR 1500 FOR CELCUITY INC. 15102K100 US15102K1007 05/14/2026 Election of Director: 3. Leo T. Furcht DIRECTOR ELECTIONS ISSUER 1500 0 FOR 1500 FOR CELCUITY INC. 15102K100 US15102K1007 05/14/2026 Election of Director: 4. Lance G. Laing DIRECTOR ELECTIONS ISSUER 1500 0 FOR 1500 FOR CELCUITY INC. 15102K100 US15102K1007 05/14/2026 Election of Director: 5. Polly A. Murphy DIRECTOR ELECTIONS ISSUER 1500 0 FOR 1500 FOR CELCUITY INC. 15102K100 US15102K1007 05/14/2026 Election of Director: 6. Richard J. Nigon DIRECTOR ELECTIONS ISSUER 1500 0 FOR 1500 FOR CELCUITY INC. 15102K100 US15102K1007 05/14/2026 Election of Director: 7. Charles R. Romp DIRECTOR ELECTIONS ISSUER 1500 0 FOR 1500 FOR CELCUITY INC. 15102K100 US15102K1007 05/14/2026 Election of Director: 8. Brian F. Sullivan DIRECTOR ELECTIONS ISSUER 1500 0 FOR 1500 FOR CELCUITY INC. 15102K100 US15102K1007 05/14/2026 To ratify the appointment of Boulay PLLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1500 0 FOR 1500 FOR CELCUITY INC. 15102K100 US15102K1007 05/14/2026 To approve, on an advisory basis, named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1500 0 FOR 1500 FOR CELCUITY INC. 15102K100 US15102K1007 05/14/2026 To approve the Celcuity Inc. 2026 Stock Incentive Plan. COMPENSATION ISSUER 1500 0 AGAINST 1500 AGAINST CELCUITY INC. 15102K100 US15102K1007 05/14/2026 To approve the Celcuity Inc. Amended and Restated Employee Stock Purchase Plan. CAPITAL STRUCTURE ISSUER 1500 0 ABSTAIN 1500 AGAINST CENCORA, INC. 03073E105 US03073E1055 03/05/2026 Election of eleven directors. Werner Baumann DIRECTOR ELECTIONS ISSUER 10100 0 FOR 10100 FOR CENCORA, INC. 03073E105 US03073E1055 03/05/2026 Election of eleven directors. Frank K. Clyburn DIRECTOR ELECTIONS ISSUER 10100 0 FOR 10100 FOR CENCORA, INC. 03073E105 US03073E1055 03/05/2026 Election of eleven directors. Ellen G. Cooper DIRECTOR ELECTIONS ISSUER 10100 0 FOR 10100 FOR CENCORA, INC. 03073E105 US03073E1055 03/05/2026 Election of eleven directors. D. Mark Durcan DIRECTOR ELECTIONS ISSUER 10100 0 FOR 10100 FOR CENCORA, INC. 03073E105 US03073E1055 03/05/2026 Election of eleven directors. Lon R. Greenberg DIRECTOR ELECTIONS ISSUER 10100 0 FOR 10100 FOR CENCORA, INC. 03073E105 US03073E1055 03/05/2026 Election of eleven directors. Lorence H. Kim, M.D. DIRECTOR ELECTIONS ISSUER 10100 0 FOR 10100 FOR CENCORA, INC. 03073E105 US03073E1055 03/05/2026 Election of eleven directors. Robert P. Mauch DIRECTOR ELECTIONS ISSUER 10100 0 FOR 10100 FOR CENCORA, INC. 03073E105 US03073E1055 03/05/2026 Election of eleven directors. Redonda G. Miller, M.D. DIRECTOR ELECTIONS ISSUER 10100 0 FOR 10100 FOR CENCORA, INC. 03073E105 US03073E1055 03/05/2026 Election of eleven directors. Dennis M. Nally DIRECTOR ELECTIONS ISSUER 10100 0 FOR 10100 FOR CENCORA, INC. 03073E105 US03073E1055 03/05/2026 Election of eleven directors. Lori J. Ryerkerk DIRECTOR ELECTIONS ISSUER 10100 0 FOR 10100 FOR CENCORA, INC. 03073E105 US03073E1055 03/05/2026 Election of eleven directors. Lauren M. Tyler DIRECTOR ELECTIONS ISSUER 10100 0 FOR 10100 FOR CENCORA, INC. 03073E105 US03073E1055 03/05/2026 Advisory vote to approve the fiscal 2025 compensation of Cencora, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 10100 0 FOR 10100 FOR CENCORA, INC. 03073E105 US03073E1055 03/05/2026 Ratify the appointment of Ernst & Young LLP as Cencora, Inc.'s independent registered public accounting firm for fiscal 2026. AUDIT-RELATED ISSUER 10100 0 FOR 10100 FOR CENTESSA PHARMACEUTICALS PLC 152309100 US1523091007 06/12/2026 For the purposes of giving effect to the Scheme: (a) to authorise the directors of the Company (or a duly authorised committee thereof) to take all such actions as they may consider necessary or appropriate for carrying the Scheme into effect; and (b) with effect from the passing of this resolution, to amend the articles of association of the Company as set out in the Notice of General Meeting. EXTRAORDINARY TRANSACTIONS ISSUER 7500 0 FOR 7500 FOR CENTESSA PHARMACEUTICALS PLC 152309100 US1523091007 06/12/2026 To re-appoint as a director Brett Zbar, M.D., who retires by rotation in accordance with the Company's articles of association. OTHER ISSUER 7500 0 FOR 7500 FOR CENTESSA PHARMACEUTICALS PLC 152309100 US1523091007 06/12/2026 To re-appoint as a director Mathias Hukkelhoven, Ph.D, who retires by rotation in accordance with the Company's articles of association. OTHER ISSUER 7500 0 FOR 7500 FOR CENTESSA PHARMACEUTICALS PLC 152309100 US1523091007 06/12/2026 To re-appoint KPMG LLP, a United Kingdom entity, as UK statutory auditors of the Company, to hold office until the conclusion of the next meeting at which the Company's annual accounts and reports are laid before the Company. OTHER ISSUER 7500 0 FOR 7500 FOR CENTESSA PHARMACEUTICALS PLC 152309100 US1523091007 06/12/2026 To ratify the re-appointment of KPMG LLP, a Delaware limited liability partnership, as the Company's independent registered public accounting firm, for the financial year ending December 31, 2026. OTHER ISSUER 7500 0 FOR 7500 FOR CENTESSA PHARMACEUTICALS PLC 152309100 US1523091007 06/12/2026 To authorize the Audit Committee to determine the Company's auditors' remuneration for the financial year ending December 31, 2026. OTHER ISSUER 7500 0 FOR 7500 FOR CENTESSA PHARMACEUTICALS PLC 152309100 US1523091007 06/12/2026 To receive and adopt our UK statutory annual accounts and reports for the financial year ended December 31, 2025 and to note that the Company's directors do not recommend the payment of any dividend for the financial year ended December 31, 2025. OTHER ISSUER 7500 0 FOR 7500 FOR CENTESSA PHARMACEUTICALS PLC 152309100 US1523091007 06/12/2026 To receive and approve, on an advisory basis, the Company's UK statutory directors' remuneration report for the financial year ended December 31, 2025, which is set forth as Annex A to the attached proxy statement. OTHER ISSUER 7500 0 FOR 7500 FOR CENTESSA PHARMACEUTICALS PLC 152309100 US1523091007 06/12/2026 To approve the Scheme of Arrangement. OTHER ISSUER 7500 0 FOR 7500 FOR CENTESSA PHARMACEUTICALS PLC 152309100 US1523091007 06/12/2026 For the purposes of giving effect to the Scheme: (a) to authorise the directors of the Company (or a duly authorised committee thereof) to take all such actions as they may consider necessary or appropriate for carrying the Scheme into effect; and (b) with effect from the passing of this resolution, to amend the articles of association of the Company as set out in the Notice of General Meeting. EXTRAORDINARY TRANSACTIONS ISSUER 7500 0 FOR 7500 FOR CHARLES RIVER LABORATORIES INTL., INC. 159864107 US1598641074 05/05/2026 Election of Directors: Nancy C. Andrews DIRECTOR ELECTIONS ISSUER 1500 0 FOR 1500 FOR CHARLES RIVER LABORATORIES INTL., INC. 159864107 US1598641074 05/05/2026 Election of Directors: Steven Barg DIRECTOR ELECTIONS ISSUER 1500 0 FOR 1500 FOR CHARLES RIVER LABORATORIES INTL., INC. 159864107 US1598641074 05/05/2026 Election of Directors: Abraham Ceesay DIRECTOR ELECTIONS ISSUER 1500 0 FOR 1500 FOR CHARLES RIVER LABORATORIES INTL., INC. 159864107 US1598641074 05/05/2026 Election of Directors: Mark Enyedy DIRECTOR ELECTIONS ISSUER 1500 0 FOR 1500 FOR CHARLES RIVER LABORATORIES INTL., INC. 159864107 US1598641074 05/05/2026 Election of Directors: James C. Foster DIRECTOR ELECTIONS ISSUER 1500 0 FOR 1500 FOR CHARLES RIVER LABORATORIES INTL., INC. 159864107 US1598641074 05/05/2026 Election of Directors: Birgit Girshick DIRECTOR ELECTIONS ISSUER 1500 0 FOR 1500 FOR CHARLES RIVER LABORATORIES INTL., INC. 159864107 US1598641074 05/05/2026 Election of Directors: Paul Graves DIRECTOR ELECTIONS ISSUER 1500 0 FOR 1500 FOR CHARLES RIVER LABORATORIES INTL., INC. 159864107 US1598641074 05/05/2026 Election of Directors: Reshema Kemps-Polanco DIRECTOR ELECTIONS ISSUER 1500 0 FOR 1500 FOR CHARLES RIVER LABORATORIES INTL., INC. 159864107 US1598641074 05/05/2026 Election of Directors: George Llado DIRECTOR ELECTIONS ISSUER 1500 0 FOR 1500 FOR CHARLES RIVER LABORATORIES INTL., INC. 159864107 US1598641074 05/05/2026 Election of Directors: Martin Mackay DIRECTOR ELECTIONS ISSUER 1500 0 FOR 1500 FOR CHARLES RIVER LABORATORIES INTL., INC. 159864107 US1598641074 05/05/2026 Election of Directors: Craig B. Thompson DIRECTOR ELECTIONS ISSUER 1500 0 FOR 1500 FOR CHARLES RIVER LABORATORIES INTL., INC. 159864107 US1598641074 05/05/2026 Election of Directors: Virginia Wilson DIRECTOR ELECTIONS ISSUER 1500 0 FOR 1500 FOR CHARLES RIVER LABORATORIES INTL., INC. 159864107 US1598641074 05/05/2026 Advisory Approval of 2025 Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 1500 0 FOR 1500 FOR CHARLES RIVER LABORATORIES INTL., INC. 159864107 US1598641074 05/05/2026 2026 Long-Term Incentive Plan COMPENSATION ISSUER 1500 0 ABSTAIN 1500 AGAINST CHARLES RIVER LABORATORIES INTL., INC. 159864107 US1598641074 05/05/2026 Ratification of Pricewaterhousecoopers LLC as independent registered public accounting firm for 2026 AUDIT-RELATED ISSUER 1500 0 FOR 1500 FOR CHEMED CORPORATION 16359R103 US16359R1032 05/18/2026 Election of directors: Kevin J. McNamara DIRECTOR ELECTIONS ISSUER 6500 0 FOR 6500 FOR CHEMED CORPORATION 16359R103 US16359R1032 05/18/2026 Election of directors: Ron DeLyons DIRECTOR ELECTIONS ISSUER 6500 0 FOR 6500 FOR CHEMED CORPORATION 16359R103 US16359R1032 05/18/2026 Election of directors: Patrick P. Grace DIRECTOR ELECTIONS ISSUER 6500 0 FOR 6500 FOR CHEMED CORPORATION 16359R103 US16359R1032 05/18/2026 Election of directors: Christopher J. Heaney DIRECTOR ELECTIONS ISSUER 6500 0 FOR 6500 FOR CHEMED CORPORATION 16359R103 US16359R1032 05/18/2026 Election of directors: Thomas C. Hutton DIRECTOR ELECTIONS ISSUER 6500 0 FOR 6500 FOR CHEMED CORPORATION 16359R103 US16359R1032 05/18/2026 Election of directors: Andrea R. Lindell DIRECTOR ELECTIONS ISSUER 6500 0 FOR 6500 FOR CHEMED CORPORATION 16359R103 US16359R1032 05/18/2026 Election of directors: Eileen P. McCarthy DIRECTOR ELECTIONS ISSUER 6500 0 FOR 6500 FOR CHEMED CORPORATION 16359R103 US16359R1032 05/18/2026 Election of directors: John M. Mount, Jr. DIRECTOR ELECTIONS ISSUER 6500 0 FOR 6500 FOR CHEMED CORPORATION 16359R103 US16359R1032 05/18/2026 Election of directors: George J. Walsh III DIRECTOR ELECTIONS ISSUER 6500 0 FOR 6500 FOR CHEMED CORPORATION 16359R103 US16359R1032 05/18/2026 Ratification of Audit Committee's selection of PricewaterhouseCoopers LLP as independent accountants for 2026. AUDIT-RELATED ISSUER 6500 0 FOR 6500 FOR CHEMED CORPORATION 16359R103 US16359R1032 05/18/2026 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 6500 0 FOR 6500 FOR CHINA MENGNIU DAIRY CO LTD G21096105 KYG210961051 06/05/2026 TO REVIEW AND CONSIDER THE AUDITED FINANCIAL STATEMENTS AND THE REPORTS OF THE DIRECTORS AND THE INDEPENDENT AUDITORS FOR THE YEAR ENDED 31 DECEMBER 2025 OTHER ISSUER 50000 0 FOR 50000 FOR CHINA MENGNIU DAIRY CO LTD G21096105 KYG210961051 06/05/2026 TO APPROVE THE PROPOSED FINAL DIVIDEND OF RMB0.52 PER SHARE FOR THE YEAR ENDED 31 DECEMBER 2025 CAPITAL STRUCTURE ISSUER 50000 0 FOR 50000 FOR CHINA MENGNIU DAIRY CO LTD G21096105 KYG210961051 06/05/2026 TO RE-ELECT MR. GAO FEI AS DIRECTOR AND AUTHORISE THE BOARD OF DIRECTORS OF THE COMPANY TO FIX HIS REMUNERATION COMPENSATION ISSUER 50000 0 FOR 50000 FOR CHINA MENGNIU DAIRY CO LTD G21096105 KYG210961051 06/05/2026 TO RE-ELECT MR. GU JUN AS DIRECTOR AND AUTHORISE THE BOARD OF DIRECTORS OF THE COMPANY TO FIX HIS REMUNERATION COMPENSATION ISSUER 50000 0 FOR 50000 FOR CHINA MENGNIU DAIRY CO LTD G21096105 KYG210961051 06/05/2026 TO RE-ELECT MR. SHEN XINWEN AS DIRECTOR AND AUTHORISE THE BOARD OF DIRECTORS OF THE COMPANY TO FIX HIS REMUNERATION COMPENSATION ISSUER 50000 0 FOR 50000 FOR CHINA MENGNIU DAIRY CO LTD G21096105 KYG210961051 06/05/2026 TO RE-APPOINT KPMG AS THE AUDITORS OF THE COMPANY AND AUTHORISE THE BOARD OF DIRECTORS OF THE COMPANY TO FIX THEIR REMUNERATION FOR THE YEAR ENDING 31 DECEMBER 2026 AUDIT-RELATED ISSUER 50000 0 FOR 50000 FOR CHINA MENGNIU DAIRY CO LTD G21096105 KYG210961051 06/05/2026 ORDINARY RESOLUTION NO. 5 SET OUT IN THE NOTICE OF AGM (TO GIVE A GENERAL MANDATE TO THE DIRECTORS TO REPURCHASE SHARES IN THE COMPANY NOT EXCEEDING 10% OF ITS ISSUED SHARE CAPITAL OF THE COMPANY) CAPITAL STRUCTURE ISSUER 50000 0 FOR 50000 FOR CHINA MENGNIU DAIRY CO LTD G21096105 KYG210961051 06/05/2026 ORDINARY RESOLUTION NO. 6 SET OUT IN THE NOTICE OF AGM (TO GIVE A GENERAL MANDATE TO THE DIRECTORS TO ALLOT, ISSUE AND DEAL WITH ADDITIONAL SHARES NOT EXCEEDING 10% OF THE ISSUED SHARE CAPITAL OF THE COMPANY AND AT A DISCOUNT OF NOT MORE THAN 10% TO THE BENCHMARKED PRICE (AS DEFINED IN THE NOTICE OF AGM)) CAPITAL STRUCTURE ISSUER 50000 0 FOR 50000 FOR CHURCH & DWIGHT CO., INC. 171340102 US1713401024 05/01/2026 Election of 11 nominees to serve as directors for a term of one year; Bradlen S. Cashaw DIRECTOR ELECTIONS ISSUER 12000 0 FOR 12000 FOR CHURCH & DWIGHT CO., INC. 171340102 US1713401024 05/01/2026 Election of 11 nominees to serve as directors for a term of one year; Richard A. Dierker DIRECTOR ELECTIONS ISSUER 12000 0 FOR 12000 FOR CHURCH & DWIGHT CO., INC. 171340102 US1713401024 05/01/2026 Election of 11 nominees to serve as directors for a term of one year; Bradley C. Irwin DIRECTOR ELECTIONS ISSUER 12000 0 FOR 12000 FOR CHURCH & DWIGHT CO., INC. 171340102 US1713401024 05/01/2026 Election of 11 nominees to serve as directors for a term of one year; Penry W. Price DIRECTOR ELECTIONS ISSUER 12000 0 FOR 12000 FOR CHURCH & DWIGHT CO., INC. 171340102 US1713401024 05/01/2026 Election of 11 nominees to serve as directors for a term of one year; Susan G. Saideman DIRECTOR ELECTIONS ISSUER 12000 0 FOR 12000 FOR CHURCH & DWIGHT CO., INC. 171340102 US1713401024 05/01/2026 Election of 11 nominees to serve as directors for a term of one year; Ravichandra K. Saligram DIRECTOR ELECTIONS ISSUER 12000 0 FOR 12000 FOR CHURCH & DWIGHT CO., INC. 171340102 US1713401024 05/01/2026 Election of 11 nominees to serve as directors for a term of one year; Robert K. Shearer DIRECTOR ELECTIONS ISSUER 12000 0 FOR 12000 FOR CHURCH & DWIGHT CO., INC. 171340102 US1713401024 05/01/2026 Election of 11 nominees to serve as directors for a term of one year; Michael R. Smith DIRECTOR ELECTIONS ISSUER 12000 0 FOR 12000 FOR CHURCH & DWIGHT CO., INC. 171340102 US1713401024 05/01/2026 Election of 11 nominees to serve as directors for a term of one year; Janet S. Vergis DIRECTOR ELECTIONS ISSUER 12000 0 FOR 12000 FOR CHURCH & DWIGHT CO., INC. 171340102 US1713401024 05/01/2026 Election of 11 nominees to serve as directors for a term of one year; Arthur B. Winkleblack DIRECTOR ELECTIONS ISSUER 12000 0 FOR 12000 FOR CHURCH & DWIGHT CO., INC. 171340102 US1713401024 05/01/2026 Election of 11 nominees to serve as directors for a term of one year; Laurie J. Yoler DIRECTOR ELECTIONS ISSUER 12000 0 FOR 12000 FOR CHURCH & DWIGHT CO., INC. 171340102 US1713401024 05/01/2026 An advisory vote to approve compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 12000 0 FOR 12000 FOR CHURCH & DWIGHT CO., INC. 171340102 US1713401024 05/01/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2026; AUDIT-RELATED ISSUER 12000 0 FOR 12000 FOR CHURCH & DWIGHT CO., INC. 171340102 US1713401024 05/01/2026 Stockholder Proposal - Permit Stockholder Action by Written Consent. CORPORATE GOVERNANCE SECURITY HOLDER 12000 0 AGAINST 12000 FOR COGENT BIOSCIENCES, INC. 19240Q201 US19240Q2012 06/09/2026 Election of Director: 1. Dr. Chris Cain DIRECTOR ELECTIONS ISSUER 3500 0 FOR 3500 FOR COGENT BIOSCIENCES, INC. 19240Q201 US19240Q2012 06/09/2026 Election of Director: 2. Arlene M. Morris DIRECTOR ELECTIONS ISSUER 3500 0 FOR 3500 FOR COGENT BIOSCIENCES, INC. 19240Q201 US19240Q2012 06/09/2026 Election of Director: 3. Todd Shegog DIRECTOR ELECTIONS ISSUER 3500 0 FOR 3500 FOR COGENT BIOSCIENCES, INC. 19240Q201 US19240Q2012 06/09/2026 Ratification of the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 3500 0 FOR 3500 FOR COGENT BIOSCIENCES, INC. 19240Q201 US19240Q2012 06/09/2026 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3500 0 FOR 3500 FOR COLGATE-PALMOLIVE COMPANY 194162103 US1941621039 05/08/2026 Election of directors John P. Bilbrey DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR COLGATE-PALMOLIVE COMPANY 194162103 US1941621039 05/08/2026 Election of directors Christopher S. Boerner DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR COLGATE-PALMOLIVE COMPANY 194162103 US1941621039 05/08/2026 Election of directors John T. Cahill DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR COLGATE-PALMOLIVE COMPANY 194162103 US1941621039 05/08/2026 Election of directors Lisa M. Edwards DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR COLGATE-PALMOLIVE COMPANY 194162103 US1941621039 05/08/2026 Election of directors C. Martin Harris DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR COLGATE-PALMOLIVE COMPANY 194162103 US1941621039 05/08/2026 Election of directors Martina Hund-Mejean DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR COLGATE-PALMOLIVE COMPANY 194162103 US1941621039 05/08/2026 Election of directors Kimberly A. Nelson DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR COLGATE-PALMOLIVE COMPANY 194162103 US1941621039 05/08/2026 Election of directors Brian O. Newman DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR COLGATE-PALMOLIVE COMPANY 194162103 US1941621039 05/08/2026 Election of directors Lorrie M. Norrington DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR COLGATE-PALMOLIVE COMPANY 194162103 US1941621039 05/08/2026 Election of directors Noel Wallace DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR COLGATE-PALMOLIVE COMPANY 194162103 US1941621039 05/08/2026 Ratify selection of PricewaterhouseCoopers LLP as Colgate's independent registered public accounting firm. AUDIT-RELATED ISSUER 10000 0 FOR 10000 FOR COLGATE-PALMOLIVE COMPANY 194162103 US1941621039 05/08/2026 Advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 10000 0 FOR 10000 FOR COLGATE-PALMOLIVE COMPANY 194162103 US1941621039 05/08/2026 Stockholder proposal entitled "Remove DEI from Board Candidate Considerations." CORPORATE GOVERNANCE SECURITY HOLDER 10000 0 ABSTAIN 10000 AGAINST COLGATE-PALMOLIVE COMPANY 194162103 US1941621039 05/08/2026 Stockholder proposal entitled "Independent Board Chairman." CORPORATE GOVERNANCE SECURITY HOLDER 10000 0 AGAINST 10000 FOR CONAGRA BRANDS, INC. 205887102 US2058871029 09/17/2025 Election of Directors Anil Arora DIRECTOR ELECTIONS ISSUER 15000 0 FOR 15000 FOR CONAGRA BRANDS, INC. 205887102 US2058871029 09/17/2025 Election of Directors Thomas K. Brown DIRECTOR ELECTIONS ISSUER 15000 0 FOR 15000 FOR CONAGRA BRANDS, INC. 205887102 US2058871029 09/17/2025 Election of Directors Emanuel Chirico DIRECTOR ELECTIONS ISSUER 15000 0 FOR 15000 FOR CONAGRA BRANDS, INC. 205887102 US2058871029 09/17/2025 Election of Directors Sean M. Connolly DIRECTOR ELECTIONS ISSUER 15000 0 FOR 15000 FOR CONAGRA BRANDS, INC. 205887102 US2058871029 09/17/2025 Election of Directors George Dowdie DIRECTOR ELECTIONS ISSUER 15000 0 FOR 15000 FOR CONAGRA BRANDS, INC. 205887102 US2058871029 09/17/2025 Election of Directors Francisco J. Fraga DIRECTOR ELECTIONS ISSUER 15000 0 FOR 15000 FOR CONAGRA BRANDS, INC. 205887102 US2058871029 09/17/2025 Election of Directors Richard H. Lenny DIRECTOR ELECTIONS ISSUER 15000 0 FOR 15000 FOR CONAGRA BRANDS, INC. 205887102 US2058871029 09/17/2025 Election of Directors Melissa Lora DIRECTOR ELECTIONS ISSUER 15000 0 FOR 15000 FOR CONAGRA BRANDS, INC. 205887102 US2058871029 09/17/2025 Election of Directors Ruth Ann Marshall DIRECTOR ELECTIONS ISSUER 15000 0 FOR 15000 FOR CONAGRA BRANDS, INC. 205887102 US2058871029 09/17/2025 Election of Directors Denise A. Paulonis DIRECTOR ELECTIONS ISSUER 15000 0 FOR 15000 FOR CONAGRA BRANDS, INC. 205887102 US2058871029 09/17/2025 Advisory vote to approve named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 15000 0 FOR 15000 FOR CONAGRA BRANDS, INC. 205887102 US2058871029 09/17/2025 Ratification of the appointment of KPMG LLP as our independent auditor for fiscal 2026 AUDIT-RELATED ISSUER 15000 0 FOR 15000 FOR CONFLUENT, INC. 20717M103 US20717M1036 02/12/2026 To adopt the Agreement and Plan of Merger, dated as of December 7, 2025 (as it may be amended, modified, supplemented or waived from time to time), by and among International Business Machines Corporation, Corvo Merger Sub, Inc., and Confluent, Inc. (the "merger agreement"). CORPORATE GOVERNANCE ISSUER 15000 0 FOR 15000 FOR CONFLUENT, INC. 20717M103 US20717M1036 02/12/2026 To approve, on a non-binding, advisory basis, the compensation that will or may become payable by Confluent, Inc. to its named executive officers in connection with the merger contemplated by the merger agreement. SECTION 14A SAY-ON-PAY VOTES ISSUER 15000 0 FOR 15000 FOR CONFLUENT, INC. 20717M103 US20717M1036 02/12/2026 To adjourn the Special Meeting, from time to time, to a later date or dates, if necessary or appropriate, including to solicit additional proxies if there are insufficient votes to adopt the merger agreement at the time of the Special Meeting. CORPORATE GOVERNANCE ISSUER 15000 0 FOR 15000 FOR CRINETICS PHARMACEUTICALS, INC. 22663K107 US22663K1079 06/18/2026 To elect three directors to serve as Class II directors for a three- year term to expire at the 2029 annual meeting of shareholders; Caren Deardorf DIRECTOR ELECTIONS ISSUER 6000 0 FOR 6000 FOR CRINETICS PHARMACEUTICALS, INC. 22663K107 US22663K1079 06/18/2026 To elect three directors to serve as Class II directors for a three- year term to expire at the 2029 annual meeting of shareholders; Weston Nichols, Ph.D DIRECTOR ELECTIONS ISSUER 6000 0 FOR 6000 FOR CRINETICS PHARMACEUTICALS, INC. 22663K107 US22663K1079 06/18/2026 To elect three directors to serve as Class II directors for a three- year term to expire at the 2029 annual meeting of shareholders; Stephanie S. Okey, M.S. DIRECTOR ELECTIONS ISSUER 6000 0 FOR 6000 FOR CRINETICS PHARMACEUTICALS, INC. 22663K107 US22663K1079 06/18/2026 To ratify the selection of PricewaterhouseCoopers LLP (''PwC'') as our independent registered public accounting firm for the fiscal year ending December 31, 2026; AUDIT-RELATED ISSUER 6000 0 FOR 6000 FOR CRINETICS PHARMACEUTICALS, INC. 22663K107 US22663K1079 06/18/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission; SECTION 14A SAY-ON-PAY VOTES ISSUER 6000 0 FOR 6000 FOR CVS HEALTH CORPORATION 126650100 US1266501006 05/14/2026 Election of Directors Fernando Aguirre DIRECTOR ELECTIONS ISSUER 20000 0 FOR 20000 FOR CVS HEALTH CORPORATION 126650100 US1266501006 05/14/2026 Election of Directors Jeffrey R. Balser, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 20000 0 FOR 20000 FOR CVS HEALTH CORPORATION 126650100 US1266501006 05/14/2026 Election of Directors C. David Brown II DIRECTOR ELECTIONS ISSUER 20000 0 FOR 20000 FOR CVS HEALTH CORPORATION 126650100 US1266501006 05/14/2026 Election of Directors Alecia A. DeCoudreaux DIRECTOR ELECTIONS ISSUER 20000 0 FOR 20000 FOR CVS HEALTH CORPORATION 126650100 US1266501006 05/14/2026 Election of Directors Anne M. Finucane DIRECTOR ELECTIONS ISSUER 20000 0 FOR 20000 FOR CVS HEALTH CORPORATION 126650100 US1266501006 05/14/2026 Election of Directors John E. Gallina DIRECTOR ELECTIONS ISSUER 20000 0 FOR 20000 FOR CVS HEALTH CORPORATION 126650100 US1266501006 05/14/2026 Election of Directors J. David Joyner DIRECTOR ELECTIONS ISSUER 20000 0 FOR 20000 FOR CVS HEALTH CORPORATION 126650100 US1266501006 05/14/2026 Election of Directors J. Scott Kirby DIRECTOR ELECTIONS ISSUER 20000 0 FOR 20000 FOR CVS HEALTH CORPORATION 126650100 US1266501006 05/14/2026 Election of Directors Michael F. Mahoney DIRECTOR ELECTIONS ISSUER 20000 0 FOR 20000 FOR CVS HEALTH CORPORATION 126650100 US1266501006 05/14/2026 Election of Directors Leslie V. Norwalk DIRECTOR ELECTIONS ISSUER 20000 0 FOR 20000 FOR CVS HEALTH CORPORATION 126650100 US1266501006 05/14/2026 Election of Directors Larry M. Robbins DIRECTOR ELECTIONS ISSUER 20000 0 FOR 20000 FOR CVS HEALTH CORPORATION 126650100 US1266501006 05/14/2026 Election of Directors Guy P. Sansone DIRECTOR ELECTIONS ISSUER 20000 0 FOR 20000 FOR CVS HEALTH CORPORATION 126650100 US1266501006 05/14/2026 Election of Directors Douglas H. Shulman DIRECTOR ELECTIONS ISSUER 20000 0 FOR 20000 FOR CVS HEALTH CORPORATION 126650100 US1266501006 05/14/2026 Ratification of the Appointment of Our Independent Registered Public Accounting Firm for 2026. AUDIT-RELATED ISSUER 20000 0 FOR 20000 FOR CVS HEALTH CORPORATION 126650100 US1266501006 05/14/2026 Say on Pay, a Proposal to Approve, on an Advisory Basis, the Company's Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 20000 0 FOR 20000 FOR CVS HEALTH CORPORATION 126650100 US1266501006 05/14/2026 Proposal to Approve the Company's 2026 Incentive Compensation Plan. COMPENSATION ISSUER 20000 0 FOR 20000 FOR CVS HEALTH CORPORATION 126650100 US1266501006 05/14/2026 Stockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent. CORPORATE GOVERNANCE SECURITY HOLDER 20000 0 AGAINST 20000 FOR CYTOKINETICS, INCORPORATED 23282W605 US23282W6057 05/27/2026 Election of Class I Directors for terms expiring in 2029. Edward M. Kaye, M.D. DIRECTOR ELECTIONS ISSUER 3000 0 FOR 3000 FOR CYTOKINETICS, INCORPORATED 23282W605 US23282W6057 05/27/2026 Election of Class I Directors for terms expiring in 2029. Wendell Wierenga, Ph.D. DIRECTOR ELECTIONS ISSUER 3000 0 FOR 3000 FOR CYTOKINETICS, INCORPORATED 23282W605 US23282W6057 05/27/2026 Election of Class I Directors for terms expiring in 2029. Nancy J. Wysenski DIRECTOR ELECTIONS ISSUER 3000 0 FOR 3000 FOR CYTOKINETICS, INCORPORATED 23282W605 US23282W6057 05/27/2026 To approve the amendment and restatement of the Company's Amended and Restated 2015 Employee Stock Purchase Plan to increase the number of authorized shares reserved for issuance thereunder by 1,000,000 shares of common stock. CAPITAL STRUCTURE ISSUER 3000 0 FOR 3000 FOR CYTOKINETICS, INCORPORATED 23282W605 US23282W6057 05/27/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 3000 0 FOR 3000 FOR CYTOKINETICS, INCORPORATED 23282W605 US23282W6057 05/27/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 3000 0 FOR 3000 FOR CYTOMX THERAPEUTICS, INC. 23284F105 US23284F1057 06/17/2026 To elect two directors with terms to expire at the 2029 Annual Meeting of Stockholders; Matthew P. Young DIRECTOR ELECTIONS ISSUER 33000 0 FOR 33000 FOR CYTOMX THERAPEUTICS, INC. 23284F105 US23284F1057 06/17/2026 To elect two directors with terms to expire at the 2029 Annual Meeting of Stockholders; Elaine V. Jones, Ph.D. DIRECTOR ELECTIONS ISSUER 33000 0 FOR 33000 FOR CYTOMX THERAPEUTICS, INC. 23284F105 US23284F1057 06/17/2026 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026; AUDIT-RELATED ISSUER 33000 0 FOR 33000 FOR CYTOMX THERAPEUTICS, INC. 23284F105 US23284F1057 06/17/2026 To approve an amendment to our Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 300,000,000 shares to 600,000,000 shares; CAPITAL STRUCTURE ISSUER 33000 0 FOR 33000 FOR CYTOMX THERAPEUTICS, INC. 23284F105 US23284F1057 06/17/2026 To approve an amendment to our Amended and Restated 2015 Equity Incentive Plan; COMPENSATION ISSUER 33000 0 AGAINST 33000 AGAINST CYTOMX THERAPEUTICS, INC. 23284F105 US23284F1057 06/17/2026 To approve an amendment to our Amended and Restated Employee Stock Purchase Plan; CAPITAL STRUCTURE ISSUER 33000 0 FOR 33000 FOR CYTOMX THERAPEUTICS, INC. 23284F105 US23284F1057 06/17/2026 To approve, on a nonbinding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders; and SECTION 14A SAY-ON-PAY VOTES ISSUER 33000 0 FOR 33000 FOR CYTOMX THERAPEUTICS, INC. 23284F105 US23284F1057 06/17/2026 To hold a non-binding advisory vote on the frequency of future advisory votes by stockholders on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 33000 0 1 Year 33000 FOR DANAHER CORPORATION 235851102 US2358511028 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified. Rainer M. Blair DIRECTOR ELECTIONS ISSUER 50 0 FOR 50 FOR DANAHER CORPORATION 235851102 US2358511028 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified. Feroz Dewan DIRECTOR ELECTIONS ISSUER 50 0 FOR 50 FOR DANAHER CORPORATION 235851102 US2358511028 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified. Linda Filler DIRECTOR ELECTIONS ISSUER 50 0 FOR 50 FOR DANAHER CORPORATION 235851102 US2358511028 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified. Charles W. Lamanna DIRECTOR ELECTIONS ISSUER 50 0 FOR 50 FOR DANAHER CORPORATION 235851102 US2358511028 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified. Teri L. List DIRECTOR ELECTIONS ISSUER 50 0 FOR 50 FOR DANAHER CORPORATION 235851102 US2358511028 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified. Mitchell P. Rales DIRECTOR ELECTIONS ISSUER 50 0 FOR 50 FOR DANAHER CORPORATION 235851102 US2358511028 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified. Steven M. Rales DIRECTOR ELECTIONS ISSUER 50 0 FOR 50 FOR DANAHER CORPORATION 235851102 US2358511028 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified. A. Shane Sanders DIRECTOR ELECTIONS ISSUER 50 0 FOR 50 FOR DANAHER CORPORATION 235851102 US2358511028 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified. Alan G. Spoon DIRECTOR ELECTIONS ISSUER 50 0 FOR 50 FOR DANAHER CORPORATION 235851102 US2358511028 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified. Raymond C. Stevens, Ph.D DIRECTOR ELECTIONS ISSUER 50 0 FOR 50 FOR DANAHER CORPORATION 235851102 US2358511028 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified. Elias A. Zerhouni, MD DIRECTOR ELECTIONS ISSUER 50 0 FOR 50 FOR DANAHER CORPORATION 235851102 US2358511028 05/05/2026 To ratify the selection of Ernst & Young LLP as Danaher's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 50 0 FOR 50 FOR DANAHER CORPORATION 235851102 US2358511028 05/05/2026 To approve on an advisory basis the Company's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 50 0 FOR 50 FOR DANAHER CORPORATION 235851102 US2358511028 05/05/2026 To approve the Company's Amended and Restated Omnibus Incentive Plan. COMPENSATION ISSUER 50 0 AGAINST 50 AGAINST DANONE SA F12033134 FR0000120644 04/23/2026 APPROVAL OF THE STATUTORY FINANCIAL STATEMENTS FOR THE FISCAL YEAR ENDED DECEMBER 31ST, 2025 OTHER ISSUER 0 0 DANONE SA F12033134 FR0000120644 04/23/2026 APPROVAL OF THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE FISCAL YEAR ENDED DECEMBER 31ST, 2025 OTHER ISSUER 0 0 DANONE SA F12033134 FR0000120644 04/23/2026 ALLOCATION OF EARNINGS FOR THE FISCAL YEAR ENDED DECEMBER 31ST, 2025, AND SETTING OF THE DIVIDEND AT '2.25 PER SHARE CAPITAL STRUCTURE ISSUER 0 0 DANONE SA F12033134 FR0000120644 04/23/2026 RENEWAL OF THE TERM OF OFFICE OF GILLES SCHNEPP AS DIRECTOR, IN ACCORDANCE WITH ARTICLE 15- II PARAGRAPH 2, OF THE BY-LAWS DIRECTOR ELECTIONS ISSUER 0 0 DANONE SA F12033134 FR0000120644 04/23/2026 RENEWAL OF THE TERM OF OFFICE OF VALERIE CHAPOULAUD-FLOQUET AS DIRECTOR DIRECTOR ELECTIONS ISSUER 0 0 DANONE SA F12033134 FR0000120644 04/23/2026 RENEWAL OF THE TERM OF OFFICE OF SANJIV MEHTA AS DIRECTOR DIRECTOR ELECTIONS ISSUER 0 0 DANONE SA F12033134 FR0000120644 04/23/2026 APPROVAL OF THE INFORMATION REGARDING THE COMPENSATION OF THE CORPORATE OFFICERS REFERRED TO IN PARAGRAPH I OF ARTICLE L.22-10-9 OF THE FRENCH COMMERCIAL CODE FOR THE 2025 FISCAL YEAR COMPENSATION ISSUER 0 0 DANONE SA F12033134 FR0000120644 04/23/2026 APPROVAL OF THE COMPONENTS OF COMPENSATION PAID IN OR AWARDED FOR THE FISCAL YEAR ENDED DECEMBER 31ST, 2025 TO ANTOINE DE SAINT-AFFRIQUE, CHIEF EXECUTIVE OFFICER SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 DANONE SA F12033134 FR0000120644 04/23/2026 APPROVAL OF THE COMPONENTS OF COMPENSATION PAID IN OR AWARDED FOR THE FISCAL YEAR ENDED DECEMBER 31ST, 2025 TO GILLES SCHNEPP, CHAIRMAN OF THE BOARD OF DIRECTORS SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 DANONE SA F12033134 FR0000120644 04/23/2026 APPROVAL OF THE COMPENSATION POLICY FOR THE EXECUTIVE CORPORATE OFFICERS FOR THE 2026 FISCAL YEAR COMPENSATION ISSUER 0 0 DANONE SA F12033134 FR0000120644 04/23/2026 APPROVAL OF THE COMPENSATION POLICY FOR THE CHAIRMAN OF THE BOARD OF DIRECTORS FOR THE 2026 FISCAL YEAR COMPENSATION ISSUER 0 0 DANONE SA F12033134 FR0000120644 04/23/2026 APPROVAL OF THE COMPENSATION POLICY FOR DIRECTORS FOR THE 2026 FISCAL YEAR COMPENSATION ISSUER 0 0 DANONE SA F12033134 FR0000120644 04/23/2026 AUTHORIZATION GRANTED TO THE BOARD OF DIRECTORS TO PURCHASE, RETAIN OR TRANSFER THE COMPANY'S SHARES CAPITAL STRUCTURE ISSUER 0 0 DANONE SA F12033134 FR0000120644 04/23/2026 RATIFICATION OF THE TRANSFER OF THE REGISTERED OFFICE CORPORATE GOVERNANCE ISSUER 0 0 DANONE SA F12033134 FR0000120644 04/23/2026 DELEGATION OF AUTHORITY TO THE BOARD OF DIRECTORS TO ISSUE ORDINARY SHARES AND SECURITIES IN FAVOR OF EMPLOYEES WHO ARE MEMBERS OF A COMPANY'S SAVINGS PLAN AND/OR TO CARRY OUT RESERVED SALES OF SECURITIES, WITHOUT PREFERENTIAL SUBSCRIPTION RIGHT OF THE SHAREHOLDERS CAPITAL STRUCTURE ISSUER 0 0 DANONE SA F12033134 FR0000120644 04/23/2026 DELEGATION OF AUTHORITY TO THE BOARD OF DIRECTORS TO ISSUE ORDINARY SHARES AND SECURITIES GIVING ACCESS TO THE SHARE CAPITAL, WITH CANCELLATION OF THE PREFERENTIAL SUBSCRIPTION RIGHT, IN FAVOR OF CATEGORIES OF BENEFICIARIES MADE UP OF EMPLOYEES WORKING WITHIN FOREIGN COMPANIES OF DANONE'S GROUP OR IN INTERNATIONAL MOBILITY, IN THE FRAMEWORK OF EMPLOYEE SHAREHOLDING PLANS CAPITAL STRUCTURE ISSUER 0 0 DANONE SA F12033134 FR0000120644 04/23/2026 POWERS TO CARRY OUT FORMALITIES OTHER ISSUER 0 0 DAVITA INC. 23918K108 US23918K1088 06/04/2026 Election of Directors Pamela M. Arway DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR DAVITA INC. 23918K108 US23918K1088 06/04/2026 Election of Directors Barbara J. Desoer DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR DAVITA INC. 23918K108 US23918K1088 06/04/2026 Election of Directors Jason M. Hollar DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR DAVITA INC. 23918K108 US23918K1088 06/04/2026 Election of Directors Gregory J. Moore, MD, PhD DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR DAVITA INC. 23918K108 US23918K1088 06/04/2026 Election of Directors Dennis W. Pullin DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR DAVITA INC. 23918K108 US23918K1088 06/04/2026 Election of Directors Javier J. Rodriguez DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR DAVITA INC. 23918K108 US23918K1088 06/04/2026 Election of Directors Adam H. Schechter DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR DAVITA INC. 23918K108 US23918K1088 06/04/2026 Election of Directors Wendy L. Schoppert DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR DAVITA INC. 23918K108 US23918K1088 06/04/2026 Election of Directors Phyllis R. Yale DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR DAVITA INC. 23918K108 US23918K1088 06/04/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal year 2026. AUDIT-RELATED ISSUER 5000 0 FOR 5000 FOR DAVITA INC. 23918K108 US23918K1088 06/04/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 5000 0 FOR 5000 FOR DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Approval of the annual financial statements for the year ended December 31, 2025 OTHER ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Approval of the consolidated financial statements for the year ended December 31, 2025 OTHER ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Allocation of income for the year ended December 31, 2025 CAPITAL STRUCTURE ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Allocation of the accumulated deficit to the ''Additional paid-in capital'' CAPITAL STRUCTURE ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Statutory auditors' special report on regulated agreements OTHER ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Renewal of the term of office of KPMG, as statutory auditor AUDIT-RELATED ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting. DIRECTOR ELECTIONS ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting. DIRECTOR ELECTIONS ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting. DIRECTOR ELECTIONS ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting. DIRECTOR ELECTIONS ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Approval of the information set out in section I of Article L.22-10-9 of the French Commercial Code on the compensation of corporate officers for the year ended December 31, 2025 COMPENSATION ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Approval of the fixed, variable and non-recurring components of overall compensation and benefits of all types paid or assigned during the year ended December 31, 2025, to Mr. Michel de Rosen, Chairman of the Board of Directors COMPENSATION ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Approval of the fixed, variable and non-recurring components ofoverall compensation and benefits of all types paid or assignedduring the year ended December 31, 2025, to Mr. Daniel Tasse,Chief Executive Officer COMPENSATION ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Advisory opinion on the compensation of named executive officers other than the Chief Executive Officer SECTION 14A SAY-ON-PAY VOTES ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Increase of the total remuneration (annual budget) allocated to Directors COMPENSATION ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Approval of the compensation policy for the Chairman of the Board of Directors for the year ending December 31, 2026 COMPENSATION ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Approval of the compensation policy for the Directors for the year ending December 31, 2026 COMPENSATION ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Approval of the compensation policy for the Chief Executive Officer and Deputy Chief Executive Officer for the year ending December 31, 2026 COMPENSATION ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Authorization to be granted to the Board of Directors to buy back company shares on the Company's behalf pursuant to Article L.22- 10-62 of the French Commercial Code CAPITAL STRUCTURE ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Delegation to be granted to the Board of Directors to reduce the share capital by cancellation of shares pursuant to Article L.22-10- 62 of the French Commercial Code CAPITAL STRUCTURE ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Delegation of authority to be granted to the Board of Directors to issue ordinary shares and/or equity securities giving access to other equity securities or to the allocation of debt securities and/or securities giving access to ordinary shares with preferential subscription rights CAPITAL STRUCTURE ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Delegation of authority to be granted to the Board of Directors to issue ordinary shares and/or equity securities giving access to other equity securities or to the allocation of debt securities, and/or securities giving access to equity securities to be issued, without preferential subscription rights by means of a public offer excluding the offers set out in paragraph 1 of Article L.411-2 of the French Monetary and Financial Code, and/or as consideration for securities in the context of a public exchange offer CAPITAL STRUCTURE ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Delegation of authority to be granted to the Board of Directors to issue ordinary shares and/or equity securities giving access to other equity securities or to the allocation of debt securities, and/or securities giving access to equity securities to be issued, without preferential subscription rights by means of a public offer referred to in paragraph 1 of Article L.411-2 of the French Monetary and Financial Code CAPITAL STRUCTURE ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Delegation of powers to be granted to the Board of Directors to issue ordinary shares and/or equity securities giving access to other equity securities or to the allocation of debt securities and/or securities giving access to ordinary shares, without preferential subscription rights in favor of one or more persons specifically designated by the Board of Directors CAPITAL STRUCTURE ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Delegation of authority to be granted to the Board of Directors to issue ordinary shares, giving, as the case may be, access to ordinary shares or the allocation of debt securities (of the Company or a group company) and/or securities giving access to ordinary shares (of the Company or a group company), without preferential subscription rights in favor of a category of persons satisfying determined characteristics CAPITAL STRUCTURE ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Delegation of authority to be granted to the Board of Directors to decide on the issue of ordinary shares to be issued immediately or in the future by the Company, without preferential subscription rights in favor of a category of persons satisfying determined characteristics within the framework of an equity financing agreement on the United States stock market known as ''At-The- Market'' or ''ATM Program'' CAPITAL STRUCTURE ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Delegation of authority to be granted to the Board of Directors to increase the number of securities to be issued in the event of a capital increase with or without preferential subscription rights, in the event of excess demand CAPITAL STRUCTURE ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Delegation to be granted to the Board of Directors to increase the share capital by issuance of ordinary shares and/or securities giving access to the share capital within the limits set by the applicable legal and regulatory provisions on the date of the capital increase in consideration for contributions in kind of securities or securities giving access to the share capital CAPITAL STRUCTURE ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Delegation of authority to be granted to the Board of Directors to decide on any merger-absorption, spin-off or partial contribution of assets EXTRAORDINARY TRANSACTIONS ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Delegation of authority to be granted to the Board of Directors to issue ordinary shares giving, as the case may be, access to ordinary shares or to the allocation of debt securities (of the Company or of a group company), and/or securities giving access to ordinary shares (of the Company or of a group company), in the context of a merger, spin-off or partial contribution of assets decided by the Board of Directors pursuant to the delegation referred to in the twenty-ninth resolution CAPITAL STRUCTURE ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Overall limit on the maximum authorized amounts set under the resolutions twenty-second, twenty-third, twenty-fourth, twenty-fifth, twenty-sixth, twenty-eighth and thirtieth resolutions CAPITAL STRUCTURE ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Delegation of authority to be granted to the Board of Directors to increase the capital by means of the incorporation of reserves, profits and/or premiums CAPITAL STRUCTURE ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Delegation of authority to be granted to the Board of Directors to increase the capital by the issue of ordinary shares and/or securities giving access to the share capital, without preferential subscription rights in favor of the members of a company savings plan pursuant to Articles L.3332-18 and seq. of the French Labor Code CAPITAL STRUCTURE ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Delegation of authority to be granted to the Board of Directors to issue warrants (BSA), subscription and/or acquisition of new and/or existing warrants (BSAANE) and/or subscription and/or acquisition of new and/or existing redeemable warrants (BSAAR) without preferential subscription rights in favor of a category of persons CAPITAL STRUCTURE ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Authorization to be granted to the Board of Directors to allocate for free existing and/or to be issued shares to employees and/or certain corporate officers of the Company or related companies or economic interest groups CAPITAL STRUCTURE ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Authorization to be granted to the Board of Directors to grant stock options to employees and/or certain officers of the Company or related companies or economic interest groups COMPENSATION ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Overall limit on the maximum authorized amounts set under the resolutions thirty-fifth and thirty-sixth CAPITAL STRUCTURE ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Ratification of the amendment to Article 18 and Article 21 of the Company's bylaws CORPORATE GOVERNANCE ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Amendment to Article 15 of the Company's bylaws to set the age limit for the Chief Executive Officer at 70 years CORPORATE GOVERNANCE ISSUER 800 0 ABSTAIN 800 AGAINST DBV TECHNOLOGIES S.A. 23306J309 US23306J3095 06/03/2026 Powers to complete formalities OTHER ISSUER 800 0 ABSTAIN 800 AGAINST DENALI THERAPEUTICS INC. 24823R105 US24823R1059 06/03/2026 Election of Director: 1. Jennifer Cook DIRECTOR ELECTIONS ISSUER 1000 0 FOR 1000 FOR DENALI THERAPEUTICS INC. 24823R105 US24823R1059 06/03/2026 Election of Director: 2. David Schenkein, M.D. DIRECTOR ELECTIONS ISSUER 1000 0 FOR 1000 FOR DENALI THERAPEUTICS INC. 24823R105 US24823R1059 06/03/2026 Election of Director: 3. Ryan Watts, Ph.D. DIRECTOR ELECTIONS ISSUER 1000 0 FOR 1000 FOR DENALI THERAPEUTICS INC. 24823R105 US24823R1059 06/03/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1000 0 FOR 1000 FOR DENALI THERAPEUTICS INC. 24823R105 US24823R1059 06/03/2026 Advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1000 0 FOR 1000 FOR DEXCOM, INC. 252131107 US2521311074 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Steven Altman DIRECTOR ELECTIONS ISSUER 1300 0 FOR 1300 FOR DEXCOM, INC. 252131107 US2521311074 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Dr. Euan Ashley DIRECTOR ELECTIONS ISSUER 1300 0 FOR 1300 FOR DEXCOM, INC. 252131107 US2521311074 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Nicholas Augustinos DIRECTOR ELECTIONS ISSUER 1300 0 FOR 1300 FOR DEXCOM, INC. 252131107 US2521311074 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Richard Collins DIRECTOR ELECTIONS ISSUER 1300 0 FOR 1300 FOR DEXCOM, INC. 252131107 US2521311074 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Rimma Driscoll DIRECTOR ELECTIONS ISSUER 1300 0 FOR 1300 FOR DEXCOM, INC. 252131107 US2521311074 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Mark Foletta DIRECTOR ELECTIONS ISSUER 1300 0 FOR 1300 FOR DEXCOM, INC. 252131107 US2521311074 05/27/2026 To elect twelve nominees for director, each to hold office until our2027 annual meeting of stockholders: Renee Gala DIRECTOR ELECTIONS ISSUER 1300 0 FOR 1300 FOR DEXCOM, INC. 252131107 US2521311074 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Bridgette Heller DIRECTOR ELECTIONS ISSUER 1300 0 FOR 1300 FOR DEXCOM, INC. 252131107 US2521311074 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Jacob Leach DIRECTOR ELECTIONS ISSUER 1300 0 FOR 1300 FOR DEXCOM, INC. 252131107 US2521311074 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Kyle Malady DIRECTOR ELECTIONS ISSUER 1300 0 FOR 1300 FOR DEXCOM, INC. 252131107 US2521311074 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Rick Osterloh DIRECTOR ELECTIONS ISSUER 1300 0 FOR 1300 FOR DEXCOM, INC. 252131107 US2521311074 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Kevin Sayer DIRECTOR ELECTIONS ISSUER 1300 0 FOR 1300 FOR DEXCOM, INC. 252131107 US2521311074 05/27/2026 To ratify the selection by the Audit Committee of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1300 0 FOR 1300 FOR DEXCOM, INC. 252131107 US2521311074 05/27/2026 To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 1300 0 FOR 1300 FOR DYNE THERAPEUTICS, INC. 26818M108 US26818M1080 06/05/2026 To elect three Class III directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified. David Lubner DIRECTOR ELECTIONS ISSUER 1200 0 FOR 1200 FOR DYNE THERAPEUTICS, INC. 26818M108 US26818M1080 06/05/2026 To elect three Class III directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified. Brian Posner DIRECTOR ELECTIONS ISSUER 1200 0 FOR 1200 FOR DYNE THERAPEUTICS, INC. 26818M108 US26818M1080 06/05/2026 To elect three Class III directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified. Jason Rhodes DIRECTOR ELECTIONS ISSUER 1200 0 FOR 1200 FOR DYNE THERAPEUTICS, INC. 26818M108 US26818M1080 06/05/2026 To vote, on an advisory basis, to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1200 0 FOR 1200 FOR DYNE THERAPEUTICS, INC. 26818M108 US26818M1080 06/05/2026 To approve an amendment to our Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 200,000,000 shares to 400,000,000 shares. CAPITAL STRUCTURE ISSUER 1200 0 FOR 1200 FOR DYNE THERAPEUTICS, INC. 26818M108 US26818M1080 06/05/2026 To approve an amendment to our Restated Certificate of Incorporation to provide for officer exculpation. CORPORATE GOVERNANCE ISSUER 1200 0 FOR 1200 FOR DYNE THERAPEUTICS, INC. 26818M108 US26818M1080 06/05/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1200 0 FOR 1200 FOR ELANCO ANIMAL HEALTH INCORPORATED 28414H103 US28414H1032 05/21/2026 Election of two Class I director nominees and three Class II director nominees: Kapila Anand DIRECTOR ELECTIONS ISSUER 40000 0 FOR 40000 FOR ELANCO ANIMAL HEALTH INCORPORATED 28414H103 US28414H1032 05/21/2026 Election of two Class I director nominees and three Class II director nominees: Paul Herendeen DIRECTOR ELECTIONS ISSUER 40000 0 FOR 40000 FOR ELANCO ANIMAL HEALTH INCORPORATED 28414H103 US28414H1032 05/21/2026 Election of two Class I director nominees and three Class II director nominees: Michael Harrington DIRECTOR ELECTIONS ISSUER 40000 0 FOR 40000 FOR ELANCO ANIMAL HEALTH INCORPORATED 28414H103 US28414H1032 05/21/2026 Election of two Class I director nominees and three Class II director nominees: Lawrence Kurzius DIRECTOR ELECTIONS ISSUER 40000 0 FOR 40000 FOR ELANCO ANIMAL HEALTH INCORPORATED 28414H103 US28414H1032 05/21/2026 Election of two Class I director nominees and three Class II director nominees: Kirk McDonald DIRECTOR ELECTIONS ISSUER 40000 0 FOR 40000 FOR ELANCO ANIMAL HEALTH INCORPORATED 28414H103 US28414H1032 05/21/2026 Ratification of the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 40000 0 FOR 40000 FOR ELANCO ANIMAL HEALTH INCORPORATED 28414H103 US28414H1032 05/21/2026 Advisory vote on the compensation of the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 40000 0 FOR 40000 FOR ELEVANCE HEALTH, INC. 036752103 US0367521038 05/13/2026 Election of Directors: Gail K. Boudreaux DIRECTOR ELECTIONS ISSUER 2710 0 FOR 2710 FOR ELEVANCE HEALTH, INC. 036752103 US0367521038 05/13/2026 Election of Directors: Robert L. Dixon, Jr. DIRECTOR ELECTIONS ISSUER 2710 0 FOR 2710 FOR ELEVANCE HEALTH, INC. 036752103 US0367521038 05/13/2026 Election of Directors: Deanna D. Strable DIRECTOR ELECTIONS ISSUER 2710 0 FOR 2710 FOR ELEVANCE HEALTH, INC. 036752103 US0367521038 05/13/2026 Advisory Vote to Approve the Compensation of Our Named Executive Officers ("Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 2710 0 FOR 2710 FOR ELEVANCE HEALTH, INC. 036752103 US0367521038 05/13/2026 Ratification of Ernst & Young LLP as Auditors for 2026. AUDIT-RELATED ISSUER 2710 0 FOR 2710 FOR ELEVANCE HEALTH, INC. 036752103 US0367521038 05/13/2026 Shareholder Proposal Requesting an Independent Study on the Impact of Prohibiting Corporate Contributions to Partisan 527 Tax- Exempt Political Groups. OTHER SOCIAL ISSUES SECURITY HOLDER 2710 0 ABSTAIN 2710 AGAINST ELI LILLY AND COMPANY 532457108 US5324571083 05/04/2026 Election of the following directors, each to serve a three-year term. Carolyn Bertozzi DIRECTOR ELECTIONS ISSUER 750 0 FOR 750 FOR ELI LILLY AND COMPANY 532457108 US5324571083 05/04/2026 Election of the following directors, each to serve a three-year term. William Kaelin, Jr. DIRECTOR ELECTIONS ISSUER 750 0 FOR 750 FOR ELI LILLY AND COMPANY 532457108 US5324571083 05/04/2026 Election of the following directors, each to serve a three-year term. Jon Moeller DIRECTOR ELECTIONS ISSUER 750 0 FOR 750 FOR ELI LILLY AND COMPANY 532457108 US5324571083 05/04/2026 Election of the following directors, each to serve a three-year term. David Ricks DIRECTOR ELECTIONS ISSUER 750 0 FOR 750 FOR ELI LILLY AND COMPANY 532457108 US5324571083 05/04/2026 Approval, on an advisory basis, of the compensation paid to the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 750 0 FOR 750 FOR ELI LILLY AND COMPANY 532457108 US5324571083 05/04/2026 Ratification of the appointment of Ernst & Young LLP as the independent auditor for 2026. AUDIT-RELATED ISSUER 750 0 FOR 750 FOR ELI LILLY AND COMPANY 532457108 US5324571083 05/04/2026 Approval of amendments to the company's articles of incorporation to eliminate the classified board structure. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 750 0 FOR 750 FOR ELI LILLY AND COMPANY 532457108 US5324571083 05/04/2026 Approval of amendments to the company's articles of incorporation to eliminate supermajority voting provisions. CORPORATE GOVERNANCE ISSUER 750 0 FOR 750 FOR ELI LILLY AND COMPANY 532457108 US5324571083 05/04/2026 Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. CORPORATE GOVERNANCE SECURITY HOLDER 750 0 AGAINST 750 FOR ELI LILLY AND COMPANY 532457108 US5324571083 05/04/2026 Shareholder proposal to prepare an annual lobbying report. OTHER SOCIAL ISSUES SECURITY HOLDER 750 0 ABSTAIN 750 AGAINST EMERGENT BIOSOLUTIONS INC. 29089Q105 US29089Q1058 04/29/2026 To elect four Class II directors to hold office for a term expiring at our 2029 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified; Sujata Dayal DIRECTOR ELECTIONS ISSUER 500 0 FOR 500 FOR EMERGENT BIOSOLUTIONS INC. 29089Q105 US29089Q1058 04/29/2026 To elect four Class II directors to hold office for a term expiring at our 2029 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified; John Fowler, Jr. DIRECTOR ELECTIONS ISSUER 500 0 FOR 500 FOR EMERGENT BIOSOLUTIONS INC. 29089Q105 US29089Q1058 04/29/2026 To elect four Class II directors to hold office for a term expiring at our 2029 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified; Zsolt Harsanyi, Ph.D. DIRECTOR ELECTIONS ISSUER 500 0 FOR 500 FOR EMERGENT BIOSOLUTIONS INC. 29089Q105 US29089Q1058 04/29/2026 To elect four Class II directors to hold office for a term expiring at our 2029 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified; Joseph Papa DIRECTOR ELECTIONS ISSUER 500 0 FOR 500 FOR EMERGENT BIOSOLUTIONS INC. 29089Q105 US29089Q1058 04/29/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 500 0 FOR 500 FOR EMERGENT BIOSOLUTIONS INC. 29089Q105 US29089Q1058 04/29/2026 To hold, on an advisory basis, a vote to approve the 2025 compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 500 0 FOR 500 FOR EMERGENT BIOSOLUTIONS INC. 29089Q105 US29089Q1058 04/29/2026 To approve an amendment to the Emergent BioSolutions Inc. Amended and Restated Stock Incentive Plan to increase the number of shares of common stock for the grant of awards under the plan. COMPENSATION ISSUER 500 0 ABSTAIN 500 AGAINST ERASCA, INC. 29479A108 US29479A1088 06/26/2026 To elect three directors to serve as Class II directors for a three- year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified Alexander W. Casdin DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR ERASCA, INC. 29479A108 US29479A1088 06/26/2026 To elect three directors to serve as Class II directors for a three- year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified Julie Hambleton, M.D. DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR ERASCA, INC. 29479A108 US29479A1088 06/26/2026 To elect three directors to serve as Class II directors for a three- year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified Michael D. Varney, Ph.D. DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR ERASCA, INC. 29479A108 US29479A1088 06/26/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 10000 0 FOR 10000 FOR EVOLENT HEALTH, INC. 30050B101 US30050B1017 06/04/2026 Election of Directors: Toyin Ajayi, MD DIRECTOR ELECTIONS ISSUER 107500 0 FOR 107500 FOR EVOLENT HEALTH, INC. 30050B101 US30050B1017 06/04/2026 Election of Directors: Craig Barbarosh DIRECTOR ELECTIONS ISSUER 107500 0 FOR 107500 FOR EVOLENT HEALTH, INC. 30050B101 US30050B1017 06/04/2026 Election of Directors: Seth Blackley DIRECTOR ELECTIONS ISSUER 107500 0 FOR 107500 FOR EVOLENT HEALTH, INC. 30050B101 US30050B1017 06/04/2026 Election of Directors: Russell Glass DIRECTOR ELECTIONS ISSUER 107500 0 FOR 107500 FOR EVOLENT HEALTH, INC. 30050B101 US30050B1017 06/04/2026 Election of Directors: Peter Grua DIRECTOR ELECTIONS ISSUER 107500 0 FOR 107500 FOR EVOLENT HEALTH, INC. 30050B101 US30050B1017 06/04/2026 Election of Directors: Shawn Guertin DIRECTOR ELECTIONS ISSUER 107500 0 FOR 107500 FOR EVOLENT HEALTH, INC. 30050B101 US30050B1017 06/04/2026 Election of Directors: Richard Jelinek DIRECTOR ELECTIONS ISSUER 107500 0 FOR 107500 FOR EVOLENT HEALTH, INC. 30050B101 US30050B1017 06/04/2026 Election of Directors: Kim Keck DIRECTOR ELECTIONS ISSUER 107500 0 FOR 107500 FOR EVOLENT HEALTH, INC. 30050B101 US30050B1017 06/04/2026 Election of Directors: Jill Smith DIRECTOR ELECTIONS ISSUER 107500 0 FOR 107500 FOR EVOLENT HEALTH, INC. 30050B101 US30050B1017 06/04/2026 Election of Directors: Brendan Springstubb DIRECTOR ELECTIONS ISSUER 107500 0 FOR 107500 FOR EVOLENT HEALTH, INC. 30050B101 US30050B1017 06/04/2026 Proposal to ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 107500 0 FOR 107500 FOR EVOLENT HEALTH, INC. 30050B101 US30050B1017 06/04/2026 Proposal to approve the compensation of our named executive officers for 2025 on an advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 107500 0 FOR 107500 FOR EVOLENT HEALTH, INC. 30050B101 US30050B1017 06/04/2026 Proposal to approve an amendment to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. COMPENSATION ISSUER 107500 0 AGAINST 107500 AGAINST EVOMMUNE, INC. 30054Y107 US30054Y1073 06/02/2026 Election of Director: 1. Luis Pena DIRECTOR ELECTIONS ISSUER 4750 0 FOR 4750 FOR EVOMMUNE, INC. 30054Y107 US30054Y1073 06/02/2026 Election of Director: 2. Eugene A. Bauer DIRECTOR ELECTIONS ISSUER 4750 0 FOR 4750 FOR EVOMMUNE, INC. 30054Y107 US30054Y1073 06/02/2026 To ratify the appointment by the Audit Committee of the Board of Directors of BDO USA, P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 4750 0 FOR 4750 FOR EXACT SCIENCES CORPORATION 30063P105 US30063P1057 02/20/2026 Proposal to adopt the Agreement and Plan of Merger, dated as of November 19, 2025, as it may be amended from time to time (the "Merger Agreement"), by and among Exact Sciences Corporation, Abbott Laboratories and Badger Merger Sub I, Inc. (the "Merger Agreement Proposal"). CORPORATE GOVERNANCE ISSUER 1980 0 FOR 1980 FOR EXACT SCIENCES CORPORATION 30063P105 US30063P1057 02/20/2026 Proposal to approve, on an advisory (nonbinding) basis, the compensation that may be paid or become payable to Exact Sciences Corporation's named executive officers that is based on or otherwise related to the Merger Agreement and the transactions contemplated by the Merger Agreement (the "Compensation Proposal"). SECTION 14A SAY-ON-PAY VOTES ISSUER 1980 0 FOR 1980 FOR EXACT SCIENCES CORPORATION 30063P105 US30063P1057 02/20/2026 Proposal to approve any adjournment of the Special Meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the Special Meeting to approve the Merger Agreement Proposal (the "Adjournment Proposal"). CORPORATE GOVERNANCE ISSUER 1980 0 FOR 1980 FOR GENEDX HOLDINGS CORP. 81663L200 US81663L2007 06/18/2026 Election of Director: 1. Katherine Stueland DIRECTOR ELECTIONS ISSUER 50 0 FOR 50 FOR GENEDX HOLDINGS CORP. 81663L200 US81663L2007 06/18/2026 Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 50 0 FOR 50 FOR GENEDX HOLDINGS CORP. 81663L200 US81663L2007 06/18/2026 Approval, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 50 0 FOR 50 FOR GENEDX HOLDINGS CORP. 81663L200 US81663L2007 06/18/2026 Indicate, on a non-binding advisory basis, whether future advisory votes on the compensation paid by us to our named executive officers should be held every one, two, or three years. SECTION 14A SAY-ON-PAY VOTES ISSUER 50 0 1 Year 50 FOR GENERAL MILLS, INC. 370334104 US3703341046 09/30/2025 Election of Directors Benno O. Dorer DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR GENERAL MILLS, INC. 370334104 US3703341046 09/30/2025 Election of Directors Jeffrey L. Harmening DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR GENERAL MILLS, INC. 370334104 US3703341046 09/30/2025 Election of Directors Maria G. Henry DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR GENERAL MILLS, INC. 370334104 US3703341046 09/30/2025 Election of Directors Jo Ann Jenkins DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR GENERAL MILLS, INC. 370334104 US3703341046 09/30/2025 Election of Directors Elizabeth C. Lempres DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR GENERAL MILLS, INC. 370334104 US3703341046 09/30/2025 Election of Directors John G. Morikis DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR GENERAL MILLS, INC. 370334104 US3703341046 09/30/2025 Election of Directors Diane L. Neal DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR GENERAL MILLS, INC. 370334104 US3703341046 09/30/2025 Election of Directors Steve Odland DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR GENERAL MILLS, INC. 370334104 US3703341046 09/30/2025 Election of Directors Maria A. Sastre DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR GENERAL MILLS, INC. 370334104 US3703341046 09/30/2025 Election of Directors Eric D. Sprunk DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR GENERAL MILLS, INC. 370334104 US3703341046 09/30/2025 Election of Directors Jorge A. Uribe DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR GENERAL MILLS, INC. 370334104 US3703341046 09/30/2025 Advisory Vote on Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 5000 0 FOR 5000 FOR GENERAL MILLS, INC. 370334104 US3703341046 09/30/2025 Ratify Appointment of the Independent Registered Public Accounting Firm. AUDIT-RELATED ISSUER 5000 0 FOR 5000 FOR GENERAL MILLS, INC. 370334104 US3703341046 09/30/2025 Shareholder Proposal - Disclosure of Regenerative Agriculture Practices Within Supply Chain. ENVIRONMENT OR CLIMATE SECURITY HOLDER 5000 0 ABSTAIN 5000 AGAINST GENERAL MILLS, INC. 370334104 US3703341046 09/30/2025 Shareholder Proposal - Adopt Policy to Separate the Board Chair and CEO Roles. CORPORATE GOVERNANCE SECURITY HOLDER 5000 0 AGAINST 5000 FOR GILEAD SCIENCES, INC. 375558103 US3755581036 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified. Jacqueline K. Barton, Ph.D. DIRECTOR ELECTIONS ISSUER 4500 0 FOR 4500 FOR GILEAD SCIENCES, INC. 375558103 US3755581036 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified. Jeffrey A. Bluestone, Ph.D. DIRECTOR ELECTIONS ISSUER 4500 0 FOR 4500 FOR GILEAD SCIENCES, INC. 375558103 US3755581036 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified. Sandra J. Horning, M.D. DIRECTOR ELECTIONS ISSUER 4500 0 FOR 4500 FOR GILEAD SCIENCES, INC. 375558103 US3755581036 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified. Kelly A. Kramer DIRECTOR ELECTIONS ISSUER 4500 0 FOR 4500 FOR GILEAD SCIENCES, INC. 375558103 US3755581036 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified. Ted W. Love, M.D. DIRECTOR ELECTIONS ISSUER 4500 0 FOR 4500 FOR GILEAD SCIENCES, INC. 375558103 US3755581036 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified. Harish Manwani DIRECTOR ELECTIONS ISSUER 4500 0 FOR 4500 FOR GILEAD SCIENCES, INC. 375558103 US3755581036 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified. Daniel P. O'Day DIRECTOR ELECTIONS ISSUER 4500 0 FOR 4500 FOR GILEAD SCIENCES, INC. 375558103 US3755581036 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified. Javier J. Rodriguez DIRECTOR ELECTIONS ISSUER 4500 0 FOR 4500 FOR GILEAD SCIENCES, INC. 375558103 US3755581036 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified. Anthony Welters DIRECTOR ELECTIONS ISSUER 4500 0 FOR 4500 FOR GILEAD SCIENCES, INC. 375558103 US3755581036 04/30/2026 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 4500 0 FOR 4500 FOR GILEAD SCIENCES, INC. 375558103 US3755581036 04/30/2026 To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 4500 0 FOR 4500 FOR GILEAD SCIENCES, INC. 375558103 US3755581036 04/30/2026 To approve the amended and restated Gilead Sciences, Inc. 2022 Equity Incentive Plan. COMPENSATION ISSUER 4500 0 AGAINST 4500 AGAINST GILEAD SCIENCES, INC. 375558103 US3755581036 04/30/2026 To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting. CORPORATE GOVERNANCE SECURITY HOLDER 4500 0 AGAINST 4500 FOR GILEAD SCIENCES, INC. 375558103 US3755581036 04/30/2026 To vote on a stockholder proposal requesting a report on the impact of extended patent exclusivities on patient access, if properly presented at the Annual Meeting. HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE SECURITY HOLDER 4500 0 ABSTAIN 4500 AGAINST GILEAD SCIENCES, INC. 375558103 US3755581036 04/30/2026 To vote on a stockholder proposal requesting a report on the risks of ESG and DEI executive compensation metrics, if properly presented at the Annual Meeting. HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE SECURITY HOLDER 4500 0 ABSTAIN 4500 AGAINST GLOBUS MEDICAL, INC. 379577208 US3795772082 06/03/2026 Election of two Class II directors to serve until the 2029 Annual Meeting of Stockholders: Robert Douglas DIRECTOR ELECTIONS ISSUER 7500 0 FOR 7500 FOR GLOBUS MEDICAL, INC. 379577208 US3795772082 06/03/2026 Election of two Class II directors to serve until the 2029 Annual Meeting of Stockholders: Keith W. Pfeil DIRECTOR ELECTIONS ISSUER 7500 0 FOR 7500 FOR GLOBUS MEDICAL, INC. 379577208 US3795772082 06/03/2026 Approval of an amendment to the Globus Medical, Inc. 2021 Equity Incentive Plan to increase the number of authorized shares thereunder by 1,000,000. COMPENSATION ISSUER 7500 0 AGAINST 7500 AGAINST GLOBUS MEDICAL, INC. 379577208 US3795772082 06/03/2026 Ratification of the appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 7500 0 FOR 7500 FOR GLOBUS MEDICAL, INC. 379577208 US3795772082 06/03/2026 Approval, on a non-binding, advisory basis, of the 2025 compensation of the company's named executive officers (the "Say-on-Pay" Vote). SECTION 14A SAY-ON-PAY VOTES ISSUER 7500 0 FOR 7500 FOR GRAIL, INC. 384747101 US3847471014 06/18/2026 Election of Director: 1. Sarah Krevans DIRECTOR ELECTIONS ISSUER 1200 0 FOR 1200 FOR GRAIL, INC. 384747101 US3847471014 06/18/2026 Election of Director: 2. Steven Mizell DIRECTOR ELECTIONS ISSUER 1200 0 FOR 1200 FOR GRAIL, INC. 384747101 US3847471014 06/18/2026 The ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1200 0 FOR 1200 FOR GUARDANT HEALTH, INC. 40131M109 US40131M1099 06/17/2026 Election of Class II Directors Ian Clark DIRECTOR ELECTIONS ISSUER 500 0 FOR 500 FOR GUARDANT HEALTH, INC. 40131M109 US40131M1099 06/17/2026 Election of Class II Directors Manuel Hidalgo Medina DIRECTOR ELECTIONS ISSUER 500 0 FOR 500 FOR GUARDANT HEALTH, INC. 40131M109 US40131M1099 06/17/2026 Ratification of the appointment of Deloitte & Touche LLP as Guardant Health, Inc.'s independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 500 0 FOR 500 FOR GUARDANT HEALTH, INC. 40131M109 US40131M1099 06/17/2026 Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 500 0 FOR 500 FOR GUARDANT HEALTH, INC. 40131M109 US40131M1099 06/17/2026 Non-binding advisory vote on the frequency of stockholder advisory votes regarding compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 500 0 1 Year 500 FOR HALOZYME THERAPEUTICS, INC. 40637H109 US40637H1095 05/05/2026 Election of Class I Directors Bernadette Connaughton DIRECTOR ELECTIONS ISSUER 43200 0 FOR 43200 FOR HALOZYME THERAPEUTICS, INC. 40637H109 US40637H1095 05/05/2026 Election of Class I Directors Matthew L. Posard DIRECTOR ELECTIONS ISSUER 43200 0 FOR 43200 FOR HALOZYME THERAPEUTICS, INC. 40637H109 US40637H1095 05/05/2026 To approve, by a non-binding advisory vote, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 43200 0 FOR 43200 FOR HALOZYME THERAPEUTICS, INC. 40637H109 US40637H1095 05/05/2026 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 43200 0 FOR 43200 FOR HCA HEALTHCARE, INC. 40412C101 US40412C1018 04/23/2026 Election of Directors Thomas F. Frist III DIRECTOR ELECTIONS ISSUER 2000 0 FOR 2000 FOR HCA HEALTHCARE, INC. 40412C101 US40412C1018 04/23/2026 Election of Directors Samuel N. Hazen DIRECTOR ELECTIONS ISSUER 2000 0 FOR 2000 FOR HCA HEALTHCARE, INC. 40412C101 US40412C1018 04/23/2026 Election of Directors John W. Chidsey, III DIRECTOR ELECTIONS ISSUER 2000 0 FOR 2000 FOR HCA HEALTHCARE, INC. 40412C101 US40412C1018 04/23/2026 Election of Directors Nancy-Ann DeParle DIRECTOR ELECTIONS ISSUER 2000 0 FOR 2000 FOR HCA HEALTHCARE, INC. 40412C101 US40412C1018 04/23/2026 Election of Directors William R. Frist DIRECTOR ELECTIONS ISSUER 2000 0 FOR 2000 FOR HCA HEALTHCARE, INC. 40412C101 US40412C1018 04/23/2026 Election of Directors Hugh F. Johnston DIRECTOR ELECTIONS ISSUER 2000 0 FOR 2000 FOR HCA HEALTHCARE, INC. 40412C101 US40412C1018 04/23/2026 Election of Directors Michael W. Michelson DIRECTOR ELECTIONS ISSUER 2000 0 FOR 2000 FOR HCA HEALTHCARE, INC. 40412C101 US40412C1018 04/23/2026 Election of Directors Wayne J. Riley, M.D. DIRECTOR ELECTIONS ISSUER 2000 0 FOR 2000 FOR HCA HEALTHCARE, INC. 40412C101 US40412C1018 04/23/2026 Election of Directors Andrea B. Smith DIRECTOR ELECTIONS ISSUER 2000 0 FOR 2000 FOR HCA HEALTHCARE, INC. 40412C101 US40412C1018 04/23/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 2000 0 FOR 2000 FOR HCA HEALTHCARE, INC. 40412C101 US40412C1018 04/23/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2000 0 FOR 2000 FOR HCA HEALTHCARE, INC. 40412C101 US40412C1018 04/23/2026 Stockholder proposal, if properly presented at the meeting, regarding a report on healthcare consequences. HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE SECURITY HOLDER 2000 0 ABSTAIN 2000 AGAINST HCA HEALTHCARE, INC. 40412C101 US40412C1018 04/23/2026 Stockholder proposal, if properly presented at the meeting, regarding shareholders' right to act by written consent. CORPORATE GOVERNANCE SECURITY HOLDER 2000 0 AGAINST 2000 FOR HEALTHEQUITY, INC. 42226A107 US42226A1079 06/25/2026 Election of the ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Robert Selander DIRECTOR ELECTIONS ISSUER 1600 0 FOR 1600 FOR HEALTHEQUITY, INC. 42226A107 US42226A1079 06/25/2026 Election of the ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Scott Cutler DIRECTOR ELECTIONS ISSUER 1600 0 FOR 1600 FOR HEALTHEQUITY, INC. 42226A107 US42226A1079 06/25/2026 Election of the ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Stephen Neeleman, M.D. DIRECTOR ELECTIONS ISSUER 1600 0 FOR 1600 FOR HEALTHEQUITY, INC. 42226A107 US42226A1079 06/25/2026 Election of the ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Adrian Dillon DIRECTOR ELECTIONS ISSUER 1600 0 FOR 1600 FOR HEALTHEQUITY, INC. 42226A107 US42226A1079 06/25/2026 Election of the ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Evelyn Dilsaver DIRECTOR ELECTIONS ISSUER 1600 0 FOR 1600 FOR HEALTHEQUITY, INC. 42226A107 US42226A1079 06/25/2026 Election of the ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: William Gassen DIRECTOR ELECTIONS ISSUER 1600 0 FOR 1600 FOR HEALTHEQUITY, INC. 42226A107 US42226A1079 06/25/2026 Election of the ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Debra McCowan DIRECTOR ELECTIONS ISSUER 1600 0 FOR 1600 FOR HEALTHEQUITY, INC. 42226A107 US42226A1079 06/25/2026 Election of the ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Rajesh Natarajan DIRECTOR ELECTIONS ISSUER 1600 0 FOR 1600 FOR HEALTHEQUITY, INC. 42226A107 US42226A1079 06/25/2026 Election of the ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Stuart Parker DIRECTOR ELECTIONS ISSUER 1600 0 FOR 1600 FOR HEALTHEQUITY, INC. 42226A107 US42226A1079 06/25/2026 Election of the ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Gayle Wellborn DIRECTOR ELECTIONS ISSUER 1600 0 FOR 1600 FOR HEALTHEQUITY, INC. 42226A107 US42226A1079 06/25/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending January 31, 2027. AUDIT-RELATED ISSUER 1600 0 FOR 1600 FOR HEALTHEQUITY, INC. 42226A107 US42226A1079 06/25/2026 To approve, on a non-binding, advisory basis, the fiscal 2026 compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1600 0 FOR 1600 FOR HEALTHEQUITY, INC. 42226A107 US42226A1079 06/25/2026 Approval of the HealthEquity, Inc. 2026 Employee Stock Purchase Plan. CAPITAL STRUCTURE ISSUER 1600 0 FOR 1600 FOR HEALTHEQUITY, INC. 42226A107 US42226A1079 06/25/2026 To approve the Amended and Restated HealthEquity, Inc. 2024 Equity Incentive Plan. COMPENSATION ISSUER 1600 0 ABSTAIN 1600 AGAINST HENRY SCHEIN, INC. 806407102 US8064071025 05/21/2026 Election of Incumbent Directors Mohamad Ali DIRECTOR ELECTIONS ISSUER 27700 0 FOR 27700 FOR HENRY SCHEIN, INC. 806407102 US8064071025 05/21/2026 Election of Incumbent Directors William K. "Dan" Daniel DIRECTOR ELECTIONS ISSUER 27700 0 FOR 27700 FOR HENRY SCHEIN, INC. 806407102 US8064071025 05/21/2026 Election of Incumbent Directors Deborah Derby DIRECTOR ELECTIONS ISSUER 27700 0 FOR 27700 FOR HENRY SCHEIN, INC. 806407102 US8064071025 05/21/2026 Election of Incumbent Directors Carole T. Faig DIRECTOR ELECTIONS ISSUER 27700 0 FOR 27700 FOR HENRY SCHEIN, INC. 806407102 US8064071025 05/21/2026 Election of Incumbent Directors Kurt P. Kuehn DIRECTOR ELECTIONS ISSUER 27700 0 FOR 27700 FOR HENRY SCHEIN, INC. 806407102 US8064071025 05/21/2026 Election of Incumbent Directors Philip A. Laskawy DIRECTOR ELECTIONS ISSUER 27700 0 FOR 27700 FOR HENRY SCHEIN, INC. 806407102 US8064071025 05/21/2026 Election of Incumbent Directors Max Lin DIRECTOR ELECTIONS ISSUER 27700 0 FOR 27700 FOR HENRY SCHEIN, INC. 806407102 US8064071025 05/21/2026 Election of Incumbent Directors Frederick M. Lowery DIRECTOR ELECTIONS ISSUER 27700 0 FOR 27700 FOR HENRY SCHEIN, INC. 806407102 US8064071025 05/21/2026 Election of Incumbent Directors Anne H. Margulies DIRECTOR ELECTIONS ISSUER 27700 0 FOR 27700 FOR HENRY SCHEIN, INC. 806407102 US8064071025 05/21/2026 Election of Incumbent Directors Reed V. Tuckson, M.D., FACP DIRECTOR ELECTIONS ISSUER 27700 0 FOR 27700 FOR HENRY SCHEIN, INC. 806407102 US8064071025 05/21/2026 Proposal to approve, by non-binding vote, the 2025 compensation paid to the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 27700 0 FOR 27700 FOR HENRY SCHEIN, INC. 806407102 US8064071025 05/21/2026 Proposal to ratify the selection of BDO USA, P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 26, 2026. AUDIT-RELATED ISSUER 27700 0 FOR 27700 FOR HENRY SCHEIN, INC. 806407102 US8064071025 05/21/2026 Proposal to approve, by non-binding vote, a shareholder proposal to Govern by Majority Vote. CORPORATE GOVERNANCE SECURITY HOLDER 27700 0 AGAINST 27700 FOR HILLENBRAND, INC. 431571108 US4315711089 01/08/2026 Proposal to approve the Agreement and Plan of Merger, dated as of October 14, 2025, as it may be amended from time to time (the "Merger Agreement"), by and among Hillenbrand, Inc., LSF12 Helix Parent, LLC and LSF12 Helix Merger Sub, Inc. (the "Merger Agreement Proposal"). CORPORATE GOVERNANCE ISSUER 30000 0 FOR 30000 FOR HILLENBRAND, INC. 431571108 US4315711089 01/08/2026 Proposal to approve, on an advisory (nonbinding) basis, the compensation that may be paid or become payable to Hillenbrand, Inc.'s named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement (the "Compensation Proposal"). SECTION 14A SAY-ON-PAY VOTES ISSUER 30000 0 FOR 30000 FOR HILLENBRAND, INC. 431571108 US4315711089 01/08/2026 Proposal to approve any adjournment of the Special Meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the Special Meeting to approve the Merger Agreement Proposal (the "Adjournment Proposal"). CORPORATE GOVERNANCE ISSUER 30000 0 FOR 30000 FOR HINGE HEALTH, INC. 433313103 US4333131039 06/03/2026 Election of Director: 1. Teddie Wardi DIRECTOR ELECTIONS ISSUER 4500 0 FOR 4500 FOR HINGE HEALTH, INC. 433313103 US4333131039 06/03/2026 Election of Director: 2. Tyler Sloat DIRECTOR ELECTIONS ISSUER 4500 0 FOR 4500 FOR HINGE HEALTH, INC. 433313103 US4333131039 06/03/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 4500 0 FOR 4500 FOR ICU MEDICAL, INC. 44930G107 US44930G1076 05/13/2026 Election of Director: 1. Vivek Jain DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR ICU MEDICAL, INC. 44930G107 US44930G1076 05/13/2026 Election of Director: 2. David C. Greenberg DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR ICU MEDICAL, INC. 44930G107 US44930G1076 05/13/2026 Election of Director: 3. Elisha W. Finney DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR ICU MEDICAL, INC. 44930G107 US44930G1076 05/13/2026 Election of Director: 4. David F. Hoffmeister DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR ICU MEDICAL, INC. 44930G107 US44930G1076 05/13/2026 Election of Director: 5. Donald M. Abbey DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR ICU MEDICAL, INC. 44930G107 US44930G1076 05/13/2026 Election of Director: 6. Laurie Hernandez DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR ICU MEDICAL, INC. 44930G107 US44930G1076 05/13/2026 Election of Director: 7. Kolleen T. Kennedy DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR ICU MEDICAL, INC. 44930G107 US44930G1076 05/13/2026 To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 10000 0 FOR 10000 FOR ICU MEDICAL, INC. 44930G107 US44930G1076 05/13/2026 To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 10000 0 FOR 10000 FOR ICU MEDICAL, INC. 44930G107 US44930G1076 05/13/2026 To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to adopt simple majority voting provisions. CORPORATE GOVERNANCE ISSUER 10000 0 FOR 10000 FOR ICU MEDICAL, INC. 44930G107 US44930G1076 05/13/2026 To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to adopt a stockholder right to call special meetings at an ownership threshold of 25%. CORPORATE GOVERNANCE ISSUER 10000 0 FOR 10000 FOR ICU MEDICAL, INC. 44930G107 US44930G1076 05/13/2026 To approve an adjournment of the Annual Meeting, if necessary, to solicit additional proxies to approve Proposal 5. CORPORATE GOVERNANCE ISSUER 10000 0 FOR 10000 FOR ICU MEDICAL, INC. 44930G107 US44930G1076 05/13/2026 To approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right. CORPORATE GOVERNANCE SECURITY HOLDER 10000 0 AGAINST 10000 FOR IDEXX LABORATORIES, INC. 45168D104 US45168D1046 05/12/2026 Election of Directors (Proposal One). Daniel M. Junius DIRECTOR ELECTIONS ISSUER 65 0 FOR 65 FOR IDEXX LABORATORIES, INC. 45168D104 US45168D1046 05/12/2026 Election of Directors (Proposal One). Lawrence D. Kingsley DIRECTOR ELECTIONS ISSUER 65 0 FOR 65 FOR IDEXX LABORATORIES, INC. 45168D104 US45168D1046 05/12/2026 Election of Directors (Proposal One). Sophie V. Vandebroek, PhD DIRECTOR ELECTIONS ISSUER 65 0 FOR 65 FOR IDEXX LABORATORIES, INC. 45168D104 US45168D1046 05/12/2026 Ratification of Appointment of Independent Registered Public Accounting Firm. To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the current fiscal year (Proposal Two). AUDIT-RELATED ISSUER 65 0 FOR 65 FOR IDEXX LABORATORIES, INC. 45168D104 US45168D1046 05/12/2026 Advisory Vote on Executive Compensation. To approve a nonbinding advisory resolution on the Company's executive compensation (Proposal Three). SECTION 14A SAY-ON-PAY VOTES ISSUER 65 0 FOR 65 FOR IDEXX LABORATORIES, INC. 45168D104 US45168D1046 05/12/2026 Amend Certificate of Incorporation to Declassify the Board (Proposal Four). SHAREHOLDER RIGHTS AND DEFENSES ISSUER 65 0 FOR 65 FOR IDEXX LABORATORIES, INC. 45168D104 US45168D1046 05/12/2026 Amend Certificate of Incorporation to Provide Shareholders Owning 25% of the Shares of our Capital Stock the Right to Have IDEXX Call a Special Meeting (Proposal Five). CORPORATE GOVERNANCE ISSUER 65 0 FOR 65 FOR IDEXX LABORATORIES, INC. 45168D104 US45168D1046 05/12/2026 Shareholder Proposal to Give Shareholders the Ability to Call for a Special Shareholder Meeting (Proposal Six). CORPORATE GOVERNANCE SECURITY HOLDER 65 0 AGAINST 65 FOR ILLUMINA, INC. 452327109 US4523271090 05/21/2026 Election of Directors Caroline D. Dorsa DIRECTOR ELECTIONS ISSUER 3700 0 FOR 3700 FOR ILLUMINA, INC. 452327109 US4523271090 05/21/2026 Election of Directors Scott Gottlieb, M.D. DIRECTOR ELECTIONS ISSUER 3700 0 FOR 3700 FOR ILLUMINA, INC. 452327109 US4523271090 05/21/2026 Election of Directors David P. King DIRECTOR ELECTIONS ISSUER 3700 0 FOR 3700 FOR ILLUMINA, INC. 452327109 US4523271090 05/21/2026 Election of Directors Keith A. Meister DIRECTOR ELECTIONS ISSUER 3700 0 FOR 3700 FOR ILLUMINA, INC. 452327109 US4523271090 05/21/2026 Election of Directors Anna Richo DIRECTOR ELECTIONS ISSUER 3700 0 FOR 3700 FOR ILLUMINA, INC. 452327109 US4523271090 05/21/2026 Election of Directors Philip W. Schiller DIRECTOR ELECTIONS ISSUER 3700 0 FOR 3700 FOR ILLUMINA, INC. 452327109 US4523271090 05/21/2026 Election of Directors Susan E. Siegel DIRECTOR ELECTIONS ISSUER 3700 0 FOR 3700 FOR ILLUMINA, INC. 452327109 US4523271090 05/21/2026 Election of Directors Jacob Thaysen, Ph.D. DIRECTOR ELECTIONS ISSUER 3700 0 FOR 3700 FOR ILLUMINA, INC. 452327109 US4523271090 05/21/2026 Election of Directors Scott B. Ullem DIRECTOR ELECTIONS ISSUER 3700 0 FOR 3700 FOR ILLUMINA, INC. 452327109 US4523271090 05/21/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending January 3, 2027. AUDIT-RELATED ISSUER 3700 0 FOR 3700 FOR ILLUMINA, INC. 452327109 US4523271090 05/21/2026 To approve, on an advisory basis, the compensation of the named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 3700 0 FOR 3700 FOR IMMUNOME INC. 45257U108 US45257U1088 06/09/2026 To elect the three nominees named in the Proxy Statement to serve as Class III directors, to hold office until the 2029 Annual Meeting of Stockholders and such time as their successors are duly elected and qualified, or until their earlier death, resignation or removal. James Boylan DIRECTOR ELECTIONS ISSUER 8500 0 FOR 8500 FOR IMMUNOME INC. 45257U108 US45257U1088 06/09/2026 To elect the three nominees named in the Proxy Statement to serve as Class III directors, to hold office until the 2029 Annual Meeting of Stockholders and such time as their successors are duly elected and qualified, or until their earlier death, resignation or removal. Sandra M. Swain, M.D. DIRECTOR ELECTIONS ISSUER 8500 0 FOR 8500 FOR IMMUNOME INC. 45257U108 US45257U1088 06/09/2026 To elect the three nominees named in the Proxy Statement to serve as Class III directors, to hold office until the 2029 Annual Meeting of Stockholders and such time as their successors are duly elected and qualified, or until their earlier death, resignation or removal. Philip Wagenheim DIRECTOR ELECTIONS ISSUER 8500 0 FOR 8500 FOR IMMUNOME INC. 45257U108 US45257U1088 06/09/2026 To ratify the appointment of Ernst & Young LLP our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 8500 0 FOR 8500 FOR IMMUNOME INC. 45257U108 US45257U1088 06/09/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 8500 0 FOR 8500 FOR IMMUNOME INC. 45257U108 US45257U1088 06/09/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 8500 0 1 Year 8500 FOR INFUSYSTEM HOLDINGS, INC. 45685K102 US45685K1025 05/11/2026 Election of Directors: Dr. Kenneth D. Eichenbaum, MD, MSE DIRECTOR ELECTIONS ISSUER 142085 0 FOR 142085 FOR INFUSYSTEM HOLDINGS, INC. 45685K102 US45685K1025 05/11/2026 Election of Directors: Paul A. Gendron DIRECTOR ELECTIONS ISSUER 142085 0 FOR 142085 FOR INFUSYSTEM HOLDINGS, INC. 45685K102 US45685K1025 05/11/2026 Election of Directors: Ronald Hundzinski DIRECTOR ELECTIONS ISSUER 142085 0 FOR 142085 FOR INFUSYSTEM HOLDINGS, INC. 45685K102 US45685K1025 05/11/2026 Election of Directors: Beverly A. Huss DIRECTOR ELECTIONS ISSUER 142085 0 FOR 142085 FOR INFUSYSTEM HOLDINGS, INC. 45685K102 US45685K1025 05/11/2026 Election of Directors: Carrie Lachance DIRECTOR ELECTIONS ISSUER 142085 0 FOR 142085 FOR INFUSYSTEM HOLDINGS, INC. 45685K102 US45685K1025 05/11/2026 Election of Directors: Scott Shuda DIRECTOR ELECTIONS ISSUER 142085 0 FOR 142085 FOR INFUSYSTEM HOLDINGS, INC. 45685K102 US45685K1025 05/11/2026 Election of Directors: Dr. John J. Sviokla DIRECTOR ELECTIONS ISSUER 142085 0 FOR 142085 FOR INFUSYSTEM HOLDINGS, INC. 45685K102 US45685K1025 05/11/2026 Approval, on an advisory basis, of the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 142085 0 FOR 142085 FOR INFUSYSTEM HOLDINGS, INC. 45685K102 US45685K1025 05/11/2026 Approval of an amendment increasing the number of shares reserved under the InfuSystem Holdings, Inc. 2021 Equity Incentive Plan. COMPENSATION ISSUER 142085 0 AGAINST 142085 AGAINST INFUSYSTEM HOLDINGS, INC. 45685K102 US45685K1025 05/11/2026 Ratification of the appointment of Grant Thornton LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 142085 0 FOR 142085 FOR INGLES MARKETS, INCORPORATED 457030104 US4570301048 04/30/2026 SUMMER ROAD NOMINEE: Rory A. Held DIRECTOR ELECTIONS ISSUER 25000 0 FOR 25000 FOR INGLES MARKETS, INCORPORATED 457030104 US4570301048 04/30/2026 COMPANY NOMINEE UNOPPOSED BY SUMMER ROAD: Dwight Jacobs DIRECTOR ELECTIONS ISSUER 25000 0 FOR 25000 FOR INGLES MARKETS, INCORPORATED 457030104 US4570301048 04/30/2026 COMPANY NOMINEE OPPOSED BY SUMMER ROAD: Rebekah Lowe DIRECTOR ELECTIONS ISSUER 25000 0 WITHHOLD 25000 AGAINST INGLES MARKETS, INCORPORATED 457030104 US4570301048 04/30/2026 Company's proposal to approve, by non-binding vote, executive compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 25000 0 FOR 25000 AGAINST INSMED INCORPORATED 457669307 US4576693075 05/13/2026 Election of Director: 1. E. McKee Anderson DIRECTOR ELECTIONS ISSUER 2700 0 FOR 2700 FOR INSMED INCORPORATED 457669307 US4576693075 05/13/2026 Election of Director: 2. C. Desjardins, Ph.D. DIRECTOR ELECTIONS ISSUER 2700 0 FOR 2700 FOR INSMED INCORPORATED 457669307 US4576693075 05/13/2026 An advisory vote on the 2025 compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2700 0 FOR 2700 FOR INSMED INCORPORATED 457669307 US4576693075 05/13/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 2700 0 FOR 2700 FOR INSPIRE MEDICAL SYSTEMS, INC. 457730109 US4577301090 04/30/2026 Election of Director: 1. Gary L. Ellis DIRECTOR ELECTIONS ISSUER 1500 0 FOR 1500 FOR INSPIRE MEDICAL SYSTEMS, INC. 457730109 US4577301090 04/30/2026 Election of Director: 2. Georgia Melenikiotou DIRECTOR ELECTIONS ISSUER 1500 0 FOR 1500 FOR INSPIRE MEDICAL SYSTEMS, INC. 457730109 US4577301090 04/30/2026 Election of Director: 3. Dana G. Mead, Jr. DIRECTOR ELECTIONS ISSUER 1500 0 FOR 1500 FOR INSPIRE MEDICAL SYSTEMS, INC. 457730109 US4577301090 04/30/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 1500 0 FOR 1500 FOR INSPIRE MEDICAL SYSTEMS, INC. 457730109 US4577301090 04/30/2026 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1500 0 FOR 1500 FOR INSPIRE MEDICAL SYSTEMS, INC. 457730109 US4577301090 04/30/2026 Approval, on an advisory (non-binding) basis, of the frequency of future advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1500 0 1 Year 1500 FOR INSPIRE MEDICAL SYSTEMS, INC. 457730109 US4577301090 04/30/2026 Approval of an amendment to the Company's Seventh Amended and Restated Certificate of Incorporation to phase out the classified Board structure and provide for the annual election of all directors beginning with the Company's 2029 annual meeting of stockholders. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 1500 0 FOR 1500 FOR INSPIRE MEDICAL SYSTEMS, INC. 457730109 US4577301090 04/30/2026 Approval of an amendment and restatement of the Inspire Medical Systems, Inc. 2018 Incentive Award Plan. COMPENSATION ISSUER 1500 0 ABSTAIN 1500 AGAINST INSPIRE MEDICAL SYSTEMS, INC. 457730109 US4577301090 04/30/2026 Approval of an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve Proposal No. 5 and/or Proposal No. 6. CORPORATE GOVERNANCE ISSUER 1500 0 FOR 1500 FOR INTEGER HOLDINGS CORPORATION 45826H109 US45826H1095 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified. Sheila Antrum DIRECTOR ELECTIONS ISSUER 18500 0 FOR 18500 FOR INTEGER HOLDINGS CORPORATION 45826H109 US45826H1095 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified. Cheryl C. Capps DIRECTOR ELECTIONS ISSUER 18500 0 FOR 18500 FOR INTEGER HOLDINGS CORPORATION 45826H109 US45826H1095 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified. Michael J. Coyle DIRECTOR ELECTIONS ISSUER 18500 0 FOR 18500 FOR INTEGER HOLDINGS CORPORATION 45826H109 US45826H1095 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified. James F. Flanagan DIRECTOR ELECTIONS ISSUER 18500 0 FOR 18500 FOR INTEGER HOLDINGS CORPORATION 45826H109 US45826H1095 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified. James F. Hinrichs DIRECTOR ELECTIONS ISSUER 18500 0 FOR 18500 FOR INTEGER HOLDINGS CORPORATION 45826H109 US45826H1095 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified. Alvin (Tyrone) Jeffers DIRECTOR ELECTIONS ISSUER 18500 0 FOR 18500 FOR INTEGER HOLDINGS CORPORATION 45826H109 US45826H1095 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified. Aaron Kapito DIRECTOR ELECTIONS ISSUER 18500 0 FOR 18500 FOR INTEGER HOLDINGS CORPORATION 45826H109 US45826H1095 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified. Payman Khales DIRECTOR ELECTIONS ISSUER 18500 0 FOR 18500 FOR INTEGER HOLDINGS CORPORATION 45826H109 US45826H1095 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified. M. Craig Maxwell DIRECTOR ELECTIONS ISSUER 18500 0 FOR 18500 FOR INTEGER HOLDINGS CORPORATION 45826H109 US45826H1095 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified. Filippo Passerini DIRECTOR ELECTIONS ISSUER 18500 0 FOR 18500 FOR INTEGER HOLDINGS CORPORATION 45826H109 US45826H1095 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified. Donald J. Spence DIRECTOR ELECTIONS ISSUER 18500 0 FOR 18500 FOR INTEGER HOLDINGS CORPORATION 45826H109 US45826H1095 05/20/2026 To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for Integer Holdings Corporation for fiscal year 2026. AUDIT-RELATED ISSUER 18500 0 FOR 18500 FOR INTEGER HOLDINGS CORPORATION 45826H109 US45826H1095 05/20/2026 To approve, in an advisory non-binding vote, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 18500 0 FOR 18500 FOR INTEGER HOLDINGS CORPORATION 45826H109 US45826H1095 05/20/2026 To approve the Integer Holdings Corporation 2026 Omnibus Incentive Plan. COMPENSATION ISSUER 18500 0 FOR 18500 FOR INTUITIVE SURGICAL, INC. 46120E602 US46120E6023 04/30/2026 Election of Directors Craig H. Barratt, Ph.D. DIRECTOR ELECTIONS ISSUER 2000 0 FOR 2000 FOR INTUITIVE SURGICAL, INC. 46120E602 US46120E6023 04/30/2026 Election of Directors Joseph C. Beery DIRECTOR ELECTIONS ISSUER 2000 0 FOR 2000 FOR INTUITIVE SURGICAL, INC. 46120E602 US46120E6023 04/30/2026 Election of Directors Lewis Chew DIRECTOR ELECTIONS ISSUER 2000 0 FOR 2000 FOR INTUITIVE SURGICAL, INC. 46120E602 US46120E6023 04/30/2026 Election of Directors Gary S. Guthart, Ph.D. DIRECTOR ELECTIONS ISSUER 2000 0 FOR 2000 FOR INTUITIVE SURGICAL, INC. 46120E602 US46120E6023 04/30/2026 Election of Directors Sreelakshmi Kolli DIRECTOR ELECTIONS ISSUER 2000 0 FOR 2000 FOR INTUITIVE SURGICAL, INC. 46120E602 US46120E6023 04/30/2026 Election of Directors Amy L. Ladd, M.D. DIRECTOR ELECTIONS ISSUER 2000 0 FOR 2000 FOR INTUITIVE SURGICAL, INC. 46120E602 US46120E6023 04/30/2026 Election of Directors Keith R. Leonard, Jr. DIRECTOR ELECTIONS ISSUER 2000 0 FOR 2000 FOR INTUITIVE SURGICAL, INC. 46120E602 US46120E6023 04/30/2026 Election of Directors Jami Dover Nachtsheim DIRECTOR ELECTIONS ISSUER 2000 0 FOR 2000 FOR INTUITIVE SURGICAL, INC. 46120E602 US46120E6023 04/30/2026 Election of Directors Monica P. Reed, M.D. DIRECTOR ELECTIONS ISSUER 2000 0 FOR 2000 FOR INTUITIVE SURGICAL, INC. 46120E602 US46120E6023 04/30/2026 Election of Directors David J. Rosa DIRECTOR ELECTIONS ISSUER 2000 0 FOR 2000 FOR INTUITIVE SURGICAL, INC. 46120E602 US46120E6023 04/30/2026 To approve, by advisory vote, the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2000 0 FOR 2000 FOR INTUITIVE SURGICAL, INC. 46120E602 US46120E6023 04/30/2026 The ratification of appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2000 0 FOR 2000 FOR INTUITIVE SURGICAL, INC. 46120E602 US46120E6023 04/30/2026 To approve the amendment and restatement of the Company's Amended and Restated 2010 Incentive Award Plan. COMPENSATION ISSUER 2000 0 AGAINST 2000 AGAINST IONIS PHARMACEUTICALS, INC. 462222100 US4622221004 06/04/2026 Election of Directors Spencer R. Berthelsen DIRECTOR ELECTIONS ISSUER 1800 0 FOR 1800 FOR IONIS PHARMACEUTICALS, INC. 462222100 US4622221004 06/04/2026 Election of Directors Joan E. Herman DIRECTOR ELECTIONS ISSUER 1800 0 FOR 1800 FOR IONIS PHARMACEUTICALS, INC. 462222100 US4622221004 06/04/2026 To make an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1800 0 FOR 1800 FOR IONIS PHARMACEUTICALS, INC. 462222100 US4622221004 06/04/2026 To approve an amendment of the Amended and Restated Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under such plan by 9,500,000 shares to an aggregate of 52,000,000 shares. COMPENSATION ISSUER 1800 0 ABSTAIN 1800 AGAINST IONIS PHARMACEUTICALS, INC. 462222100 US4622221004 06/04/2026 To approve an amendment of the Amended and Restated 2000 Employee Stock Purchase Plan to increase the number of shares of common stock authorized for purchase under such plan by 750,000 shares and remove the termination date of the plan. CAPITAL STRUCTURE ISSUER 1800 0 FOR 1800 FOR IONIS PHARMACEUTICALS, INC. 462222100 US4622221004 06/04/2026 To ratify the Audit Committee's selection of Ernst & Young LLP as independent auditors for the 2026 fiscal year. AUDIT-RELATED ISSUER 1800 0 FOR 1800 FOR ITO EN,LTD. J25027103 JP3143000002 07/25/2025 Approve Appropriation of Surplus CAPITAL STRUCTURE ISSUER 40000 0 FOR 40000 FOR ITO EN,LTD. J25027103 JP3143000002 07/25/2025 Appoint a Director who is not Audit and Supervisory Committee Member Honjo, Hachiro DIRECTOR ELECTIONS ISSUER 40000 0 FOR 40000 FOR ITO EN,LTD. J25027103 JP3143000002 07/25/2025 Appoint a Director who is not Audit and Supervisory Committee Member Honjo, Daisuke DIRECTOR ELECTIONS ISSUER 40000 0 FOR 40000 FOR ITO EN,LTD. J25027103 JP3143000002 07/25/2025 Appoint a Director who is not Audit and Supervisory Committee Member Honjo, Shusuke DIRECTOR ELECTIONS ISSUER 40000 0 FOR 40000 FOR ITO EN,LTD. J25027103 JP3143000002 07/25/2025 Appoint a Director who is not Audit and Supervisory Committee Member Nakano, Yoshihisa DIRECTOR ELECTIONS ISSUER 40000 0 FOR 40000 FOR ITO EN,LTD. J25027103 JP3143000002 07/25/2025 Appoint a Director who is not Audit and Supervisory Committee Member Kamiya, Shigeru DIRECTOR ELECTIONS ISSUER 40000 0 FOR 40000 FOR ITO EN,LTD. J25027103 JP3143000002 07/25/2025 Appoint a Director who is not Audit and Supervisory Committee Member Yosuke Jay Oceanbright Honjo DIRECTOR ELECTIONS ISSUER 40000 0 FOR 40000 FOR ITO EN,LTD. J25027103 JP3143000002 07/25/2025 Appoint a Director who is not Audit and Supervisory Committee Member Hirata, Atsushi DIRECTOR ELECTIONS ISSUER 40000 0 FOR 40000 FOR ITO EN,LTD. J25027103 JP3143000002 07/25/2025 Appoint a Director who is not Audit and Supervisory Committee Member Takano, Hideo DIRECTOR ELECTIONS ISSUER 40000 0 FOR 40000 FOR ITO EN,LTD. J25027103 JP3143000002 07/25/2025 Appoint a Director who is not Audit and Supervisory Committee Member Abe, Keiko DIRECTOR ELECTIONS ISSUER 40000 0 FOR 40000 FOR ITO EN,LTD. J25027103 JP3143000002 07/25/2025 Appoint a Director who is Audit and Supervisory Committee Member Kondo, Kiyoshi DIRECTOR ELECTIONS ISSUER 40000 0 AGAINST 40000 AGAINST ITO EN,LTD. J25027103 JP3143000002 07/25/2025 Appoint a Director who is Audit and Supervisory Committee Member Usui, Yuichi DIRECTOR ELECTIONS ISSUER 40000 0 FOR 40000 FOR ITO EN,LTD. J25027103 JP3143000002 07/25/2025 Appoint a Director who is Audit and Supervisory Committee Member Yokokura, Hitoshi DIRECTOR ELECTIONS ISSUER 40000 0 FOR 40000 FOR ITO EN,LTD. J25027103 JP3143000002 07/25/2025 Appoint a Director who is Audit and Supervisory Committee Member Okuda, Yoshihiko DIRECTOR ELECTIONS ISSUER 40000 0 FOR 40000 FOR JOHNSON & JOHNSON 478160104 US4781601046 04/23/2026 Election of Directors Mary C. Beckerle DIRECTOR ELECTIONS ISSUER 9200 0 FOR 9200 FOR JOHNSON & JOHNSON 478160104 US4781601046 04/23/2026 Election of Directors Jennifer A. Doudna DIRECTOR ELECTIONS ISSUER 9200 0 FOR 9200 FOR JOHNSON & JOHNSON 478160104 US4781601046 04/23/2026 Election of Directors Joaquin Duato DIRECTOR ELECTIONS ISSUER 9200 0 FOR 9200 FOR JOHNSON & JOHNSON 478160104 US4781601046 04/23/2026 Election of Directors Marillyn A. Hewson DIRECTOR ELECTIONS ISSUER 9200 0 FOR 9200 FOR JOHNSON & JOHNSON 478160104 US4781601046 04/23/2026 Election of Directors Paula A. Johnson DIRECTOR ELECTIONS ISSUER 9200 0 FOR 9200 FOR JOHNSON & JOHNSON 478160104 US4781601046 04/23/2026 Election of Directors Hubert Joly DIRECTOR ELECTIONS ISSUER 9200 0 FOR 9200 FOR JOHNSON & JOHNSON 478160104 US4781601046 04/23/2026 Election of Directors Mark B. McClellan DIRECTOR ELECTIONS ISSUER 9200 0 FOR 9200 FOR JOHNSON & JOHNSON 478160104 US4781601046 04/23/2026 Election of Directors John G. Morikis DIRECTOR ELECTIONS ISSUER 9200 0 FOR 9200 FOR JOHNSON & JOHNSON 478160104 US4781601046 04/23/2026 Election of Directors Daniel E. Pinto DIRECTOR ELECTIONS ISSUER 9200 0 FOR 9200 FOR JOHNSON & JOHNSON 478160104 US4781601046 04/23/2026 Election of Directors Mark A. Weinberger DIRECTOR ELECTIONS ISSUER 9200 0 FOR 9200 FOR JOHNSON & JOHNSON 478160104 US4781601046 04/23/2026 Election of Directors Nadja Y. West DIRECTOR ELECTIONS ISSUER 9200 0 FOR 9200 FOR JOHNSON & JOHNSON 478160104 US4781601046 04/23/2026 Election of Directors Eugene A. Woods DIRECTOR ELECTIONS ISSUER 9200 0 FOR 9200 FOR JOHNSON & JOHNSON 478160104 US4781601046 04/23/2026 Advisory Vote to Approve Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 9200 0 FOR 9200 FOR JOHNSON & JOHNSON 478160104 US4781601046 04/23/2026 Ratification of Appointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 9200 0 FOR 9200 FOR JOHNSON & JOHNSON 478160104 US4781601046 04/23/2026 Independent Board Chair CORPORATE GOVERNANCE SECURITY HOLDER 9200 0 AGAINST 9200 FOR KALVISTA PHARMACEUTICALS, INC. 483497103 US4834971032 10/01/2025 The election of two Class I directors to hold office until the earliest of our 2028 annual meeting of stockholders and such individual's death, resignation or removal and the election and qualification of his or her successor. Benjamin L. Palleiko DIRECTOR ELECTIONS ISSUER 1875 0 FOR 1875 FOR KALVISTA PHARMACEUTICALS, INC. 483497103 US4834971032 10/01/2025 The election of two Class I directors to hold office until the earliest of our 2028 annual meeting of stockholders and such individual's death, resignation or removal and the election and qualification of his or her successor. Brian J.G. Pereira DIRECTOR ELECTIONS ISSUER 1875 0 FOR 1875 FOR KALVISTA PHARMACEUTICALS, INC. 483497103 US4834971032 10/01/2025 The ratification of the selection by the audit committee of our Board, of Deloitte & Touche LLP as our independent registered public accounting firm for our eight-month transition period ending December 31, 2025. AUDIT-RELATED ISSUER 1875 0 FOR 1875 FOR KALVISTA PHARMACEUTICALS, INC. 483497103 US4834971032 10/01/2025 Approval, on a non-binding advisory basis, of the compensation paid by us to our named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1875 0 FOR 1875 FOR KERRY GROUP PLC G52416107 IE0004906560 04/30/2026 TO REVIEW THE COMPANY'S AFFAIRS AND TO RECEIVE AND CONSIDER THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025, TOGETHER WITH THE REPORTS OF THE DIRECTORS AND THE AUDITORS THEREON OTHER ISSUER 0 0 KERRY GROUP PLC G52416107 IE0004906560 04/30/2026 TO DECLARE A FINAL DIVIDEND CAPITAL STRUCTURE ISSUER 0 0 KERRY GROUP PLC G52416107 IE0004906560 04/30/2026 TO RE-ELECT DR GENEVIEVE BERGER DIRECTOR ELECTIONS ISSUER 0 0 KERRY GROUP PLC G52416107 IE0004906560 04/30/2026 TO RE-ELECT MS FIONA DAWSON DIRECTOR ELECTIONS ISSUER 0 0 KERRY GROUP PLC G52416107 IE0004906560 04/30/2026 TO RE-ELECT MS EMER GILVARRY DIRECTOR ELECTIONS ISSUER 0 0 KERRY GROUP PLC G52416107 IE0004906560 04/30/2026 TO RE-ELECT PROF CATHERINE GODSON DIRECTOR ELECTIONS ISSUER 0 0 KERRY GROUP PLC G52416107 IE0004906560 04/30/2026 TO RE-ELECT MS LIZ HEWITT DIRECTOR ELECTIONS ISSUER 0 0 KERRY GROUP PLC G52416107 IE0004906560 04/30/2026 TO RE-ELECT MR MICHAEL KERR DIRECTOR ELECTIONS ISSUER 0 0 KERRY GROUP PLC G52416107 IE0004906560 04/30/2026 TO RE-ELECT MS MARGUERITE LARKIN DIRECTOR ELECTIONS ISSUER 0 0 KERRY GROUP PLC G52416107 IE0004906560 04/30/2026 TO RE-ELECT MR CHRISTOPHER ROGERS DIRECTOR ELECTIONS ISSUER 0 0 KERRY GROUP PLC G52416107 IE0004906560 04/30/2026 TO RE-ELECT MR EDMOND SCANLON DIRECTOR ELECTIONS ISSUER 0 0 KERRY GROUP PLC G52416107 IE0004906560 04/30/2026 TO RE-ELECT MR JINLONG WANG DIRECTOR ELECTIONS ISSUER 0 0 KERRY GROUP PLC G52416107 IE0004906560 04/30/2026 TO APPROVE THE APPOINTMENT OF KPMG CHARTERED ACCOUNTANTS AS EXTERNAL AUDITOR OF THE COMPANY AUDIT-RELATED ISSUER 0 0 KERRY GROUP PLC G52416107 IE0004906560 04/30/2026 AUTHORITY TO DETERMINE THE AUDITORS' REMUNERATION AUDIT-RELATED ISSUER 0 0 KERRY GROUP PLC G52416107 IE0004906560 04/30/2026 TO RECEIVE AND CONSIDER THE DIRECTORS' REMUNERATION REPORT (EXCLUDING SECTION C) SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 KERRY GROUP PLC G52416107 IE0004906560 04/30/2026 AUTHORITY TO ISSUE ORDINARY SHARES CAPITAL STRUCTURE ISSUER 0 0 KERRY GROUP PLC G52416107 IE0004906560 04/30/2026 AUTHORITY TO DISAPPLY PRE-EMPTION RIGHTS CAPITAL STRUCTURE ISSUER 0 0 KERRY GROUP PLC G52416107 IE0004906560 04/30/2026 AUTHORITY TO DISAPPLY PRE-EMPTION RIGHTS FOR AN ADDITIONAL 5 FOR SPECIFIED TRANSACTIONS CAPITAL STRUCTURE ISSUER 0 0 KERRY GROUP PLC G52416107 IE0004906560 04/30/2026 AUTHORITY TO MAKE MARKET PURCHASES OF THE COMPANY'S OWN SHARES CAPITAL STRUCTURE ISSUER 0 0 KIKKOMAN CORPORATION J32620106 JP3240400006 06/23/2026 Approve Appropriation of Surplus CAPITAL STRUCTURE ISSUER 215000 0 FOR 215000 FOR KIKKOMAN CORPORATION J32620106 JP3240400006 06/23/2026 Appoint a Director Mogi, Yuzaburo DIRECTOR ELECTIONS ISSUER 215000 0 FOR 215000 FOR KIKKOMAN CORPORATION J32620106 JP3240400006 06/23/2026 Appoint a Director Horikiri, Noriaki DIRECTOR ELECTIONS ISSUER 215000 0 FOR 215000 FOR KIKKOMAN CORPORATION J32620106 JP3240400006 06/23/2026 Appoint a Director Nakano, Shozaburo DIRECTOR ELECTIONS ISSUER 215000 0 FOR 215000 FOR KIKKOMAN CORPORATION J32620106 JP3240400006 06/23/2026 Appoint a Director Mogi, Osamu DIRECTOR ELECTIONS ISSUER 215000 0 FOR 215000 FOR KIKKOMAN CORPORATION J32620106 JP3240400006 06/23/2026 Appoint a Director Matsuyama, Asahi DIRECTOR ELECTIONS ISSUER 215000 0 FOR 215000 FOR KIKKOMAN CORPORATION J32620106 JP3240400006 06/23/2026 Appoint a Director Tsuji, Ryohei DIRECTOR ELECTIONS ISSUER 215000 0 FOR 215000 FOR KIKKOMAN CORPORATION J32620106 JP3240400006 06/23/2026 Appoint a Director Fukui, Toshihiko DIRECTOR ELECTIONS ISSUER 215000 0 FOR 215000 FOR KIKKOMAN CORPORATION J32620106 JP3240400006 06/23/2026 Appoint a Director Inokuchi, Takeo DIRECTOR ELECTIONS ISSUER 215000 0 FOR 215000 FOR KIKKOMAN CORPORATION J32620106 JP3240400006 06/23/2026 Appoint a Director Iino, Masako DIRECTOR ELECTIONS ISSUER 215000 0 FOR 215000 FOR KIKKOMAN CORPORATION J32620106 JP3240400006 06/23/2026 Appoint a Director Sugiyama, Shinsuke DIRECTOR ELECTIONS ISSUER 215000 0 FOR 215000 FOR KIKKOMAN CORPORATION J32620106 JP3240400006 06/23/2026 Appoint a Director Endo, Nobuhiro DIRECTOR ELECTIONS ISSUER 215000 0 FOR 215000 FOR KIKKOMAN CORPORATION J32620106 JP3240400006 06/23/2026 Appoint a Director Arthur M. Mitchell DIRECTOR ELECTIONS ISSUER 215000 0 FOR 215000 FOR KIKKOMAN CORPORATION J32620106 JP3240400006 06/23/2026 Appoint a Director Kuniya, Hiroko DIRECTOR ELECTIONS ISSUER 215000 0 FOR 215000 FOR KIKKOMAN CORPORATION J32620106 JP3240400006 06/23/2026 Appoint a Corporate Auditor Nagata, Takashi AUDIT-RELATED ISSUER 215000 0 FOR 215000 FOR KIKKOMAN CORPORATION J32620106 JP3240400006 06/23/2026 Appoint a Substitute Corporate Auditor Kambe, Kenichi AUDIT-RELATED ISSUER 215000 0 FOR 215000 FOR LABCORP HOLDINGS INC. 504922105 US5049221055 05/21/2026 Election of the members of the Company's Board of Directors. Kerrii B. Anderson DIRECTOR ELECTIONS ISSUER 7570 0 FOR 7570 FOR LABCORP HOLDINGS INC. 504922105 US5049221055 05/21/2026 Election of the members of the Company's Board of Directors. Victor Bulto DIRECTOR ELECTIONS ISSUER 7570 0 FOR 7570 FOR LABCORP HOLDINGS INC. 504922105 US5049221055 05/21/2026 Election of the members of the Company's Board of Directors. Jeffrey A. Davis DIRECTOR ELECTIONS ISSUER 7570 0 FOR 7570 FOR LABCORP HOLDINGS INC. 504922105 US5049221055 05/21/2026 Election of the members of the Company's Board of Directors. Kirsten M. Kliphouse DIRECTOR ELECTIONS ISSUER 7570 0 FOR 7570 FOR LABCORP HOLDINGS INC. 504922105 US5049221055 05/21/2026 Election of the members of the Company's Board of Directors. Garheng Kong, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 7570 0 FOR 7570 FOR LABCORP HOLDINGS INC. 504922105 US5049221055 05/21/2026 Election of the members of the Company's Board of Directors. Peter M. Neupert DIRECTOR ELECTIONS ISSUER 7570 0 FOR 7570 FOR LABCORP HOLDINGS INC. 504922105 US5049221055 05/21/2026 Election of the members of the Company's Board of Directors. Richelle P. Parham DIRECTOR ELECTIONS ISSUER 7570 0 FOR 7570 FOR LABCORP HOLDINGS INC. 504922105 US5049221055 05/21/2026 Election of the members of the Company's Board of Directors. Paul B. Rothman, M.D. DIRECTOR ELECTIONS ISSUER 7570 0 FOR 7570 FOR LABCORP HOLDINGS INC. 504922105 US5049221055 05/21/2026 Election of the members of the Company's Board of Directors. John H. Sampson, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 7570 0 FOR 7570 FOR LABCORP HOLDINGS INC. 504922105 US5049221055 05/21/2026 Election of the members of the Company's Board of Directors. Adam H. Schechter DIRECTOR ELECTIONS ISSUER 7570 0 FOR 7570 FOR LABCORP HOLDINGS INC. 504922105 US5049221055 05/21/2026 Election of the members of the Company's Board of Directors. Kathryn E. Wengel DIRECTOR ELECTIONS ISSUER 7570 0 FOR 7570 FOR LABCORP HOLDINGS INC. 504922105 US5049221055 05/21/2026 To approve, by non-binding vote, the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 7570 0 FOR 7570 FOR LABCORP HOLDINGS INC. 504922105 US5049221055 05/21/2026 Ratification of the appointment of Deloitte and Touche LLP as Labcorp Holdings Inc.'s independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 7570 0 FOR 7570 FOR LANTHEUS HOLDINGS, INC. 516544103 US5165441032 04/30/2026 The election of four Class II directors to our Board of Directors. Ms. Minnie Baylor-Henry DIRECTOR ELECTIONS ISSUER 24000 0 FOR 24000 FOR LANTHEUS HOLDINGS, INC. 516544103 US5165441032 04/30/2026 The election of four Class II directors to our Board of Directors. Mr.Heinz Mausli DIRECTOR ELECTIONS ISSUER 24000 0 FOR 24000 FOR LANTHEUS HOLDINGS, INC. 516544103 US5165441032 04/30/2026 The election of four Class II directors to our Board of Directors. Ms. Julie McHugh DIRECTOR ELECTIONS ISSUER 24000 0 FOR 24000 FOR LANTHEUS HOLDINGS, INC. 516544103 US5165441032 04/30/2026 The election of four Class II directors to our Board of Directors. Dr. Phuong Khanh (P.K.) Morrow DIRECTOR ELECTIONS ISSUER 24000 0 FOR 24000 FOR LANTHEUS HOLDINGS, INC. 516544103 US5165441032 04/30/2026 The approval, on an advisory basis, of the compensation paid to our named executive officers (commonly referred to as ''say on pay''). SECTION 14A SAY-ON-PAY VOTES ISSUER 24000 0 FOR 24000 FOR LANTHEUS HOLDINGS, INC. 516544103 US5165441032 04/30/2026 The approval, on an advisory basis, of the frequency of holding future ''say on pay'' votes. SECTION 14A SAY-ON-PAY VOTES ISSUER 24000 0 1 Year 24000 FOR LANTHEUS HOLDINGS, INC. 516544103 US5165441032 04/30/2026 The approval of an amendment to our Amended and Restated Certificate of Incorporation to declassify our Board of Directors. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 24000 0 FOR 24000 FOR LANTHEUS HOLDINGS, INC. 516544103 US5165441032 04/30/2026 The approval of the Lantheus Holdings, Inc. Amended and Restated 2026 Equity Incentive Plan. COMPENSATION ISSUER 24000 0 ABSTAIN 24000 AGAINST LANTHEUS HOLDINGS, INC. 516544103 US5165441032 04/30/2026 The ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 24000 0 FOR 24000 FOR LUCID DIAGNOSTICS INC. 54948X109 US54948X1090 06/24/2026 Election of Director: 1. James L. Cox, M.D. DIRECTOR ELECTIONS ISSUER 19500 0 FOR 19500 FOR LUCID DIAGNOSTICS INC. 54948X109 US54948X1090 06/24/2026 Election of Director: 2. John R. Palumbo DIRECTOR ELECTIONS ISSUER 19500 0 FOR 19500 FOR LUCID DIAGNOSTICS INC. 54948X109 US54948X1090 06/24/2026 Election of Director: 3. Ronald M. Sparks DIRECTOR ELECTIONS ISSUER 19500 0 FOR 19500 FOR LUCID DIAGNOSTICS INC. 54948X109 US54948X1090 06/24/2026 Approval of an amendment to the Certificate of Incorporation to increase the total number of shares of common stock the Company is authorized to issue by 100,000,000 shares, from 300,000,000 shares to 400,000,000 shares. CAPITAL STRUCTURE ISSUER 19500 0 FOR 19500 FOR LUCID DIAGNOSTICS INC. 54948X109 US54948X1090 06/24/2026 Ratification of the appointment of the independent registered certified public accounting firm. AUDIT-RELATED ISSUER 19500 0 FOR 19500 FOR MADRIGAL PHARMACEUTICALS INC. 558868105 US5588681057 06/17/2026 Re-election of Class I directors: Julian Baker DIRECTOR ELECTIONS ISSUER 300 0 FOR 300 FOR MADRIGAL PHARMACEUTICALS INC. 558868105 US5588681057 06/17/2026 Re-election of Class I directors: Daniel Brennan DIRECTOR ELECTIONS ISSUER 300 0 FOR 300 FOR MADRIGAL PHARMACEUTICALS INC. 558868105 US5588681057 06/17/2026 Re-election of Class I directors: James Daly DIRECTOR ELECTIONS ISSUER 300 0 FOR 300 FOR MADRIGAL PHARMACEUTICALS INC. 558868105 US5588681057 06/17/2026 Advisory vote to approve executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 300 0 FOR 300 FOR MADRIGAL PHARMACEUTICALS INC. 558868105 US5588681057 06/17/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 300 0 FOR 300 FOR MADRIGAL PHARMACEUTICALS INC. 558868105 US5588681057 06/17/2026 Approval of Madrigal Pharmaceuticals, Inc. 2026 Stock Plan COMPENSATION ISSUER 300 0 AGAINST 300 AGAINST MADRIGAL PHARMACEUTICALS INC. 558868105 US5588681057 06/17/2026 Approval of Madrigal Pharmaceuticals, Inc. 2026 Employee Stock Purchase Plan CAPITAL STRUCTURE ISSUER 300 0 FOR 300 FOR MAPLE LEAF FOODS INC 564905107 CA5649051078 05/07/2026 ELECTION OF DIRECTOR: WILLIAM E. AZIZ DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR MAPLE LEAF FOODS INC 564905107 CA5649051078 05/07/2026 ELECTION OF DIRECTOR: RONALD G. CLOSE DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR MAPLE LEAF FOODS INC 564905107 CA5649051078 05/07/2026 ELECTION OF DIRECTOR: CURTIS E. FRANK DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR MAPLE LEAF FOODS INC 564905107 CA5649051078 05/07/2026 ELECTION OF DIRECTOR: THOMAS P. HAYES DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR MAPLE LEAF FOODS INC 564905107 CA5649051078 05/07/2026 ELECTION OF DIRECTOR: LAUREN JONES-DAVIES DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR MAPLE LEAF FOODS INC 564905107 CA5649051078 05/07/2026 ELECTION OF DIRECTOR: FAREED KHAN DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR MAPLE LEAF FOODS INC 564905107 CA5649051078 05/07/2026 ELECTION OF DIRECTOR: KATHERINE N. LEMON DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR MAPLE LEAF FOODS INC 564905107 CA5649051078 05/07/2026 ELECTION OF DIRECTOR: ANDREW G. MACDONALD DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR MAPLE LEAF FOODS INC 564905107 CA5649051078 05/07/2026 ELECTION OF DIRECTOR: LINDA MANTIA DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR MAPLE LEAF FOODS INC 564905107 CA5649051078 05/07/2026 ELECTION OF DIRECTOR: JONATHAN W.F. MCCAIN DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR MAPLE LEAF FOODS INC 564905107 CA5649051078 05/07/2026 ELECTION OF DIRECTOR: MICHAEL H. MCCAIN DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR MAPLE LEAF FOODS INC 564905107 CA5649051078 05/07/2026 ELECTION OF DIRECTOR: BETH NEWLANDS CAMPBELL DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR MAPLE LEAF FOODS INC 564905107 CA5649051078 05/07/2026 APPOINTMENT OF KPMG LLP, AS AUDITORS OF MAPLE LEAF FOODS INC. FOR THE ENSUING YEAR AND AUTHORIZING THE DIRECTORS TO FIX THEIR REMUNERATION AUDIT-RELATED ISSUER 10000 0 FOR 10000 FOR MAPLE LEAF FOODS INC 564905107 CA5649051078 05/07/2026 TO APPROVE, ON AN ADVISORY AND NON-BINDING BASIS, MAPLE LEAF FOODS INC.S APPROACH TO EXECUTIVE COMPENSATION SECTION 14A SAY-ON-PAY VOTES ISSUER 10000 0 FOR 10000 FOR MAZE THERAPEUTICS INC 578784100 US5787841007 06/08/2026 Election of Director: 1. Jason Coloma, Ph.D. DIRECTOR ELECTIONS ISSUER 100 0 FOR 100 FOR MAZE THERAPEUTICS INC 578784100 US5787841007 06/08/2026 Election of Director: 2. Neil Kumar, Ph.D. DIRECTOR ELECTIONS ISSUER 100 0 FOR 100 FOR MAZE THERAPEUTICS INC 578784100 US5787841007 06/08/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 100 0 FOR 100 FOR MCKESSON CORPORATION 58155Q103 US58155Q1031 07/30/2025 Election of Director for a One-Year Term: Dominic J. Caruso DIRECTOR ELECTIONS ISSUER 3805 0 FOR 3805 FOR MCKESSON CORPORATION 58155Q103 US58155Q1031 07/30/2025 Election of Director for a One-Year Term: Lynne M. Doughtie DIRECTOR ELECTIONS ISSUER 3805 0 FOR 3805 FOR MCKESSON CORPORATION 58155Q103 US58155Q1031 07/30/2025 Election of Director for a One-Year Term: W. Roy Dunbar DIRECTOR ELECTIONS ISSUER 3805 0 FOR 3805 FOR MCKESSON CORPORATION 58155Q103 US58155Q1031 07/30/2025 Election of Director for a One-Year Term: Deborah Dunsire, M.D. DIRECTOR ELECTIONS ISSUER 3805 0 FOR 3805 FOR MCKESSON CORPORATION 58155Q103 US58155Q1031 07/30/2025 Election of Director for a One-Year Term: Julie L. Gerberding, M.D., M.P.H. DIRECTOR ELECTIONS ISSUER 3805 0 FOR 3805 FOR MCKESSON CORPORATION 58155Q103 US58155Q1031 07/30/2025 Election of Director for a One-Year Term: James H. Hinton DIRECTOR ELECTIONS ISSUER 3805 0 FOR 3805 FOR MCKESSON CORPORATION 58155Q103 US58155Q1031 07/30/2025 Election of Director for a One-Year Term: Donald R. Knauss DIRECTOR ELECTIONS ISSUER 3805 0 FOR 3805 FOR MCKESSON CORPORATION 58155Q103 US58155Q1031 07/30/2025 Election of Director for a One-Year Term: Bradley E. Lerman DIRECTOR ELECTIONS ISSUER 3805 0 FOR 3805 FOR MCKESSON CORPORATION 58155Q103 US58155Q1031 07/30/2025 Election of Director for a One-Year Term: Maria N. Martinez DIRECTOR ELECTIONS ISSUER 3805 0 FOR 3805 FOR MCKESSON CORPORATION 58155Q103 US58155Q1031 07/30/2025 Election of Director for a One-Year Term: Kevin M. Ozan DIRECTOR ELECTIONS ISSUER 3805 0 FOR 3805 FOR MCKESSON CORPORATION 58155Q103 US58155Q1031 07/30/2025 Election of Director for a One-Year Term: Brian S. Tyler DIRECTOR ELECTIONS ISSUER 3805 0 FOR 3805 FOR MCKESSON CORPORATION 58155Q103 US58155Q1031 07/30/2025 Election of Director for a One-Year Term: Kathleen Wilson- Thompson DIRECTOR ELECTIONS ISSUER 3805 0 FOR 3805 FOR MCKESSON CORPORATION 58155Q103 US58155Q1031 07/30/2025 Ratification of Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm for Fiscal Year 2026 AUDIT-RELATED ISSUER 3805 0 FOR 3805 FOR MCKESSON CORPORATION 58155Q103 US58155Q1031 07/30/2025 Advisory Vote to Approve the Company's Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 3805 0 FOR 3805 FOR MEDLINE INC. 58507V107 US58507V1070 06/11/2026 Election of Director: 1. Charles N. Mills DIRECTOR ELECTIONS ISSUER 4000 0 FOR 4000 FOR MEDLINE INC. 58507V107 US58507V1070 06/11/2026 Election of Director: 2. Joseph P. Baratta DIRECTOR ELECTIONS ISSUER 4000 0 FOR 4000 FOR MEDLINE INC. 58507V107 US58507V1070 06/11/2026 Election of Director: 3. Jacob D. Best DIRECTOR ELECTIONS ISSUER 4000 0 FOR 4000 FOR MEDLINE INC. 58507V107 US58507V1070 06/11/2026 Election of Director: 4. Todd M. Bluedorn DIRECTOR ELECTIONS ISSUER 4000 0 FOR 4000 FOR MEDLINE INC. 58507V107 US58507V1070 06/11/2026 Election of Director: 5. James M. Boyle DIRECTOR ELECTIONS ISSUER 4000 0 FOR 4000 FOR MEDLINE INC. 58507V107 US58507V1070 06/11/2026 Election of Director: 6. Richard A. Galanti DIRECTOR ELECTIONS ISSUER 4000 0 FOR 4000 FOR MEDLINE INC. 58507V107 US58507V1070 06/11/2026 Election of Director: 7. Patrick J. Healy DIRECTOR ELECTIONS ISSUER 4000 0 FOR 4000 FOR MEDLINE INC. 58507V107 US58507V1070 06/11/2026 Election of Director: 8. Andrew J. Mills DIRECTOR ELECTIONS ISSUER 4000 0 FOR 4000 FOR MEDLINE INC. 58507V107 US58507V1070 06/11/2026 Election of Director: 9. Robert R. Schmidt DIRECTOR ELECTIONS ISSUER 4000 0 FOR 4000 FOR MEDLINE INC. 58507V107 US58507V1070 06/11/2026 Election of Director: 10. Anushka M. Sunder DIRECTOR ELECTIONS ISSUER 4000 0 FOR 4000 FOR MEDLINE INC. 58507V107 US58507V1070 06/11/2026 Election of Director: 11. Thomas W. Sweet DIRECTOR ELECTIONS ISSUER 4000 0 FOR 4000 FOR MEDLINE INC. 58507V107 US58507V1070 06/11/2026 Election of Director: 12. Stephen H. Wise DIRECTOR ELECTIONS ISSUER 4000 0 FOR 4000 FOR MEDLINE INC. 58507V107 US58507V1070 06/11/2026 Advisory Vote to Approve Our Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 4000 0 FOR 4000 FOR MEDLINE INC. 58507V107 US58507V1070 06/11/2026 Advisory Vote on the Frequency of Votes on Our Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 4000 0 1 Year 4000 FOR MEDLINE INC. 58507V107 US58507V1070 06/11/2026 Ratification of the Selection of Ernst & Young LLP as Our Independent Auditor for Fiscal Year 2026. AUDIT-RELATED ISSUER 4000 0 FOR 4000 FOR MEDPACE HOLDINGS, INC. 58506Q109 US58506Q1094 05/15/2026 Election of Director: 1. Brian T. Carley DIRECTOR ELECTIONS ISSUER 350 0 FOR 350 FOR MEDPACE HOLDINGS, INC. 58506Q109 US58506Q1094 05/15/2026 Election of Director: 2. Femida H Gwadry-Sridhar DIRECTOR ELECTIONS ISSUER 350 0 FOR 350 FOR MEDPACE HOLDINGS, INC. 58506Q109 US58506Q1094 05/15/2026 Election of Director: 3. Robert O. Kraft DIRECTOR ELECTIONS ISSUER 350 0 FOR 350 FOR MEDPACE HOLDINGS, INC. 58506Q109 US58506Q1094 05/15/2026 Election of Director: 4. August J. Troendle DIRECTOR ELECTIONS ISSUER 350 0 FOR 350 FOR MEDPACE HOLDINGS, INC. 58506Q109 US58506Q1094 05/15/2026 Election of Director: 5. Dani S. Zander DIRECTOR ELECTIONS ISSUER 350 0 FOR 350 FOR MEDPACE HOLDINGS, INC. 58506Q109 US58506Q1094 05/15/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 350 0 FOR 350 FOR MEDPACE HOLDINGS, INC. 58506Q109 US58506Q1094 05/15/2026 To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement for the 2026 Annual Meeting. SECTION 14A SAY-ON-PAY VOTES ISSUER 350 0 FOR 350 FOR MEDPACE HOLDINGS, INC. 58506Q109 US58506Q1094 05/15/2026 To recommend, on an advisory basis, the frequency of future advisory votes on named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 350 0 1 Year 350 FOR MEDPACE HOLDINGS, INC. 58506Q109 US58506Q1094 05/15/2026 To approve an amendment to the Company's Certificate of Incorporation to remove supermajority voting requirements. CORPORATE GOVERNANCE ISSUER 350 0 FOR 350 FOR MEDPACE HOLDINGS, INC. 58506Q109 US58506Q1094 05/15/2026 To approve an amendment to the Company's Certificate of Incorporation to remove the limitation on stockholders calling special meetings of stockholders. CORPORATE GOVERNANCE ISSUER 350 0 FOR 350 FOR MEDPACE HOLDINGS, INC. 58506Q109 US58506Q1094 05/15/2026 Stockholder proposal regarding giving shareholders an ability to call for a special shareholder meeting, if properly presented at the meeting. CORPORATE GOVERNANCE SECURITY HOLDER 350 0 AGAINST 350 FOR MEDTRONIC PLC G5960L103 IE00BTN1Y115 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the ''Company''); Craig Arnold DIRECTOR ELECTIONS ISSUER 21000 0 FOR 21000 FOR MEDTRONIC PLC G5960L103 IE00BTN1Y115 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the ''Company''); Scott C. Donnelly DIRECTOR ELECTIONS ISSUER 21000 0 FOR 21000 FOR MEDTRONIC PLC G5960L103 IE00BTN1Y115 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the ''Company''); Lidia L. Fonseca DIRECTOR ELECTIONS ISSUER 21000 0 FOR 21000 FOR MEDTRONIC PLC G5960L103 IE00BTN1Y115 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the ''Company''); John P. Groetelaars DIRECTOR ELECTIONS ISSUER 21000 0 FOR 21000 FOR MEDTRONIC PLC G5960L103 IE00BTN1Y115 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the ''Company''); Randall J. Hogan, III DIRECTOR ELECTIONS ISSUER 21000 0 FOR 21000 FOR MEDTRONIC PLC G5960L103 IE00BTN1Y115 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the ''Company''); William R. Jellison DIRECTOR ELECTIONS ISSUER 21000 0 FOR 21000 FOR MEDTRONIC PLC G5960L103 IE00BTN1Y115 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the ''Company''); Joon S. Lee, M.D. DIRECTOR ELECTIONS ISSUER 21000 0 FOR 21000 FOR MEDTRONIC PLC G5960L103 IE00BTN1Y115 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the ''Company''); Gregory P. Lewis DIRECTOR ELECTIONS ISSUER 21000 0 FOR 21000 FOR MEDTRONIC PLC G5960L103 IE00BTN1Y115 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the ''Company''); Kevin E. Lofton DIRECTOR ELECTIONS ISSUER 21000 0 FOR 21000 FOR MEDTRONIC PLC G5960L103 IE00BTN1Y115 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the ''Company''); Geoffrey S. Martha DIRECTOR ELECTIONS ISSUER 21000 0 FOR 21000 FOR MEDTRONIC PLC G5960L103 IE00BTN1Y115 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the ''Company''); Elizabeth G. Nabel, M.D. DIRECTOR ELECTIONS ISSUER 21000 0 FOR 21000 FOR MEDTRONIC PLC G5960L103 IE00BTN1Y115 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the ''Company''); Kendall J. Powell DIRECTOR ELECTIONS ISSUER 21000 0 FOR 21000 FOR MEDTRONIC PLC G5960L103 IE00BTN1Y115 10/16/2025 Ratifying, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for fiscal year 2026 and authorizing, in a binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor's remuneration; AUDIT-RELATED ISSUER 21000 0 FOR 21000 FOR MEDTRONIC PLC G5960L103 IE00BTN1Y115 10/16/2025 Approving, on an advisory basis, the Company's executive compensation; SECTION 14A SAY-ON-PAY VOTES ISSUER 21000 0 FOR 21000 FOR MEDTRONIC PLC G5960L103 IE00BTN1Y115 10/16/2025 Renewing the Board of Directors' authority to issue shares under Irish law; CAPITAL STRUCTURE ISSUER 21000 0 FOR 21000 FOR MEDTRONIC PLC G5960L103 IE00BTN1Y115 10/16/2025 Renewing the Board of Directors' authority to opt out of pre- emption rights under Irish law; CAPITAL STRUCTURE ISSUER 21000 0 AGAINST 21000 AGAINST MEDTRONIC PLC G5960L103 IE00BTN1Y115 10/16/2025 Authorizing the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares; CAPITAL STRUCTURE ISSUER 21000 0 FOR 21000 FOR MEDTRONIC PLC G5960L103 IE00BTN1Y115 10/16/2025 Approving an amendment to Article 177 of the Company's Articles of Association, to facilitate the capitalization of certain of the Company's non-distributable reserves; CAPITAL STRUCTURE ISSUER 21000 0 FOR 21000 FOR MEDTRONIC PLC G5960L103 IE00BTN1Y115 10/16/2025 Approving a Capital Reduction to Create Distributable Reserves under Irish Law; and CAPITAL STRUCTURE ISSUER 21000 0 FOR 21000 FOR MEDTRONIC PLC G5960L103 IE00BTN1Y115 10/16/2025 Approving amendments to the Company's Articles of Association, to update the advance notice provisions. CORPORATE GOVERNANCE ISSUER 21000 0 AGAINST 21000 AGAINST MEIJI HOLDINGS CO.,LTD. J41729104 JP3918000005 06/26/2026 Appoint a Director Matsuda, Katsunari DIRECTOR ELECTIONS ISSUER 27000 0 FOR 27000 FOR MEIJI HOLDINGS CO.,LTD. J41729104 JP3918000005 06/26/2026 Appoint a Director Nagasato, Toshiaki DIRECTOR ELECTIONS ISSUER 27000 0 FOR 27000 FOR MEIJI HOLDINGS CO.,LTD. J41729104 JP3918000005 06/26/2026 Appoint a Director Yao, Bunjiro DIRECTOR ELECTIONS ISSUER 27000 0 FOR 27000 FOR MEIJI HOLDINGS CO.,LTD. J41729104 JP3918000005 06/26/2026 Appoint a Director Hishinuma, Jun DIRECTOR ELECTIONS ISSUER 27000 0 FOR 27000 FOR MEIJI HOLDINGS CO.,LTD. J41729104 JP3918000005 06/26/2026 Appoint a Director Kawata, Masaya DIRECTOR ELECTIONS ISSUER 27000 0 FOR 27000 FOR MEIJI HOLDINGS CO.,LTD. J41729104 JP3918000005 06/26/2026 Appoint a Director Kuboyama, Michiko DIRECTOR ELECTIONS ISSUER 27000 0 FOR 27000 FOR MEIJI HOLDINGS CO.,LTD. J41729104 JP3918000005 06/26/2026 Appoint a Director Peter D. Pedersen DIRECTOR ELECTIONS ISSUER 27000 0 FOR 27000 FOR MEIJI HOLDINGS CO.,LTD. J41729104 JP3918000005 06/26/2026 Appoint a Director Omae, Yuko DIRECTOR ELECTIONS ISSUER 27000 0 FOR 27000 FOR MEIJI HOLDINGS CO.,LTD. J41729104 JP3918000005 06/26/2026 Appoint a Substitute Corporate Auditor Mikura, Kazumi AUDIT-RELATED ISSUER 27000 0 FOR 27000 FOR MEIJI HOLDINGS CO.,LTD. J41729104 JP3918000005 06/26/2026 Amend Articles to: Approve Minor Revisions CORPORATE GOVERNANCE ISSUER 27000 0 FOR 27000 FOR MEIJI HOLDINGS CO.,LTD. J41729104 JP3918000005 06/26/2026 Shareholder Proposal: Amend Articles of Incorporation (the Establishment of the Strategic Review Committee) CORPORATE GOVERNANCE SECURITY HOLDER 27000 0 ABSTAIN 27000 AGAINST MEIJI HOLDINGS CO.,LTD. J41729104 JP3918000005 06/26/2026 Shareholder Proposal: Approve Purchase of Own Shares CAPITAL STRUCTURE SECURITY HOLDER 27000 0 ABSTAIN 27000 AGAINST MEIJI HOLDINGS CO.,LTD. J41729104 JP3918000005 06/26/2026 Shareholder Proposal: Approve Details of the Restricted-Stock Compensation to be received by Corporate Officers COMPENSATION SECURITY HOLDER 27000 0 ABSTAIN 27000 AGAINST MEIJI HOLDINGS CO.,LTD. J41729104 JP3918000005 06/26/2026 Shareholder Proposal: Amend Articles of Incorporation (the composition of outside Directors) CORPORATE GOVERNANCE SECURITY HOLDER 27000 0 ABSTAIN 27000 AGAINST MEIJI HOLDINGS CO.,LTD. J41729104 JP3918000005 06/26/2026 Shareholder Proposal: Amend Articles of Incorporation (Change Record Date of Annual General Meeting of Shareholders) CORPORATE GOVERNANCE SECURITY HOLDER 27000 0 ABSTAIN 27000 AGAINST MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Election of Directors Douglas M. Baker, Jr. DIRECTOR ELECTIONS ISSUER 43850 0 FOR 43850 FOR MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Election of Directors Mary Ellen Coe DIRECTOR ELECTIONS ISSUER 43850 0 FOR 43850 FOR MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Election of Directors Pamela J. Craig DIRECTOR ELECTIONS ISSUER 43850 0 FOR 43850 FOR MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Election of Directors Robert M. Davis DIRECTOR ELECTIONS ISSUER 43850 0 FOR 43850 FOR MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Election of Directors Thomas H. Glocer DIRECTOR ELECTIONS ISSUER 43850 0 FOR 43850 FOR MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Election of Directors Surendralal L. Karsanbhai DIRECTOR ELECTIONS ISSUER 43850 0 FOR 43850 FOR MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Election of Directors Risa J. Lavizzo-Mourey, M.D. DIRECTOR ELECTIONS ISSUER 43850 0 FOR 43850 FOR MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Election of Directors Stephen L. Mayo, Ph.D. DIRECTOR ELECTIONS ISSUER 43850 0 FOR 43850 FOR MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Election of Directors Paul B. Rothman, M.D. DIRECTOR ELECTIONS ISSUER 43850 0 FOR 43850 FOR MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Election of Directors Patricia F. Russo DIRECTOR ELECTIONS ISSUER 43850 0 FOR 43850 FOR MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Election of Directors Christine E. Seidman, M.D. DIRECTOR ELECTIONS ISSUER 43850 0 FOR 43850 FOR MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Election of Directors Inge G. Thulin DIRECTOR ELECTIONS ISSUER 43850 0 FOR 43850 FOR MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Election of Directors Kathy J. Warden DIRECTOR ELECTIONS ISSUER 43850 0 FOR 43850 FOR MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Non-binding advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 43850 0 FOR 43850 FOR MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Ratification of the appointment of the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 43850 0 FOR 43850 FOR MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Shareholder proposal regarding a report on DEI risks in federal contracting. HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE SECURITY HOLDER 43850 0 ABSTAIN 43850 AGAINST MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Shareholder proposal regarding a report on healthcare coverage gaps. HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE SECURITY HOLDER 43850 0 ABSTAIN 43850 AGAINST MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Shareholder proposal regarding a report on political contributions. OTHER SOCIAL ISSUES SECURITY HOLDER 43850 0 ABSTAIN 43850 AGAINST MIRUM PHARMACEUTICALS, INC. 604749101 US6047491013 06/15/2026 To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal. Lon Cardon, Ph.D., FMedSci DIRECTOR ELECTIONS ISSUER 1500 0 FOR 1500 FOR MIRUM PHARMACEUTICALS, INC. 604749101 US6047491013 06/15/2026 To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal. William Fairey DIRECTOR ELECTIONS ISSUER 1500 0 FOR 1500 FOR MIRUM PHARMACEUTICALS, INC. 604749101 US6047491013 06/15/2026 To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal. Timothy Walbert DIRECTOR ELECTIONS ISSUER 1500 0 WITHHOLD 1500 AGAINST MIRUM PHARMACEUTICALS, INC. 604749101 US6047491013 06/15/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1500 0 FOR 1500 FOR MIRUM PHARMACEUTICALS, INC. 604749101 US6047491013 06/15/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1500 0 FOR 1500 FOR MONDELEZ INTERNATIONAL, INC. 609207105 US6092071058 05/20/2026 To elect as directors the 10 director nominees named in the Proxy Statement Ertharin Cousin DIRECTOR ELECTIONS ISSUER 13000 0 FOR 13000 FOR MONDELEZ INTERNATIONAL, INC. 609207105 US6092071058 05/20/2026 To elect as directors the 10 director nominees named in the Proxy Statement Cees 't Hart DIRECTOR ELECTIONS ISSUER 13000 0 FOR 13000 FOR MONDELEZ INTERNATIONAL, INC. 609207105 US6092071058 05/20/2026 To elect as directors the 10 director nominees named in the Proxy Statement Nancy McKinstry DIRECTOR ELECTIONS ISSUER 13000 0 FOR 13000 FOR MONDELEZ INTERNATIONAL, INC. 609207105 US6092071058 05/20/2026 To elect as directors the 10 director nominees named in the Proxy Statement Brian J. McNamara DIRECTOR ELECTIONS ISSUER 13000 0 FOR 13000 FOR MONDELEZ INTERNATIONAL, INC. 609207105 US6092071058 05/20/2026 To elect as directors the 10 director nominees named in the Proxy Statement Jorge S. Mesquita DIRECTOR ELECTIONS ISSUER 13000 0 FOR 13000 FOR MONDELEZ INTERNATIONAL, INC. 609207105 US6092071058 05/20/2026 To elect as directors the 10 director nominees named in the Proxy Statement Jane Hamilton Nielsen DIRECTOR ELECTIONS ISSUER 13000 0 FOR 13000 FOR MONDELEZ INTERNATIONAL, INC. 609207105 US6092071058 05/20/2026 To elect as directors the 10 director nominees named in the Proxy Statement Paula A. Price DIRECTOR ELECTIONS ISSUER 13000 0 FOR 13000 FOR MONDELEZ INTERNATIONAL, INC. 609207105 US6092071058 05/20/2026 To elect as directors the 10 director nominees named in the Proxy Statement Patrick T. Siewert DIRECTOR ELECTIONS ISSUER 13000 0 FOR 13000 FOR MONDELEZ INTERNATIONAL, INC. 609207105 US6092071058 05/20/2026 To elect as directors the 10 director nominees named in the Proxy Statement Michael A. Todman DIRECTOR ELECTIONS ISSUER 13000 0 FOR 13000 FOR MONDELEZ INTERNATIONAL, INC. 609207105 US6092071058 05/20/2026 To elect as directors the 10 director nominees named in the Proxy Statement Dirk Van de Put DIRECTOR ELECTIONS ISSUER 13000 0 FOR 13000 FOR MONDELEZ INTERNATIONAL, INC. 609207105 US6092071058 05/20/2026 To approve, on an advisory basis, the Company's executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 13000 0 FOR 13000 FOR MONDELEZ INTERNATIONAL, INC. 609207105 US6092071058 05/20/2026 To ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accountants for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 13000 0 FOR 13000 FOR MONDELEZ INTERNATIONAL, INC. 609207105 US6092071058 05/20/2026 Shareholder proposal requesting a report on objective evaluation of plastics packaging policies ENVIRONMENT OR CLIMATE SECURITY HOLDER 13000 0 ABSTAIN 13000 AGAINST MONDELEZ INTERNATIONAL, INC. 609207105 US6092071058 05/20/2026 Shareholder proposal requesting adoption of an independent board chairman policy CORPORATE GOVERNANCE SECURITY HOLDER 13000 0 AGAINST 13000 FOR MORINAGA MILK INDUSTRY CO.,LTD. J46410114 JP3926800008 06/25/2026 Approve Appropriation of Surplus CAPITAL STRUCTURE ISSUER 13500 0 FOR 13500 FOR MORINAGA MILK INDUSTRY CO.,LTD. J46410114 JP3926800008 06/25/2026 Appoint a Director Onuki, Yoichi DIRECTOR ELECTIONS ISSUER 13500 0 FOR 13500 FOR MORINAGA MILK INDUSTRY CO.,LTD. J46410114 JP3926800008 06/25/2026 Appoint a Director Nozaki, Akihiro DIRECTOR ELECTIONS ISSUER 13500 0 FOR 13500 FOR MORINAGA MILK INDUSTRY CO.,LTD. J46410114 JP3926800008 06/25/2026 Appoint a Director Yanagida, Yasuhiko DIRECTOR ELECTIONS ISSUER 13500 0 FOR 13500 FOR MORINAGA MILK INDUSTRY CO.,LTD. J46410114 JP3926800008 06/25/2026 Appoint a Director Hyodo, Hitoshi DIRECTOR ELECTIONS ISSUER 13500 0 FOR 13500 FOR MORINAGA MILK INDUSTRY CO.,LTD. J46410114 JP3926800008 06/25/2026 Appoint a Director Kuno, Hiroko DIRECTOR ELECTIONS ISSUER 13500 0 FOR 13500 FOR MORINAGA MILK INDUSTRY CO.,LTD. J46410114 JP3926800008 06/25/2026 Appoint a Director Miyaji, Kazuhiro DIRECTOR ELECTIONS ISSUER 13500 0 FOR 13500 FOR MORINAGA MILK INDUSTRY CO.,LTD. J46410114 JP3926800008 06/25/2026 Appoint a Director Yoshinaga, Yasuyuki DIRECTOR ELECTIONS ISSUER 13500 0 FOR 13500 FOR MORINAGA MILK INDUSTRY CO.,LTD. J46410114 JP3926800008 06/25/2026 Appoint a Director Tominaga, Yukari DIRECTOR ELECTIONS ISSUER 13500 0 FOR 13500 FOR MORINAGA MILK INDUSTRY CO.,LTD. J46410114 JP3926800008 06/25/2026 Appoint a Director Nakamura, Hiroshi DIRECTOR ELECTIONS ISSUER 13500 0 FOR 13500 FOR MORINAGA MILK INDUSTRY CO.,LTD. J46410114 JP3926800008 06/25/2026 Appoint a Director Ikeda, Takayuki DIRECTOR ELECTIONS ISSUER 13500 0 FOR 13500 FOR MORINAGA MILK INDUSTRY CO.,LTD. J46410114 JP3926800008 06/25/2026 Appoint a Director Takatori, Yukiko DIRECTOR ELECTIONS ISSUER 13500 0 FOR 13500 FOR MORINAGA MILK INDUSTRY CO.,LTD. J46410114 JP3926800008 06/25/2026 Appoint a Corporate Auditor Yamada, Hiroshi AUDIT-RELATED ISSUER 13500 0 FOR 13500 FOR MORINAGA MILK INDUSTRY CO.,LTD. J46410114 JP3926800008 06/25/2026 Appoint a Substitute Corporate Auditor Suzuki, Michio AUDIT-RELATED ISSUER 13500 0 FOR 13500 FOR NEKTAR THERAPEUTICS 640268306 US6402683063 06/04/2026 Election of Directors Howard W. Robin DIRECTOR ELECTIONS ISSUER 2500 0 FOR 2500 FOR NEKTAR THERAPEUTICS 640268306 US6402683063 06/04/2026 To approve an amendment to our Amended and Restated 2017 Performance Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under the plan by 3,000,000 shares. COMPENSATION ISSUER 2500 0 AGAINST 2500 AGAINST NEKTAR THERAPEUTICS 640268306 US6402683063 06/04/2026 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2500 0 FOR 2500 FOR NEKTAR THERAPEUTICS 640268306 US6402683063 06/04/2026 To approve a non-binding advisory resolution regarding our executive compensation (a "say-on-pay" vote). SECTION 14A SAY-ON-PAY VOTES ISSUER 2500 0 FOR 2500 FOR NEOGEN CORPORATION 640491106 US6404911066 10/23/2025 Election of Director: 1. Thierry L. Bernard DIRECTOR ELECTIONS ISSUER 12000 0 FOR 12000 FOR NEOGEN CORPORATION 640491106 US6404911066 10/23/2025 Election of Director: 2. Mikhael Nassif DIRECTOR ELECTIONS ISSUER 12000 0 FOR 12000 FOR NEOGEN CORPORATION 640491106 US6404911066 10/23/2025 Election of Director: 3. Avi Pelossof DIRECTOR ELECTIONS ISSUER 12000 0 FOR 12000 FOR NEOGEN CORPORATION 640491106 US6404911066 10/23/2025 Election of Director: 4. Andrea F. Wainer DIRECTOR ELECTIONS ISSUER 12000 0 FOR 12000 FOR NEOGEN CORPORATION 640491106 US6404911066 10/23/2025 To Approve, On An Advisory Basis, The Compensation of Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 12000 0 FOR 12000 FOR NEOGEN CORPORATION 640491106 US6404911066 10/23/2025 Ratification of Appointment of BDO USA P.C. as the Company's Independent Registered Public Accounting Firm. AUDIT-RELATED ISSUER 12000 0 FOR 12000 FOR NEOGENOMICS, INC. 64049M209 US64049M2098 05/21/2026 Election of the directors named in the proxy statement as set forth below: Lynn A. Tetrault DIRECTOR ELECTIONS ISSUER 90000 0 FOR 90000 FOR NEOGENOMICS, INC. 64049M209 US64049M2098 05/21/2026 Election of the directors named in the proxy statement as set forth below: Marjorie C. Green DIRECTOR ELECTIONS ISSUER 90000 0 FOR 90000 FOR NEOGENOMICS, INC. 64049M209 US64049M2098 05/21/2026 Election of the directors named in the proxy statement as set forth below: Dr. Neil Gunn DIRECTOR ELECTIONS ISSUER 90000 0 FOR 90000 FOR NEOGENOMICS, INC. 64049M209 US64049M2098 05/21/2026 Election of the directors named in the proxy statement as set forth below: Stephen M. Kanovsky DIRECTOR ELECTIONS ISSUER 90000 0 FOR 90000 FOR NEOGENOMICS, INC. 64049M209 US64049M2098 05/21/2026 Election of the directors named in the proxy statement as set forth below: Michael A. Kelly DIRECTOR ELECTIONS ISSUER 90000 0 FOR 90000 FOR NEOGENOMICS, INC. 64049M209 US64049M2098 05/21/2026 Election of the directors named in the proxy statement as set forth below: John P. Kenny DIRECTOR ELECTIONS ISSUER 90000 0 FOR 90000 FOR NEOGENOMICS, INC. 64049M209 US64049M2098 05/21/2026 Election of the directors named in the proxy statement as set forth below: David B. Perez DIRECTOR ELECTIONS ISSUER 90000 0 FOR 90000 FOR NEOGENOMICS, INC. 64049M209 US64049M2098 05/21/2026 Election of the directors named in the proxy statement as set forth below: Felicia Williams DIRECTOR ELECTIONS ISSUER 90000 0 FOR 90000 FOR NEOGENOMICS, INC. 64049M209 US64049M2098 05/21/2026 Election of the directors named in the proxy statement as set forth below: Anthony P. Zook DIRECTOR ELECTIONS ISSUER 90000 0 FOR 90000 FOR NEOGENOMICS, INC. 64049M209 US64049M2098 05/21/2026 Approval, on a non-binding advisory basis, of the Compensation Paid to the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 90000 0 FOR 90000 FOR NEOGENOMICS, INC. 64049M209 US64049M2098 05/21/2026 Approval of the Second Amendment of the NeoGenomics, Inc. 2023 Equity Incentive Plan. COMPENSATION ISSUER 90000 0 AGAINST 90000 AGAINST NEOGENOMICS, INC. 64049M209 US64049M2098 05/21/2026 Ratification of the Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm. AUDIT-RELATED ISSUER 90000 0 FOR 90000 FOR NESTLE S.A. H57312649 CH0038863350 04/16/2026 APPROVAL OF THE ANNUAL REVIEW, THE FINANCIAL STATEMENTS OF NESTLE S.A. AND THE CONSOLIDATED FINANCIAL STATEMENTS OF THE NESTLE GROUP FOR 2025 OTHER ISSUER 0 0 NESTLE S.A. H57312649 CH0038863350 04/16/2026 ACCEPTANCE OF THE COMPENSATION REPORT 2025 (ADVISORY VOTE) SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 NESTLE S.A. H57312649 CH0038863350 04/16/2026 ACCEPTANCE OF THE NON-FINANCIAL STATEMENT OF THE NESTLE GROUP FOR 2025 (ADVISORY VOTE) OTHER ISSUER 0 0 NESTLE S.A. H57312649 CH0038863350 04/16/2026 DISCHARGE TO THE MEMBERS OF THE BOARD OF DIRECTORS AND OF THE MANAGEMENT FOR 2025 CORPORATE GOVERNANCE ISSUER 0 0 NESTLE S.A. H57312649 CH0038863350 04/16/2026 APPROPRIATION OF AVAILABLE EARNINGS RESULTING FROM THE BALANCE SHEET OF NESTLE S.A. (PROPOSED DIVIDEND) FOR THE FINANCIAL YEAR 2025 CAPITAL STRUCTURE ISSUER 0 0 NESTLE S.A. H57312649 CH0038863350 04/16/2026 RE-ELECTION AS MEMBER AND CHAIR OF THE BOARD OF DIRECTORS: PABLO ISLA DIRECTOR ELECTIONS ISSUER 0 0 NESTLE S.A. H57312649 CH0038863350 04/16/2026 RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: DICK BOER DIRECTOR ELECTIONS ISSUER 0 0 NESTLE S.A. H57312649 CH0038863350 04/16/2026 RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: MARIE-GABRIELLE INEICHEN-FLEISCH DIRECTOR ELECTIONS ISSUER 0 0 NESTLE S.A. H57312649 CH0038863350 04/16/2026 RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: RENATO FASSBIND DIRECTOR ELECTIONS ISSUER 0 0 NESTLE S.A. H57312649 CH0038863350 04/16/2026 RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: PATRICK AEBISCHER DIRECTOR ELECTIONS ISSUER 0 0 NESTLE S.A. H57312649 CH0038863350 04/16/2026 RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: DINESH PALIWAL DIRECTOR ELECTIONS ISSUER 0 0 NESTLE S.A. H57312649 CH0038863350 04/16/2026 RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: LINDIWE MAJELE SIBANDA DIRECTOR ELECTIONS ISSUER 0 0 NESTLE S.A. H57312649 CH0038863350 04/16/2026 RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: CHRIS LEONG DIRECTOR ELECTIONS ISSUER 0 0 NESTLE S.A. H57312649 CH0038863350 04/16/2026 RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: LUCA MAESTRI DIRECTOR ELECTIONS ISSUER 0 0 NESTLE S.A. H57312649 CH0038863350 04/16/2026 RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: RAINER BLAIR DIRECTOR ELECTIONS ISSUER 0 0 NESTLE S.A. H57312649 CH0038863350 04/16/2026 RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: GERALDINE MATCHETT DIRECTOR ELECTIONS ISSUER 0 0 NESTLE S.A. H57312649 CH0038863350 04/16/2026 ELECTION TO THE BOARD OF DIRECTORS: MA FATIMA D. (FAMA) FRANCISCO DIRECTOR ELECTIONS ISSUER 0 0 NESTLE S.A. H57312649 CH0038863350 04/16/2026 ELECTION TO THE BOARD OF DIRECTORS: THOMAS JORDAN DIRECTOR ELECTIONS ISSUER 0 0 NESTLE S.A. H57312649 CH0038863350 04/16/2026 ELECTION AS MEMBER OF THE COMPENSATION COMMITTEE: DINESH PALIWAL CORPORATE GOVERNANCE ISSUER 0 0 NESTLE S.A. H57312649 CH0038863350 04/16/2026 ELECTION AS MEMBER OF THE COMPENSATION COMMITTEE: DICK BOER CORPORATE GOVERNANCE ISSUER 0 0 NESTLE S.A. H57312649 CH0038863350 04/16/2026 ELECTION AS MEMBER OF THE COMPENSATION COMMITTEE: PATRICK AEBISCHER CORPORATE GOVERNANCE ISSUER 0 0 NESTLE S.A. H57312649 CH0038863350 04/16/2026 ELECTION AS MEMBER OF THE COMPENSATION COMMITTEE: MARIE-GABRIELLE INEICHEN-FLEISCH CORPORATE GOVERNANCE ISSUER 0 0 NESTLE S.A. H57312649 CH0038863350 04/16/2026 ELECTION AS MEMBER OF THE COMPENSATION COMMITTEE: RENATO FASSBIND CORPORATE GOVERNANCE ISSUER 0 0 NESTLE S.A. H57312649 CH0038863350 04/16/2026 ELECTION AS MEMBER OF THE COMPENSATION COMMITTEE: LUCA MAESTRI CORPORATE GOVERNANCE ISSUER 0 0 NESTLE S.A. H57312649 CH0038863350 04/16/2026 ELECTION OF THE STATUTORY AUDITORS: ERNST AND YOUNG LTD, RENENS BRANCH AUDIT-RELATED ISSUER 0 0 NESTLE S.A. H57312649 CH0038863350 04/16/2026 ELECTION OF THE INDEPENDENT REPRESENTATIVE: HARTMANN DREYER, ATTORNEYS-AT-LAW CORPORATE GOVERNANCE ISSUER 0 0 NESTLE S.A. H57312649 CH0038863350 04/16/2026 APPROVAL OF THE COMPENSATION OF THE BOARD OF DIRECTORS COMPENSATION ISSUER 0 0 NESTLE S.A. H57312649 CH0038863350 04/16/2026 APPROVAL OF THE COMPENSATION OF THE EXECUTIVE BOARD COMPENSATION ISSUER 0 0 NESTLE S.A. H57312649 CH0038863350 04/16/2026 IN THE EVENT OF ANY YET UNKNOWN OR MODIFIED PROPOSAL BY A SHAREHOLDER DURING THE GENERAL MEETING, I INSTRUCT THE INDEPENDENT REPRESENTATIVE TO VOTE AS FOLLOWS: (YES = VOTE IN FAVOR OF ANY SUCH YET UNKNOWN PROPOSAL, NO = VOTE AGAINST ANY SUCH YET UNKNOWN PROPOSAL, ABSTAIN = ABSTAIN FROM VOTING) - THE BOARD OF DIRECTORS RECOMMENDS TO VOTE NO ON ANY SUCH YET UNKNOWN PROPOSAL OTHER SECURITY HOLDER 0 0 NEUROCRINE BIOSCIENCES, INC. 64125C109 US64125C1099 05/27/2026 Election of Director: 1. Kevin C. Gorman, Ph.D. DIRECTOR ELECTIONS ISSUER 100 0 FOR 100 FOR NEUROCRINE BIOSCIENCES, INC. 64125C109 US64125C1099 05/27/2026 Election of Director: 2. Gary A. Lyons DIRECTOR ELECTIONS ISSUER 100 0 FOR 100 FOR NEUROCRINE BIOSCIENCES, INC. 64125C109 US64125C1099 05/27/2026 Election of Director: 3. Johanna Mercier DIRECTOR ELECTIONS ISSUER 100 0 FOR 100 FOR NEUROCRINE BIOSCIENCES, INC. 64125C109 US64125C1099 05/27/2026 Advisory vote on the compensation paid to the Company's named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 100 0 FOR 100 FOR NEUROCRINE BIOSCIENCES, INC. 64125C109 US64125C1099 05/27/2026 To approve an amendment of the Company's 2025 Equity Incentive Plan to increase the aggregate number of shares of common stock reserved for issuance thereunder by 4,000,000 shares; and COMPENSATION ISSUER 100 0 ABSTAIN 100 AGAINST NEUROCRINE BIOSCIENCES, INC. 64125C109 US64125C1099 05/27/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 100 0 FOR 100 FOR NOMAD FOODS LIMITED G6564A105 VGG6564A1057 07/10/2025 Election of Director for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Sir Martin Ellis Franklin, KGCN DIRECTOR ELECTIONS ISSUER 47000 0 FOR 47000 FOR NOMAD FOODS LIMITED G6564A105 VGG6564A1057 07/10/2025 Election of Director for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Noam Gottesman DIRECTOR ELECTIONS ISSUER 47000 0 FOR 47000 FOR NOMAD FOODS LIMITED G6564A105 VGG6564A1057 07/10/2025 Election of Director for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Ian G.H. Ashken DIRECTOR ELECTIONS ISSUER 47000 0 FOR 47000 FOR NOMAD FOODS LIMITED G6564A105 VGG6564A1057 07/10/2025 Election of Director for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Ruben Baldew DIRECTOR ELECTIONS ISSUER 47000 0 FOR 47000 FOR NOMAD FOODS LIMITED G6564A105 VGG6564A1057 07/10/2025 Election of Director for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Stefan Descheemaeker DIRECTOR ELECTIONS ISSUER 47000 0 FOR 47000 FOR NOMAD FOODS LIMITED G6564A105 VGG6564A1057 07/10/2025 Election of Director for a one-year term expiring at the 2026 Annual Meeting of Shareholders: James E. Lillie DIRECTOR ELECTIONS ISSUER 47000 0 FOR 47000 FOR NOMAD FOODS LIMITED G6564A105 VGG6564A1057 07/10/2025 Election of Director for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Stuart M. MacFarlane DIRECTOR ELECTIONS ISSUER 47000 0 FOR 47000 FOR NOMAD FOODS LIMITED G6564A105 VGG6564A1057 07/10/2025 Election of Director for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Victoria Parry DIRECTOR ELECTIONS ISSUER 47000 0 FOR 47000 FOR NOMAD FOODS LIMITED G6564A105 VGG6564A1057 07/10/2025 Election of Director for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Amit Pilowsky DIRECTOR ELECTIONS ISSUER 47000 0 FOR 47000 FOR NOMAD FOODS LIMITED G6564A105 VGG6564A1057 07/10/2025 Election of Director for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Melanie Stack DIRECTOR ELECTIONS ISSUER 47000 0 FOR 47000 FOR NOMAD FOODS LIMITED G6564A105 VGG6564A1057 07/10/2025 Ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2025 fiscal year. AUDIT-RELATED ISSUER 47000 0 FOR 47000 FOR NVIDIA CORPORATION 67066G104 US67066G1040 06/24/2026 Election of Directors. Tench Coxe DIRECTOR ELECTIONS ISSUER 50 0 FOR 50 FOR NVIDIA CORPORATION 67066G104 US67066G1040 06/24/2026 Election of Directors. John O. Dabiri DIRECTOR ELECTIONS ISSUER 50 0 FOR 50 FOR NVIDIA CORPORATION 67066G104 US67066G1040 06/24/2026 Election of Directors. Jen-Hsun Huang DIRECTOR ELECTIONS ISSUER 50 0 FOR 50 FOR NVIDIA CORPORATION 67066G104 US67066G1040 06/24/2026 Election of Directors. Dawn Hudson DIRECTOR ELECTIONS ISSUER 50 0 FOR 50 FOR NVIDIA CORPORATION 67066G104 US67066G1040 06/24/2026 Election of Directors. Harvey C. Jones DIRECTOR ELECTIONS ISSUER 50 0 FOR 50 FOR NVIDIA CORPORATION 67066G104 US67066G1040 06/24/2026 Election of Directors. Melissa B. Lora DIRECTOR ELECTIONS ISSUER 50 0 FOR 50 FOR NVIDIA CORPORATION 67066G104 US67066G1040 06/24/2026 Election of Directors. Stephen C. Neal DIRECTOR ELECTIONS ISSUER 50 0 FOR 50 FOR NVIDIA CORPORATION 67066G104 US67066G1040 06/24/2026 Election of Directors. A. Brooke Seawell DIRECTOR ELECTIONS ISSUER 50 0 FOR 50 FOR NVIDIA CORPORATION 67066G104 US67066G1040 06/24/2026 Election of Directors. Aarti Shah DIRECTOR ELECTIONS ISSUER 50 0 FOR 50 FOR NVIDIA CORPORATION 67066G104 US67066G1040 06/24/2026 Election of Directors. Mark A. Stevens DIRECTOR ELECTIONS ISSUER 50 0 FOR 50 FOR NVIDIA CORPORATION 67066G104 US67066G1040 06/24/2026 Advisory approval of our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 50 0 FOR 50 FOR NVIDIA CORPORATION 67066G104 US67066G1040 06/24/2026 Ratification of the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2027. AUDIT-RELATED ISSUER 50 0 FOR 50 FOR NVIDIA CORPORATION 67066G104 US67066G1040 06/24/2026 Approval of a non-binding stockholder proposal requesting the replacement of supermajority voting provisions in our charter and bylaws with a simple majority voting standard. CORPORATE GOVERNANCE SECURITY HOLDER 50 0 AGAINST 50 FOR NVIDIA CORPORATION 67066G104 US67066G1040 06/24/2026 Approval of a non-binding stockholder proposal requesting a report on faith-based community resource groups. HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE SECURITY HOLDER 50 0 ABSTAIN 50 AGAINST NVIDIA CORPORATION 67066G104 US67066G1040 06/24/2026 Approval of a non-binding stockholder proposal requesting a report on workforce civil liberties. DIVERSITY, EQUITY, AND INCLUSION SECURITY HOLDER 50 0 ABSTAIN 50 AGAINST NVIDIA CORPORATION 67066G104 US67066G1040 06/24/2026 Approval of a non-binding stockholder proposal requesting reporting on greenhouse gas emissions from the use of our sold products. ENVIRONMENT OR CLIMATE SECURITY HOLDER 50 0 ABSTAIN 50 AGAINST OPTION CARE HEALTH, INC. 68404L201 US68404L2016 05/20/2026 Election of Director: 1. Elizabeth D. Bierbower DIRECTOR ELECTIONS ISSUER 125500 0 FOR 125500 FOR OPTION CARE HEALTH, INC. 68404L201 US68404L2016 05/20/2026 Election of Director: 2. Barbara W. Bodem DIRECTOR ELECTIONS ISSUER 125500 0 FOR 125500 FOR OPTION CARE HEALTH, INC. 68404L201 US68404L2016 05/20/2026 Election of Director: 3. Eric K. Brandt DIRECTOR ELECTIONS ISSUER 125500 0 FOR 125500 FOR OPTION CARE HEALTH, INC. 68404L201 US68404L2016 05/20/2026 Election of Director: 4. Natasha Deckmann DIRECTOR ELECTIONS ISSUER 125500 0 FOR 125500 FOR OPTION CARE HEALTH, INC. 68404L201 US68404L2016 05/20/2026 Election of Director: 5. Harry Jansen Kraemer Jr DIRECTOR ELECTIONS ISSUER 125500 0 FOR 125500 FOR OPTION CARE HEALTH, INC. 68404L201 US68404L2016 05/20/2026 Election of Director: 6. R. Carter Pate DIRECTOR ELECTIONS ISSUER 125500 0 FOR 125500 FOR OPTION CARE HEALTH, INC. 68404L201 US68404L2016 05/20/2026 Election of Director: 7. John C. Rademacher DIRECTOR ELECTIONS ISSUER 125500 0 FOR 125500 FOR OPTION CARE HEALTH, INC. 68404L201 US68404L2016 05/20/2026 Election of Director: 8. Timothy P. Sullivan DIRECTOR ELECTIONS ISSUER 125500 0 FOR 125500 FOR OPTION CARE HEALTH, INC. 68404L201 US68404L2016 05/20/2026 Election of Director: 9. Norman L. Wright DIRECTOR ELECTIONS ISSUER 125500 0 FOR 125500 FOR OPTION CARE HEALTH, INC. 68404L201 US68404L2016 05/20/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 125500 0 FOR 125500 FOR OPTION CARE HEALTH, INC. 68404L201 US68404L2016 05/20/2026 To approve, on a non-binding advisory basis, our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 125500 0 FOR 125500 FOR ORTHOFIX MEDICAL INC. 68752M108 US68752M1080 06/10/2026 Election of Directors Alan L. Bazaar DIRECTOR ELECTIONS ISSUER 12500 0 FOR 12500 FOR ORTHOFIX MEDICAL INC. 68752M108 US68752M1080 06/10/2026 Election of Directors Wayne Burris DIRECTOR ELECTIONS ISSUER 12500 0 FOR 12500 FOR ORTHOFIX MEDICAL INC. 68752M108 US68752M1080 06/10/2026 Election of Directors Massimo Calafiore DIRECTOR ELECTIONS ISSUER 12500 0 FOR 12500 FOR ORTHOFIX MEDICAL INC. 68752M108 US68752M1080 06/10/2026 Election of Directors Vickie L. Capps DIRECTOR ELECTIONS ISSUER 12500 0 FOR 12500 FOR ORTHOFIX MEDICAL INC. 68752M108 US68752M1080 06/10/2026 Election of Directors Michael M. Finegan DIRECTOR ELECTIONS ISSUER 12500 0 FOR 12500 FOR ORTHOFIX MEDICAL INC. 68752M108 US68752M1080 06/10/2026 Election of Directors Jason M. Hannon DIRECTOR ELECTIONS ISSUER 12500 0 FOR 12500 FOR ORTHOFIX MEDICAL INC. 68752M108 US68752M1080 06/10/2026 Election of Directors John B. Henneman, III DIRECTOR ELECTIONS ISSUER 12500 0 FOR 12500 FOR ORTHOFIX MEDICAL INC. 68752M108 US68752M1080 06/10/2026 Election of Directors Charles R. Kummeth DIRECTOR ELECTIONS ISSUER 12500 0 FOR 12500 FOR ORTHOFIX MEDICAL INC. 68752M108 US68752M1080 06/10/2026 Election of Directors Shweta S. Maniar DIRECTOR ELECTIONS ISSUER 12500 0 FOR 12500 FOR ORTHOFIX MEDICAL INC. 68752M108 US68752M1080 06/10/2026 Election of Directors Michael E. Paolucci DIRECTOR ELECTIONS ISSUER 12500 0 FOR 12500 FOR ORTHOFIX MEDICAL INC. 68752M108 US68752M1080 06/10/2026 Advisory and Non-Binding Vote to Approve Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 12500 0 FOR 12500 FOR ORTHOFIX MEDICAL INC. 68752M108 US68752M1080 06/10/2026 Ratification of the Appointment of Ernst & Young LLP as Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2026. AUDIT-RELATED ISSUER 12500 0 FOR 12500 FOR ORTHOFIX MEDICAL INC. 68752M108 US68752M1080 06/10/2026 Approval of Amendment No. 5 to the Second Amended and Restated Stock Purchase Plan. CAPITAL STRUCTURE ISSUER 12500 0 FOR 12500 FOR PERRIGO COMPANY PLC G97822103 IE00BGH1M568 04/30/2026 To elect, by separate resolutions, nine director nominees to serve until the 2027 Annual General Meeting of Shareholders; Bradley A. Alford DIRECTOR ELECTIONS ISSUER 13000 0 FOR 13000 FOR PERRIGO COMPANY PLC G97822103 IE00BGH1M568 04/30/2026 To elect, by separate resolutions, nine director nominees to serve until the 2027 Annual General Meeting of Shareholders; Orlando D. Ashford DIRECTOR ELECTIONS ISSUER 13000 0 FOR 13000 FOR PERRIGO COMPANY PLC G97822103 IE00BGH1M568 04/30/2026 To elect, by separate resolutions, nine director nominees to serve until the 2027 Annual General Meeting of Shareholders; Julia M. Brown DIRECTOR ELECTIONS ISSUER 13000 0 FOR 13000 FOR PERRIGO COMPANY PLC G97822103 IE00BGH1M568 04/30/2026 To elect, by separate resolutions, nine director nominees to serve until the 2027 Annual General Meeting of Shareholders; Kevin Egan DIRECTOR ELECTIONS ISSUER 13000 0 FOR 13000 FOR PERRIGO COMPANY PLC G97822103 IE00BGH1M568 04/30/2026 To elect, by separate resolutions, nine director nominees to serve until the 2027 Annual General Meeting of Shareholders; Patrick Lockwood-Taylor DIRECTOR ELECTIONS ISSUER 13000 0 FOR 13000 FOR PERRIGO COMPANY PLC G97822103 IE00BGH1M568 04/30/2026 To elect, by separate resolutions, nine director nominees to serve until the 2027 Annual General Meeting of Shareholders; Albert A. Manzone DIRECTOR ELECTIONS ISSUER 13000 0 FOR 13000 FOR PERRIGO COMPANY PLC G97822103 IE00BGH1M568 04/30/2026 To elect, by separate resolutions, nine director nominees to serve until the 2027 Annual General Meeting of Shareholders; Donal O'Connor DIRECTOR ELECTIONS ISSUER 13000 0 FOR 13000 FOR PERRIGO COMPANY PLC G97822103 IE00BGH1M568 04/30/2026 To elect, by separate resolutions, nine director nominees to serve until the 2027 Annual General Meeting of Shareholders; Geoffrey M. Parker DIRECTOR ELECTIONS ISSUER 13000 0 FOR 13000 FOR PERRIGO COMPANY PLC G97822103 IE00BGH1M568 04/30/2026 To elect, by separate resolutions, nine director nominees to serve until the 2027 Annual General Meeting of Shareholders; Jonas Samuelson DIRECTOR ELECTIONS ISSUER 13000 0 FOR 13000 FOR PERRIGO COMPANY PLC G97822103 IE00BGH1M568 04/30/2026 To ratify, in a non-binding advisory vote, the appointment of Ernst & Young LLP as the Company's independent auditor, and authorize, in a binding vote, the Board of Directors, acting through the Audit Committee, to fix the remuneration of the auditor; AUDIT-RELATED ISSUER 13000 0 FOR 13000 FOR PERRIGO COMPANY PLC G97822103 IE00BGH1M568 04/30/2026 To provide advisory approval of the Company's executive compensation; SECTION 14A SAY-ON-PAY VOTES ISSUER 13000 0 FOR 13000 FOR PERRIGO COMPANY PLC G97822103 IE00BGH1M568 04/30/2026 To provide approval of the 2026 Long-Term Incentive Plan; COMPENSATION ISSUER 13000 0 AGAINST 13000 AGAINST PERRIGO COMPANY PLC G97822103 IE00BGH1M568 04/30/2026 To renew the Board's authority to issue shares under Irish law; and CAPITAL STRUCTURE ISSUER 13000 0 FOR 13000 FOR PERRIGO COMPANY PLC G97822103 IE00BGH1M568 04/30/2026 To renew the Board's authority to opt-out of statutory pre-emption rights under Irish law. CAPITAL STRUCTURE ISSUER 13000 0 AGAINST 13000 AGAINST PERSONALIS, INC. 71535D106 US71535D1063 05/12/2026 Election of Directors Olivia K. Bloom DIRECTOR ELECTIONS ISSUER 500 0 FOR 500 FOR PERSONALIS, INC. 71535D106 US71535D1063 05/12/2026 Election of Directors Woodrow A. Myers, Jr., M.D. DIRECTOR ELECTIONS ISSUER 500 0 FOR 500 FOR PERSONALIS, INC. 71535D106 US71535D1063 05/12/2026 Ratification of the selection by the Audit Committee of the Board of Directors of BDO USA, P.C. as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 500 0 FOR 500 FOR PERSONALIS, INC. 71535D106 US71535D1063 05/12/2026 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 500 0 FOR 500 FOR PFIZER INC. 717081103 US7170811035 04/23/2026 Election of Directors: Ronald E. Blaylock DIRECTOR ELECTIONS ISSUER 32600 0 FOR 32600 FOR PFIZER INC. 717081103 US7170811035 04/23/2026 Election of Directors: Albert Bourla DIRECTOR ELECTIONS ISSUER 32600 0 FOR 32600 FOR PFIZER INC. 717081103 US7170811035 04/23/2026 Election of Directors: Mortimer J. Buckley DIRECTOR ELECTIONS ISSUER 32600 0 FOR 32600 FOR PFIZER INC. 717081103 US7170811035 04/23/2026 Election of Directors: Susan Desmond-Hellmann DIRECTOR ELECTIONS ISSUER 32600 0 FOR 32600 FOR PFIZER INC. 717081103 US7170811035 04/23/2026 Election of Directors: Joseph J. Echevarria DIRECTOR ELECTIONS ISSUER 32600 0 FOR 32600 FOR PFIZER INC. 717081103 US7170811035 04/23/2026 Election of Directors: Scott Gottlieb DIRECTOR ELECTIONS ISSUER 32600 0 FOR 32600 FOR PFIZER INC. 717081103 US7170811035 04/23/2026 Election of Directors: Dan R. Littman DIRECTOR ELECTIONS ISSUER 32600 0 FOR 32600 FOR PFIZER INC. 717081103 US7170811035 04/23/2026 Election of Directors: Shantanu Narayen DIRECTOR ELECTIONS ISSUER 32600 0 FOR 32600 FOR PFIZER INC. 717081103 US7170811035 04/23/2026 Election of Directors: Suzanne Nora Johnson DIRECTOR ELECTIONS ISSUER 32600 0 FOR 32600 FOR PFIZER INC. 717081103 US7170811035 04/23/2026 Election of Directors: James Quincey DIRECTOR ELECTIONS ISSUER 32600 0 FOR 32600 FOR PFIZER INC. 717081103 US7170811035 04/23/2026 Election of Directors: James C. Smith DIRECTOR ELECTIONS ISSUER 32600 0 FOR 32600 FOR PFIZER INC. 717081103 US7170811035 04/23/2026 Election of Directors: Cyrus Taraporevala DIRECTOR ELECTIONS ISSUER 32600 0 FOR 32600 FOR PFIZER INC. 717081103 US7170811035 04/23/2026 Ratify the selection of KPMG LLP as our independent registered public accounting firm for 2026 AUDIT-RELATED ISSUER 32600 0 FOR 32600 FOR PFIZER INC. 717081103 US7170811035 04/23/2026 Approval of the Pfizer Inc. 2019 Stock Plan, as amended April 2026 COMPENSATION ISSUER 32600 0 AGAINST 32600 AGAINST PFIZER INC. 717081103 US7170811035 04/23/2026 2026 advisory approval of executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 32600 0 FOR 32600 FOR PFIZER INC. 717081103 US7170811035 04/23/2026 Adopt an Independent Chair Policy CORPORATE GOVERNANCE SECURITY HOLDER 32600 0 AGAINST 32600 FOR POST HOLDINGS, INC. 737446104 US7374461041 01/29/2026 Election of Directors: Dorothy M. Burwell DIRECTOR ELECTIONS ISSUER 35000 0 FOR 35000 FOR POST HOLDINGS, INC. 737446104 US7374461041 01/29/2026 Election of Directors: Gregory L. Curl DIRECTOR ELECTIONS ISSUER 35000 0 FOR 35000 FOR POST HOLDINGS, INC. 737446104 US7374461041 01/29/2026 Election of Directors: Thomas C. Erb DIRECTOR ELECTIONS ISSUER 35000 0 FOR 35000 FOR POST HOLDINGS, INC. 737446104 US7374461041 01/29/2026 Election of Directors: David W. Kemper DIRECTOR ELECTIONS ISSUER 35000 0 FOR 35000 FOR POST HOLDINGS, INC. 737446104 US7374461041 01/29/2026 Election of Directors: Jennifer Kuperman DIRECTOR ELECTIONS ISSUER 35000 0 FOR 35000 FOR POST HOLDINGS, INC. 737446104 US7374461041 01/29/2026 Election of Directors: David P. Skarie DIRECTOR ELECTIONS ISSUER 35000 0 FOR 35000 FOR POST HOLDINGS, INC. 737446104 US7374461041 01/29/2026 Election of Directors: Robert V. Vitale DIRECTOR ELECTIONS ISSUER 35000 0 FOR 35000 FOR POST HOLDINGS, INC. 737446104 US7374461041 01/29/2026 Ratification of PricewaterhouseCoopers LLP as the Company's Independent Registered Public Accounting Firm for the fiscal year ending September 30, 2026. AUDIT-RELATED ISSUER 35000 0 FOR 35000 FOR POST HOLDINGS, INC. 737446104 US7374461041 01/29/2026 Advisory approval of the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 35000 0 FOR 35000 FOR POST HOLDINGS, INC. 737446104 US7374461041 01/29/2026 Amendments to the Company's Amended and Restated Articles of Incorporation - Amendment to eliminate the supermajority voting requirement relating to the removal of directors. CORPORATE GOVERNANCE ISSUER 35000 0 FOR 35000 FOR POST HOLDINGS, INC. 737446104 US7374461041 01/29/2026 Amendments to the Company's Amended and Restated Articles of Incorporation - Amendment to eliminate the supermajority voting requirement relating to the approval of business combinations. CORPORATE GOVERNANCE ISSUER 35000 0 FOR 35000 FOR POST HOLDINGS, INC. 737446104 US7374461041 01/29/2026 Amendments to the Company's Amended and Restated Articles of Incorporation - Amendment to eliminate the supermajority voting requirement relating to amendments to the provisions regarding the approval process for business combinations. CORPORATE GOVERNANCE ISSUER 35000 0 FOR 35000 FOR PROCEPT BIOROBOTICS CORPORATION 74276L105 US74276L1052 06/09/2026 Election of Class II directors to serve until 2029 annual meeting of stockholders and until their successors are duly elected and qualified. Antal Desai DIRECTOR ELECTIONS ISSUER 2000 0 FOR 2000 FOR PROCEPT BIOROBOTICS CORPORATION 74276L105 US74276L1052 06/09/2026 Election of Class II directors to serve until 2029 annual meeting of stockholders and until their successors are duly elected and qualified. Mary Garrett DIRECTOR ELECTIONS ISSUER 2000 0 FOR 2000 FOR PROCEPT BIOROBOTICS CORPORATION 74276L105 US74276L1052 06/09/2026 Election of Class II directors to serve until 2029 annual meeting of stockholders and until their successors are duly elected and qualified. Frederic Moll, M.D. DIRECTOR ELECTIONS ISSUER 2000 0 FOR 2000 FOR PROCEPT BIOROBOTICS CORPORATION 74276L105 US74276L1052 06/09/2026 Ratification of the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2000 0 FOR 2000 FOR PROCEPT BIOROBOTICS CORPORATION 74276L105 US74276L1052 06/09/2026 Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2000 0 FOR 2000 FOR PROGYNY, INC. 74340E103 US74340E1038 05/21/2026 Election of Directors: Lloyd Dean DIRECTOR ELECTIONS ISSUER 100 0 FOR 100 FOR PROGYNY, INC. 74340E103 US74340E1038 05/21/2026 Election of Directors: Kevin Gordon DIRECTOR ELECTIONS ISSUER 100 0 FOR 100 FOR PROGYNY, INC. 74340E103 US74340E1038 05/21/2026 Election of Directors: Cheryl Scott DIRECTOR ELECTIONS ISSUER 100 0 FOR 100 FOR PROGYNY, INC. 74340E103 US74340E1038 05/21/2026 Ratification of the selection of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 100 0 FOR 100 FOR PROGYNY, INC. 74340E103 US74340E1038 05/21/2026 Approval, on an advisory (non-binding) basis, of the compensation of the company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 100 0 FOR 100 FOR PROGYNY, INC. 74340E103 US74340E1038 05/21/2026 Approval of the amendment to the company's certificate of incorporation to eliminate certain supermajority voting requirements CORPORATE GOVERNANCE ISSUER 100 0 FOR 100 FOR PROGYNY, INC. 74340E103 US74340E1038 05/21/2026 Approval of the amendment to the company's certificate of incorporation to eliminate the default supermajority voting requirement concerning certain business combinations CORPORATE GOVERNANCE ISSUER 100 0 FOR 100 FOR PROTAGONIST THERAPEUTICS, INC. 74366E102 US74366E1029 06/17/2026 Election of Director: 1. Dinesh V. Patel, Ph.D. DIRECTOR ELECTIONS ISSUER 2500 0 FOR 2500 FOR PROTAGONIST THERAPEUTICS, INC. 74366E102 US74366E1029 06/17/2026 Election of Director: 2. L.T. Williams, MD, PhD DIRECTOR ELECTIONS ISSUER 2500 0 FOR 2500 FOR PROTAGONIST THERAPEUTICS, INC. 74366E102 US74366E1029 06/17/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2500 0 FOR 2500 FOR PROTAGONIST THERAPEUTICS, INC. 74366E102 US74366E1029 06/17/2026 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2500 0 FOR 2500 FOR PROTAGONIST THERAPEUTICS, INC. 74366E102 US74366E1029 06/17/2026 To approve the adoption of the Company's 2026 Equity Incentive Plan. COMPENSATION ISSUER 2500 0 AGAINST 2500 AGAINST QIAGEN N.V. N72482156 NL0015002SN0 06/24/2026 Proposal to adopt the Annual Accounts for the year ended December 31, 2025. OTHER ISSUER 100 0 FOR 100 FOR QIAGEN N.V. N72482156 NL0015002SN0 06/24/2026 Proposal to cast a favorable non-binding advisory vote in respect of the Remuneration Report 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 100 0 FOR 100 FOR QIAGEN N.V. N72482156 NL0015002SN0 06/24/2026 Proposal to approve the proposed dividend for 2026. CAPITAL STRUCTURE ISSUER 100 0 FOR 100 FOR QIAGEN N.V. N72482156 NL0015002SN0 06/24/2026 Proposal to discharge from liability the Managing Directors for the performance of their duties during 2025. CORPORATE GOVERNANCE ISSUER 100 0 FOR 100 FOR QIAGEN N.V. N72482156 NL0015002SN0 06/24/2026 Proposal to discharge from liability the Supervisory Directors for the performance of their duties during 2025. CORPORATE GOVERNANCE ISSUER 100 0 FOR 100 FOR QIAGEN N.V. N72482156 NL0015002SN0 06/24/2026 Appointment/Reappointment of the Supervisory Directors for a term running up to and including the date of the Annual General Meeting in 2027: Dr. Toralf Haag DIRECTOR ELECTIONS ISSUER 100 0 FOR 100 FOR QIAGEN N.V. N72482156 NL0015002SN0 06/24/2026 Appointment/Reappointment of the Supervisory Directors for a term running up to and including the date of the Annual General Meeting in 2027: Mr. Bert van Meurs DIRECTOR ELECTIONS ISSUER 100 0 FOR 100 FOR QIAGEN N.V. N72482156 NL0015002SN0 06/24/2026 Appointment/Reappointment of the Supervisory Directors for a term running up to and including the date of the Annual General Meeting in 2027: Mr. Robert McMahon DIRECTOR ELECTIONS ISSUER 100 0 FOR 100 FOR QIAGEN N.V. N72482156 NL0015002SN0 06/24/2026 Appointment/Reappointment of the Supervisory Directors for a term running up to and including the date of the Annual General Meeting in 2027: Ms. Eva van Pelt DIRECTOR ELECTIONS ISSUER 100 0 FOR 100 FOR QIAGEN N.V. N72482156 NL0015002SN0 06/24/2026 Appointment/Reappointment of the Supervisory Directors for a term running up to and including the date of the Annual General Meeting in 2027: Dr. Eva Pisa DIRECTOR ELECTIONS ISSUER 100 0 FOR 100 FOR QIAGEN N.V. N72482156 NL0015002SN0 06/24/2026 Appointment/Reappointment of the Supervisory Directors for a term running up to and including the date of the Annual General Meeting in 2027: Mr. Stephen H. Rusckowski DIRECTOR ELECTIONS ISSUER 100 0 FOR 100 FOR QIAGEN N.V. N72482156 NL0015002SN0 06/24/2026 Appointment/Reappointment of the Supervisory Directors for a term running up to and including the date of the Annual General Meeting in 2027: Mr. Mark P. Stevenson DIRECTOR ELECTIONS ISSUER 100 0 FOR 100 FOR QIAGEN N.V. N72482156 NL0015002SN0 06/24/2026 Appointment/Reappointment of the Supervisory Directors for a term running up to and including the date of the Annual General Meeting in 2027: Ms. Elizabeth E. Tallett DIRECTOR ELECTIONS ISSUER 100 0 FOR 100 FOR QIAGEN N.V. N72482156 NL0015002SN0 06/24/2026 Reappointment of the Managing Directors for a term running up to and including the date of the Annual General Meeting in 2027: Mr. Thierry Bernard CORPORATE GOVERNANCE ISSUER 100 0 FOR 100 FOR QIAGEN N.V. N72482156 NL0015002SN0 06/24/2026 Reappointment of the Managing Directors for a term running up to and including the date of the Annual General Meeting in 2027: Mr. Roland Sackers CORPORATE GOVERNANCE ISSUER 100 0 FOR 100 FOR QIAGEN N.V. N72482156 NL0015002SN0 06/24/2026 Proposal to adopt an amendment to the Managing Board Remuneration Policy. COMPENSATION ISSUER 100 0 FOR 100 FOR QIAGEN N.V. N72482156 NL0015002SN0 06/24/2026 Proposal to reappoint EY Accountants B.V. as auditor for the year ending December 31, 2026. AUDIT-RELATED ISSUER 100 0 FOR 100 FOR QIAGEN N.V. N72482156 NL0015002SN0 06/24/2026 Proposal to reappoint EY Accountants B.V. as the assurance provider for the year ending December 31, 2026. AUDIT-RELATED ISSUER 100 0 FOR 100 FOR QIAGEN N.V. N72482156 NL0015002SN0 06/24/2026 Proposal to authorize the Supervisory Board, until December 24, 2027 to: issue a number of ordinary shares and financing preference shares and grant rights to subscribe for such shares of up to 10% of the aggregate par value of all shares issued and outstanding. CAPITAL STRUCTURE ISSUER 100 0 FOR 100 FOR QIAGEN N.V. N72482156 NL0015002SN0 06/24/2026 Proposal to authorize the Supervisory Board, until December 24, 2027 to: restrict or exclude the pre-emptive rights with respect to issuing ordinary shares or granting subscription rights of up to 10% of the aggregate par value of all shares issued and outstanding. CAPITAL STRUCTURE ISSUER 100 0 ABSTAIN 100 AGAINST QIAGEN N.V. N72482156 NL0015002SN0 06/24/2026 Proposal to authorize the Managing Board, until December 24, 2027, to acquire shares in the Company's own share capital. CAPITAL STRUCTURE ISSUER 100 0 FOR 100 FOR QIAGEN N.V. N72482156 NL0015002SN0 06/24/2026 Proposal to approve discretionary rights for the Managing Board to implement a capital repayment by means of a synthetic share repurchase. CAPITAL STRUCTURE ISSUER 100 0 FOR 100 FOR QIAGEN N.V. N72482156 NL0015002SN0 06/24/2026 Proposal to approve the cancellation of whole and/or fractional ordinary shares held by the Company. CAPITAL STRUCTURE ISSUER 100 0 FOR 100 FOR QUIDELORTHO CORPORATION 219798105 US2197981051 06/16/2026 Election of Director: 1. Brian J. Blaser DIRECTOR ELECTIONS ISSUER 11200 0 FOR 11200 FOR QUIDELORTHO CORPORATION 219798105 US2197981051 06/16/2026 Election of Director: 2. K. F. Buechler, Ph.D. DIRECTOR ELECTIONS ISSUER 11200 0 FOR 11200 FOR QUIDELORTHO CORPORATION 219798105 US2197981051 06/16/2026 Election of Director: 3. John R. Chiminski DIRECTOR ELECTIONS ISSUER 11200 0 FOR 11200 FOR QUIDELORTHO CORPORATION 219798105 US2197981051 06/16/2026 Election of Director: 4. Evelyn S. Dilsaver DIRECTOR ELECTIONS ISSUER 11200 0 FOR 11200 FOR QUIDELORTHO CORPORATION 219798105 US2197981051 06/16/2026 Election of Director: 5. R. Scott Huennekens DIRECTOR ELECTIONS ISSUER 11200 0 FOR 11200 FOR QUIDELORTHO CORPORATION 219798105 US2197981051 06/16/2026 Election of Director: 6. Edward L. Michael DIRECTOR ELECTIONS ISSUER 11200 0 FOR 11200 FOR QUIDELORTHO CORPORATION 219798105 US2197981051 06/16/2026 Election of Director: 7. M.L. Polan, MD PhD MPH DIRECTOR ELECTIONS ISSUER 11200 0 FOR 11200 FOR QUIDELORTHO CORPORATION 219798105 US2197981051 06/16/2026 Election of Director: 8. Ann D. Rhoads DIRECTOR ELECTIONS ISSUER 11200 0 FOR 11200 FOR QUIDELORTHO CORPORATION 219798105 US2197981051 06/16/2026 Election of Director: 9. Kenneth J. Widder, M.D. DIRECTOR ELECTIONS ISSUER 11200 0 FOR 11200 FOR QUIDELORTHO CORPORATION 219798105 US2197981051 06/16/2026 Election of Director: 10. Joseph D. Wilkins Jr. DIRECTOR ELECTIONS ISSUER 11200 0 FOR 11200 FOR QUIDELORTHO CORPORATION 219798105 US2197981051 06/16/2026 Approval of, on an advisory basis, the compensation of QuidelOrtho's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 11200 0 FOR 11200 FOR QUIDELORTHO CORPORATION 219798105 US2197981051 06/16/2026 Ratification of the selection of KPMG LLP as QuidelOrtho's independent registered public accounting firm for the fiscal year ending January 3, 2027. AUDIT-RELATED ISSUER 11200 0 FOR 11200 FOR RADNET, INC. 750491102 US7504911022 06/02/2026 Election of Director: 1. Howard G. Berger, M.D. DIRECTOR ELECTIONS ISSUER 200 0 FOR 200 FOR RADNET, INC. 750491102 US7504911022 06/02/2026 Election of Director: 2. A. Gregory Sorensen M.D DIRECTOR ELECTIONS ISSUER 200 0 FOR 200 FOR RADNET, INC. 750491102 US7504911022 06/02/2026 Election of Director: 3. Laura P. Jacobs DIRECTOR ELECTIONS ISSUER 200 0 FOR 200 FOR RADNET, INC. 750491102 US7504911022 06/02/2026 Election of Director: 4. Lawrence L. Levitt DIRECTOR ELECTIONS ISSUER 200 0 FOR 200 FOR RADNET, INC. 750491102 US7504911022 06/02/2026 Election of Director: 5. Gregory E. Spurlock DIRECTOR ELECTIONS ISSUER 200 0 FOR 200 FOR RADNET, INC. 750491102 US7504911022 06/02/2026 Election of Director: 6. David L. Swartz DIRECTOR ELECTIONS ISSUER 200 0 FOR 200 FOR RADNET, INC. 750491102 US7504911022 06/02/2026 The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 200 0 FOR 200 FOR RADNET, INC. 750491102 US7504911022 06/02/2026 An advisory vote to approve the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 200 0 FOR 200 FOR RADNET, INC. 750491102 US7504911022 06/02/2026 The approval of an amendment and restatement to the Company's Equity Incentive Plan. COMPENSATION ISSUER 200 0 ABSTAIN 200 AGAINST REGENERON PHARMACEUTICALS, INC. 75886F107 US75886F1075 06/12/2026 Election of Directors Joseph L. Goldstein, M.D. DIRECTOR ELECTIONS ISSUER 1465 0 FOR 1465 FOR REGENERON PHARMACEUTICALS, INC. 75886F107 US75886F1075 06/12/2026 Election of Directors Christine A. Poon DIRECTOR ELECTIONS ISSUER 1465 0 FOR 1465 FOR REGENERON PHARMACEUTICALS, INC. 75886F107 US75886F1075 06/12/2026 Election of Directors David P. Schenkein, M.D. DIRECTOR ELECTIONS ISSUER 1465 0 FOR 1465 FOR REGENERON PHARMACEUTICALS, INC. 75886F107 US75886F1075 06/12/2026 Election of Directors Craig B. Thompson, M.D. DIRECTOR ELECTIONS ISSUER 1465 0 FOR 1465 FOR REGENERON PHARMACEUTICALS, INC. 75886F107 US75886F1075 06/12/2026 Election of Directors Huda Y. Zoghbi, M.D. DIRECTOR ELECTIONS ISSUER 1465 0 FOR 1465 FOR REGENERON PHARMACEUTICALS, INC. 75886F107 US75886F1075 06/12/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1465 0 FOR 1465 FOR REGENERON PHARMACEUTICALS, INC. 75886F107 US75886F1075 06/12/2026 Proposal to approve, on an advisory basis, compensation of the Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1465 0 FOR 1465 FOR REGENXBIO INC. 75901B107 US75901B1070 05/29/2026 Election of Director: 1. Jean Bennett, M.D., PhD DIRECTOR ELECTIONS ISSUER 100 0 FOR 100 FOR REGENXBIO INC. 75901B107 US75901B1070 05/29/2026 Election of Director: 2. A.N. Karabelas, Ph.D. DIRECTOR ELECTIONS ISSUER 100 0 FOR 100 FOR REGENXBIO INC. 75901B107 US75901B1070 05/29/2026 Election of Director: 3. Daniel Tasse DIRECTOR ELECTIONS ISSUER 100 0 FOR 100 FOR REGENXBIO INC. 75901B107 US75901B1070 05/29/2026 To ratify the appointment of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 100 0 FOR 100 FOR REGENXBIO INC. 75901B107 US75901B1070 05/29/2026 Advisory vote on the compensation paid to the Company's executive employees. SECTION 14A SAY-ON-PAY VOTES ISSUER 100 0 FOR 100 FOR REGENXBIO INC. 75901B107 US75901B1070 05/29/2026 To approve a stock option exchange for our non-executive employees. COMPENSATION ISSUER 100 0 AGAINST 100 AGAINST REGENXBIO INC. 75901B107 US75901B1070 05/29/2026 To approve a stock option exchange for our executive employees. COMPENSATION ISSUER 100 0 AGAINST 100 AGAINST RELAY THERAPEUTICS, INC. 75943R102 US75943R1023 06/09/2026 To elect two class III directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal; Douglas S. Ingram DIRECTOR ELECTIONS ISSUER 12000 0 FOR 12000 FOR RELAY THERAPEUTICS, INC. 75943R102 US75943R1023 06/09/2026 To elect two class III directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal; Claire Mazumdar, Ph.D. DIRECTOR ELECTIONS ISSUER 12000 0 FOR 12000 FOR RELAY THERAPEUTICS, INC. 75943R102 US75943R1023 06/09/2026 To consider and act upon an advisory vote on the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 12000 0 FOR 12000 FOR RELAY THERAPEUTICS, INC. 75943R102 US75943R1023 06/09/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026; AUDIT-RELATED ISSUER 12000 0 FOR 12000 FOR RELAY THERAPEUTICS, INC. 75943R102 US75943R1023 06/09/2026 To approve an amendment to our Fourth Amended and Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of our common stock from 300,000,000 to 450,000,000; CAPITAL STRUCTURE ISSUER 12000 0 FOR 12000 FOR REVOLUTION MEDICINES, INC. 76155X100 US76155X1000 06/18/2026 Election of Director: 1. Alexis Borisy DIRECTOR ELECTIONS ISSUER 4000 0 FOR 4000 FOR REVOLUTION MEDICINES, INC. 76155X100 US76155X1000 06/18/2026 Election of Director: 2. Mark A Goldsmith MD PhD DIRECTOR ELECTIONS ISSUER 4000 0 FOR 4000 FOR REVOLUTION MEDICINES, INC. 76155X100 US76155X1000 06/18/2026 To ratify the appointment, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026; and AUDIT-RELATED ISSUER 4000 0 FOR 4000 FOR REVOLUTION MEDICINES, INC. 76155X100 US76155X1000 06/18/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 4000 0 FOR 4000 FOR ROYALTY PHARMA PLC G7709Q104 GB00BMVP7Y09 06/04/2026 Election of Directors Pablo Legorreta DIRECTOR ELECTIONS ISSUER 3000 0 FOR 3000 FOR ROYALTY PHARMA PLC G7709Q104 GB00BMVP7Y09 06/04/2026 Election of Directors Ted Love, M.D. DIRECTOR ELECTIONS ISSUER 3000 0 FOR 3000 FOR ROYALTY PHARMA PLC G7709Q104 GB00BMVP7Y09 06/04/2026 Election of Directors Bonnie Bassler, Ph.D. DIRECTOR ELECTIONS ISSUER 3000 0 FOR 3000 FOR ROYALTY PHARMA PLC G7709Q104 GB00BMVP7Y09 06/04/2026 Election of Directors Vlad Coric, M.D. DIRECTOR ELECTIONS ISSUER 3000 0 FOR 3000 FOR ROYALTY PHARMA PLC G7709Q104 GB00BMVP7Y09 06/04/2026 Election of Directors Catherine Engelbert DIRECTOR ELECTIONS ISSUER 3000 0 FOR 3000 FOR ROYALTY PHARMA PLC G7709Q104 GB00BMVP7Y09 06/04/2026 Election of Directors Carole Ho, M.D. DIRECTOR ELECTIONS ISSUER 3000 0 FOR 3000 FOR ROYALTY PHARMA PLC G7709Q104 GB00BMVP7Y09 06/04/2026 Election of Directors David Hodgson DIRECTOR ELECTIONS ISSUER 3000 0 FOR 3000 FOR ROYALTY PHARMA PLC G7709Q104 GB00BMVP7Y09 06/04/2026 Election of Directors Gregory Norden DIRECTOR ELECTIONS ISSUER 3000 0 FOR 3000 FOR ROYALTY PHARMA PLC G7709Q104 GB00BMVP7Y09 06/04/2026 Election of Directors Elizabeth Weatherman DIRECTOR ELECTIONS ISSUER 3000 0 FOR 3000 FOR ROYALTY PHARMA PLC G7709Q104 GB00BMVP7Y09 06/04/2026 A non-binding advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 3000 0 FOR 3000 FOR ROYALTY PHARMA PLC G7709Q104 GB00BMVP7Y09 06/04/2026 Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm. AUDIT-RELATED ISSUER 3000 0 FOR 3000 FOR ROYALTY PHARMA PLC G7709Q104 GB00BMVP7Y09 06/04/2026 Approve receipt of our U.K. audited annual report and accounts and related directors' and auditor's reports for the fiscal year ended December 31, 2025. OTHER ISSUER 3000 0 FOR 3000 FOR ROYALTY PHARMA PLC G7709Q104 GB00BMVP7Y09 06/04/2026 Approve on a non-binding advisory basis our U.K. directors' remuneration report for the fiscal year ended December 31, 2025. COMPENSATION ISSUER 3000 0 FOR 3000 FOR ROYALTY PHARMA PLC G7709Q104 GB00BMVP7Y09 06/04/2026 Re-appoint Ernst & Young as our U.K. statutory auditor, to hold office until the conclusion of the next general meeting at which the U.K. annual report and accounts are presented to shareholders. AUDIT-RELATED ISSUER 3000 0 FOR 3000 FOR ROYALTY PHARMA PLC G7709Q104 GB00BMVP7Y09 06/04/2026 Authorize the Board to determine the remuneration of Ernst & Young in its capacity as our U.K. statutory auditor. AUDIT-RELATED ISSUER 3000 0 FOR 3000 FOR ROYALTY PHARMA PLC G7709Q104 GB00BMVP7Y09 06/04/2026 Approve the terms of the agreements and counterparties pursuant to which we may purchase our Class A ordinary shares. CAPITAL STRUCTURE ISSUER 3000 0 FOR 3000 FOR ROYALTY PHARMA PLC G7709Q104 GB00BMVP7Y09 06/04/2026 Authorize the Board to allot shares. CAPITAL STRUCTURE ISSUER 3000 0 FOR 3000 FOR ROYALTY PHARMA PLC G7709Q104 GB00BMVP7Y09 06/04/2026 Authorize the Board to allot shares without rights of pre-emption (special resolution). CAPITAL STRUCTURE ISSUER 3000 0 AGAINST 3000 AGAINST SCHOLAR ROCK HOLDING CORPORATION 80706P103 US80706P1030 06/04/2026 Election of Director: 1. David Hallal DIRECTOR ELECTIONS ISSUER 3000 0 FOR 3000 FOR SCHOLAR ROCK HOLDING CORPORATION 80706P103 US80706P1030 06/04/2026 Election of Director: 2. Kristina Burow DIRECTOR ELECTIONS ISSUER 3000 0 FOR 3000 FOR SCHOLAR ROCK HOLDING CORPORATION 80706P103 US80706P1030 06/04/2026 Election of Director: 3. Michael Gilman DIRECTOR ELECTIONS ISSUER 3000 0 FOR 3000 FOR SCHOLAR ROCK HOLDING CORPORATION 80706P103 US80706P1030 06/04/2026 Election of Director: 4. Katie Peng DIRECTOR ELECTIONS ISSUER 3000 0 FOR 3000 FOR SCHOLAR ROCK HOLDING CORPORATION 80706P103 US80706P1030 06/04/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 3000 0 FOR 3000 FOR SCHOLAR ROCK HOLDING CORPORATION 80706P103 US80706P1030 06/04/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3000 0 FOR 3000 FOR SENSIENT TECHNOLOGIES CORPORATION 81725T100 US81725T1007 04/23/2026 Election of directors: Brett W. Bruggeman DIRECTOR ELECTIONS ISSUER 20000 0 FOR 20000 FOR SENSIENT TECHNOLOGIES CORPORATION 81725T100 US81725T1007 04/23/2026 Election of directors: Joseph Carleone DIRECTOR ELECTIONS ISSUER 20000 0 FOR 20000 FOR SENSIENT TECHNOLOGIES CORPORATION 81725T100 US81725T1007 04/23/2026 Election of directors: Mario Ferruzzi DIRECTOR ELECTIONS ISSUER 20000 0 FOR 20000 FOR SENSIENT TECHNOLOGIES CORPORATION 81725T100 US81725T1007 04/23/2026 Election of directors: Carol R. Jackson DIRECTOR ELECTIONS ISSUER 20000 0 FOR 20000 FOR SENSIENT TECHNOLOGIES CORPORATION 81725T100 US81725T1007 04/23/2026 Election of directors: Sharad P. Jain DIRECTOR ELECTIONS ISSUER 20000 0 FOR 20000 FOR SENSIENT TECHNOLOGIES CORPORATION 81725T100 US81725T1007 04/23/2026 Election of directors: Donald W. Landry DIRECTOR ELECTIONS ISSUER 20000 0 FOR 20000 FOR SENSIENT TECHNOLOGIES CORPORATION 81725T100 US81725T1007 04/23/2026 Election of directors: Paul Manning DIRECTOR ELECTIONS ISSUER 20000 0 FOR 20000 FOR SENSIENT TECHNOLOGIES CORPORATION 81725T100 US81725T1007 04/23/2026 Election of directors: Scott C. Morrison DIRECTOR ELECTIONS ISSUER 20000 0 FOR 20000 FOR SENSIENT TECHNOLOGIES CORPORATION 81725T100 US81725T1007 04/23/2026 Election of directors: Essie Whitelaw DIRECTOR ELECTIONS ISSUER 20000 0 FOR 20000 FOR SENSIENT TECHNOLOGIES CORPORATION 81725T100 US81725T1007 04/23/2026 Proposal to approve the compensation paid to Sensient's named executive officers, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables, and narrative discussion in the accompanying proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 20000 0 FOR 20000 FOR SENSIENT TECHNOLOGIES CORPORATION 81725T100 US81725T1007 04/23/2026 Proposal to ratify the appointment of Ernst & Young LLP, certified public accountants, as the independent auditors of Sensient for 2026. AUDIT-RELATED ISSUER 20000 0 FOR 20000 FOR SOLVENTUM CORPORATION 83444M101 US83444M1018 05/15/2026 Election of Directors Carlos Alban DIRECTOR ELECTIONS ISSUER 3750 0 FOR 3750 FOR SOLVENTUM CORPORATION 83444M101 US83444M1018 05/15/2026 Election of Directors Susan D. DeVore DIRECTOR ELECTIONS ISSUER 3750 0 FOR 3750 FOR SOLVENTUM CORPORATION 83444M101 US83444M1018 05/15/2026 Election of Directors Shirley Edwards DIRECTOR ELECTIONS ISSUER 3750 0 FOR 3750 FOR SOLVENTUM CORPORATION 83444M101 US83444M1018 05/15/2026 Election of Directors Dr. Bernard A. Harris Jr. DIRECTOR ELECTIONS ISSUER 3750 0 FOR 3750 FOR SOLVENTUM CORPORATION 83444M101 US83444M1018 05/15/2026 Advisory vote to approve executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 3750 0 FOR 3750 FOR SOLVENTUM CORPORATION 83444M101 US83444M1018 05/15/2026 Ratification of the appointment of PwC as Solventum's independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 3750 0 FOR 3750 FOR SPROUTS FARMERS MARKET, INC. 85208M102 US85208M1027 05/20/2026 Election of Director: 1. Joel D. Anderson DIRECTOR ELECTIONS ISSUER 15000 0 FOR 15000 FOR SPROUTS FARMERS MARKET, INC. 85208M102 US85208M1027 05/20/2026 Election of Director: 2. Terri Funk Graham DIRECTOR ELECTIONS ISSUER 15000 0 FOR 15000 FOR SPROUTS FARMERS MARKET, INC. 85208M102 US85208M1027 05/20/2026 To vote on a non-binding advisory resolution to approve the compensation paid to our named executive officers for fiscal 2025 ("say-on-pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 15000 0 FOR 15000 FOR SPROUTS FARMERS MARKET, INC. 85208M102 US85208M1027 05/20/2026 To vote on a non-binding advisory proposal on the frequency of future say-on-pay votes ("say-on-frequency"). SECTION 14A SAY-ON-PAY VOTES ISSUER 15000 0 1 Year 15000 FOR SPROUTS FARMERS MARKET, INC. 85208M102 US85208M1027 05/20/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending January 3, 2027. AUDIT-RELATED ISSUER 15000 0 FOR 15000 FOR STRUCTURE THERAPEUTICS, INC. 86366E106 US86366E1064 06/17/2026 Election of the nominees for Class III director named below to hold office until the 2029 annual general meeting of shareholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal. Ted W. Love, M.D. DIRECTOR ELECTIONS ISSUER 4050 0 FOR 4050 FOR STRUCTURE THERAPEUTICS, INC. 86366E106 US86366E1064 06/17/2026 Election of the nominees for Class III director named below to hold office until the 2029 annual general meeting of shareholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal. Raymond Stevens, Ph.D. DIRECTOR ELECTIONS ISSUER 4050 0 FOR 4050 FOR STRUCTURE THERAPEUTICS, INC. 86366E106 US86366E1064 06/17/2026 Election of the nominees for Class III director named below to hold office until the 2029 annual general meeting of shareholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal. Daniel G. Welch DIRECTOR ELECTIONS ISSUER 4050 0 FOR 4050 FOR STRUCTURE THERAPEUTICS, INC. 86366E106 US86366E1064 06/17/2026 To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 4050 0 FOR 4050 FOR STRUCTURE THERAPEUTICS, INC. 86366E106 US86366E1064 06/17/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 4050 0 FOR 4050 FOR STRYKER CORPORATION 863667101 US8636671013 05/06/2026 Election of Directors. Mary K. Brainerd DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR STRYKER CORPORATION 863667101 US8636671013 05/06/2026 Election of Directors. Giovanni Caforio, M.D. DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR STRYKER CORPORATION 863667101 US8636671013 05/06/2026 Election of Directors. Kevin A. Lobo DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR STRYKER CORPORATION 863667101 US8636671013 05/06/2026 Election of Directors. Emmanuel P. Maceda DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR STRYKER CORPORATION 863667101 US8636671013 05/06/2026 Election of Directors. Sherilyn S. McCoy DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR STRYKER CORPORATION 863667101 US8636671013 05/06/2026 Election of Directors. Rachel M. Ruggeri DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR STRYKER CORPORATION 863667101 US8636671013 05/06/2026 Election of Directors. Andrew K. Silvernail DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR STRYKER CORPORATION 863667101 US8636671013 05/06/2026 Election of Directors. Lisa M. Skeete Tatum DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR STRYKER CORPORATION 863667101 US8636671013 05/06/2026 Election of Directors. Ronda E. Stryker DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR STRYKER CORPORATION 863667101 US8636671013 05/06/2026 Election of Directors. Rajeev Suri DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR STRYKER CORPORATION 863667101 US8636671013 05/06/2026 Ratification of Appointment of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for 2026. AUDIT-RELATED ISSUER 5000 0 FOR 5000 FOR STRYKER CORPORATION 863667101 US8636671013 05/06/2026 Advisory Vote to Approve Named Executive Officer Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 5000 0 FOR 5000 FOR SUNTORY BEVERAGE & FOOD LIMITED J78186103 JP3336560002 03/25/2026 Approve Appropriation of Surplus CAPITAL STRUCTURE ISSUER 22000 0 FOR 22000 FOR SUNTORY BEVERAGE & FOOD LIMITED J78186103 JP3336560002 03/25/2026 Amend Articles to: Amend Official Company Name CORPORATE GOVERNANCE ISSUER 22000 0 FOR 22000 FOR SUNTORY BEVERAGE & FOOD LIMITED J78186103 JP3336560002 03/25/2026 Appoint a Director who is not Audit and Supervisory Committee Member Kimura, Josuke DIRECTOR ELECTIONS ISSUER 22000 0 FOR 22000 FOR SUNTORY BEVERAGE & FOOD LIMITED J78186103 JP3336560002 03/25/2026 Appoint a Director who is not Audit and Supervisory Committee Member Okinaka, Naoto DIRECTOR ELECTIONS ISSUER 22000 0 FOR 22000 FOR SUNTORY BEVERAGE & FOOD LIMITED J78186103 JP3336560002 03/25/2026 Appoint a Director who is not Audit and Supervisory Committee Member Semba, Sho DIRECTOR ELECTIONS ISSUER 22000 0 FOR 22000 FOR SUNTORY BEVERAGE & FOOD LIMITED J78186103 JP3336560002 03/25/2026 Appoint a Director who is not Audit and Supervisory Committee Member Nakamura, Maki DIRECTOR ELECTIONS ISSUER 22000 0 FOR 22000 FOR SUNTORY BEVERAGE & FOOD LIMITED J78186103 JP3336560002 03/25/2026 Appoint a Director who is Audit and Supervisory Committee Member Kanda, Hideki DIRECTOR ELECTIONS ISSUER 22000 0 FOR 22000 FOR SUNTORY BEVERAGE & FOOD LIMITED J78186103 JP3336560002 03/25/2026 Appoint a Substitute Director who is Audit and Supervisory Committee Member Amitani, Mitsuhiro DIRECTOR ELECTIONS ISSUER 22000 0 FOR 22000 FOR SURGERY PARTNERS INC. 86881A100 US86881A1007 06/05/2026 Election of Class II Directors: Devin O'Reilly DIRECTOR ELECTIONS ISSUER 45697 0 FOR 45697 FOR SURGERY PARTNERS INC. 86881A100 US86881A1007 06/05/2026 Election of Class II Directors: Brent Turner DIRECTOR ELECTIONS ISSUER 45697 0 FOR 45697 FOR SURGERY PARTNERS INC. 86881A100 US86881A1007 06/05/2026 Election of Class II Directors: Laura L. Forese, M.D. DIRECTOR ELECTIONS ISSUER 45697 0 FOR 45697 FOR SURGERY PARTNERS INC. 86881A100 US86881A1007 06/05/2026 Approval, on an advisory basis, of the compensation paid by the Company to its named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 45697 0 FOR 45697 FOR SURGERY PARTNERS INC. 86881A100 US86881A1007 06/05/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 45697 0 FOR 45697 FOR SYNDAX PHARMACEUTICALS, INC 87164F105 US87164F1057 06/10/2026 Election of Directors Pierre Legault DIRECTOR ELECTIONS ISSUER 8500 0 FOR 8500 FOR SYNDAX PHARMACEUTICALS, INC 87164F105 US87164F1057 06/10/2026 Election of Directors Michael A. Metzger DIRECTOR ELECTIONS ISSUER 8500 0 FOR 8500 FOR SYNDAX PHARMACEUTICALS, INC 87164F105 US87164F1057 06/10/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2026 proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 8500 0 FOR 8500 FOR SYNDAX PHARMACEUTICALS, INC 87164F105 US87164F1057 06/10/2026 To ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 8500 0 FOR 8500 FOR SYNDAX PHARMACEUTICALS, INC 87164F105 US87164F1057 06/10/2026 To approve the Syndax Pharmaceuticals, Inc. 2026 Equity Incentive Plan. COMPENSATION ISSUER 8500 0 AGAINST 8500 AGAINST SYNDAX PHARMACEUTICALS, INC 87164F105 US87164F1057 06/10/2026 To approve the Syndax Pharmaceuticals, Inc. 2026 Employee Stock Purchase Plan. CAPITAL STRUCTURE ISSUER 8500 0 FOR 8500 FOR TARSUS PHARMACEUTICALS, INC. 87650L103 US87650L1035 06/25/2026 To elect Class III directors, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed. Wendy Yarno DIRECTOR ELECTIONS ISSUER 3600 0 FOR 3600 FOR TARSUS PHARMACEUTICALS, INC. 87650L103 US87650L1035 06/25/2026 To elect Class III directors, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed. Andrew Goldberg DIRECTOR ELECTIONS ISSUER 3600 0 FOR 3600 FOR TARSUS PHARMACEUTICALS, INC. 87650L103 US87650L1035 06/25/2026 To elect Class III directors, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed. Scott Morrison DIRECTOR ELECTIONS ISSUER 3600 0 FOR 3600 FOR TARSUS PHARMACEUTICALS, INC. 87650L103 US87650L1035 06/25/2026 To elect Class III directors, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed. David E.I. Pyott DIRECTOR ELECTIONS ISSUER 3600 0 FOR 3600 FOR TARSUS PHARMACEUTICALS, INC. 87650L103 US87650L1035 06/25/2026 To hold an advisory vote to approve, on a non-binding basis, our named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 3600 0 FOR 3600 FOR TARSUS PHARMACEUTICALS, INC. 87650L103 US87650L1035 06/25/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 3600 0 FOR 3600 FOR TENET HEALTHCARE CORPORATION 88033G407 US88033G4073 05/27/2026 Election of Directors Saumya Sutaria DIRECTOR ELECTIONS ISSUER 9900 0 FOR 9900 FOR TENET HEALTHCARE CORPORATION 88033G407 US88033G4073 05/27/2026 Election of Directors J. Robert Kerrey DIRECTOR ELECTIONS ISSUER 9900 0 FOR 9900 FOR TENET HEALTHCARE CORPORATION 88033G407 US88033G4073 05/27/2026 Election of Directors Vineeta Agarwala DIRECTOR ELECTIONS ISSUER 9900 0 FOR 9900 FOR TENET HEALTHCARE CORPORATION 88033G407 US88033G4073 05/27/2026 Election of Directors James L. Bierman DIRECTOR ELECTIONS ISSUER 9900 0 FOR 9900 FOR TENET HEALTHCARE CORPORATION 88033G407 US88033G4073 05/27/2026 Election of Directors Roy Blunt DIRECTOR ELECTIONS ISSUER 9900 0 FOR 9900 FOR TENET HEALTHCARE CORPORATION 88033G407 US88033G4073 05/27/2026 Election of Directors Richard W. Fisher DIRECTOR ELECTIONS ISSUER 9900 0 FOR 9900 FOR TENET HEALTHCARE CORPORATION 88033G407 US88033G4073 05/27/2026 Election of Directors Meghan M. FitzGerald DIRECTOR ELECTIONS ISSUER 9900 0 FOR 9900 FOR TENET HEALTHCARE CORPORATION 88033G407 US88033G4073 05/27/2026 Election of Directors Cecil D. Haney DIRECTOR ELECTIONS ISSUER 9900 0 FOR 9900 FOR TENET HEALTHCARE CORPORATION 88033G407 US88033G4073 05/27/2026 Election of Directors Christopher S. Lynch DIRECTOR ELECTIONS ISSUER 9900 0 FOR 9900 FOR TENET HEALTHCARE CORPORATION 88033G407 US88033G4073 05/27/2026 Election of Directors Richard J. Mark DIRECTOR ELECTIONS ISSUER 9900 0 FOR 9900 FOR TENET HEALTHCARE CORPORATION 88033G407 US88033G4073 05/27/2026 Election of Directors Tammy Romo DIRECTOR ELECTIONS ISSUER 9900 0 FOR 9900 FOR TENET HEALTHCARE CORPORATION 88033G407 US88033G4073 05/27/2026 Election of Directors Nadja Y. West DIRECTOR ELECTIONS ISSUER 9900 0 FOR 9900 FOR TENET HEALTHCARE CORPORATION 88033G407 US88033G4073 05/27/2026 To approve, on an advisory basis, the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 9900 0 FOR 9900 FOR TENET HEALTHCARE CORPORATION 88033G407 US88033G4073 05/27/2026 To ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accountants for the year ending December 31, 2026. AUDIT-RELATED ISSUER 9900 0 FOR 9900 FOR TEVA PHARMACEUTICAL INDUSTRIES LIMITED 881624209 US8816242098 05/28/2026 TO APPOINT DR. SOL J. BARER TO SERVE AS A DIRECTOR UNTIL TEVA'S 2029 ANNUAL MEETING OF SHAREHOLDERS Dr. Sol J. Barer DIRECTOR ELECTIONS ISSUER 117500 0 FOR 117500 FOR TEVA PHARMACEUTICAL INDUSTRIES LIMITED 881624209 US8816242098 05/28/2026 TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION FOR TEVA'S NAMED EXECUTIVE OFFICERS SECTION 14A SAY-ON-PAY VOTES ISSUER 117500 0 FOR 117500 FOR TEVA PHARMACEUTICAL INDUSTRIES LIMITED 881624209 US8816242098 05/28/2026 TO APPOINT KESSELMAN & KESSELMAN, A MEMBER OF PRICEWATERHOUSECOOPERS INTERNATIONAL LTD., AS TEVA'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM UNTIL TEVA'S 2027 ANNUAL MEETING OF SHAREHOLDERS AUDIT-RELATED ISSUER 117500 0 FOR 117500 FOR THE CAMPBELL'S COMPANY 134429109 US1344291091 11/18/2025 The election of twelve directors, each for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Fabiola R. Arredondo DIRECTOR ELECTIONS ISSUER 85000 0 FOR 85000 FOR THE CAMPBELL'S COMPANY 134429109 US1344291091 11/18/2025 The election of twelve directors, each for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Howard M. Averill DIRECTOR ELECTIONS ISSUER 85000 0 FOR 85000 FOR THE CAMPBELL'S COMPANY 134429109 US1344291091 11/18/2025 The election of twelve directors, each for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Mick J. Beekhuizen DIRECTOR ELECTIONS ISSUER 85000 0 FOR 85000 FOR THE CAMPBELL'S COMPANY 134429109 US1344291091 11/18/2025 The election of twelve directors, each for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Bennett Dorrance, Jr. DIRECTOR ELECTIONS ISSUER 85000 0 FOR 85000 FOR THE CAMPBELL'S COMPANY 134429109 US1344291091 11/18/2025 The election of twelve directors, each for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Maria Teresa (Tessa) Hilado DIRECTOR ELECTIONS ISSUER 85000 0 FOR 85000 FOR THE CAMPBELL'S COMPANY 134429109 US1344291091 11/18/2025 The election of twelve directors, each for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Grant H. Hill DIRECTOR ELECTIONS ISSUER 85000 0 FOR 85000 FOR THE CAMPBELL'S COMPANY 134429109 US1344291091 11/18/2025 The election of twelve directors, each for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Sarah Hofstetter DIRECTOR ELECTIONS ISSUER 85000 0 FOR 85000 FOR THE CAMPBELL'S COMPANY 134429109 US1344291091 11/18/2025 The election of twelve directors, each for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Marc B. Lautenbach DIRECTOR ELECTIONS ISSUER 85000 0 FOR 85000 FOR THE CAMPBELL'S COMPANY 134429109 US1344291091 11/18/2025 The election of twelve directors, each for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Mary Alice D. Malone, Jr. DIRECTOR ELECTIONS ISSUER 85000 0 FOR 85000 FOR THE CAMPBELL'S COMPANY 134429109 US1344291091 11/18/2025 The election of twelve directors, each for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Keith R. McLoughlin DIRECTOR ELECTIONS ISSUER 85000 0 FOR 85000 FOR THE CAMPBELL'S COMPANY 134429109 US1344291091 11/18/2025 The election of twelve directors, each for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Kurt T. Schmidt DIRECTOR ELECTIONS ISSUER 85000 0 FOR 85000 FOR THE CAMPBELL'S COMPANY 134429109 US1344291091 11/18/2025 The election of twelve directors, each for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Archbold D. van Beuren DIRECTOR ELECTIONS ISSUER 85000 0 FOR 85000 FOR THE CAMPBELL'S COMPANY 134429109 US1344291091 11/18/2025 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal 2026. AUDIT-RELATED ISSUER 85000 0 FOR 85000 FOR THE CAMPBELL'S COMPANY 134429109 US1344291091 11/18/2025 To vote on an advisory resolution to approve the fiscal 2025 compensation of our named executive officers, commonly referred to as a ''say on pay'' vote. SECTION 14A SAY-ON-PAY VOTES ISSUER 85000 0 FOR 85000 FOR THE CAMPBELL'S COMPANY 134429109 US1344291091 11/18/2025 To vote on a shareholder proposal regarding simple majority voting. CORPORATE GOVERNANCE SECURITY HOLDER 85000 0 AGAINST 85000 FOR THE CAMPBELL'S COMPANY 134429109 US1344291091 11/18/2025 To vote on a shareholder proposal regarding a report on the effectiveness of the Company's regenerative agriculture program including pesticide reduction outcomes. ENVIRONMENT OR CLIMATE SECURITY HOLDER 85000 0 ABSTAIN 85000 AGAINST THE CIGNA GROUP 125523100 US1255231003 04/22/2026 Election of Directors: David M. Cordani DIRECTOR ELECTIONS ISSUER 14000 0 FOR 14000 FOR THE CIGNA GROUP 125523100 US1255231003 04/22/2026 Election of Directors: Brian C. Evanko DIRECTOR ELECTIONS ISSUER 14000 0 FOR 14000 FOR THE CIGNA GROUP 125523100 US1255231003 04/22/2026 Election of Directors: Eric J. Foss DIRECTOR ELECTIONS ISSUER 14000 0 FOR 14000 FOR THE CIGNA GROUP 125523100 US1255231003 04/22/2026 Election of Directors: Neesha Hathi DIRECTOR ELECTIONS ISSUER 14000 0 FOR 14000 FOR THE CIGNA GROUP 125523100 US1255231003 04/22/2026 Election of Directors: Michael J. Hennigan DIRECTOR ELECTIONS ISSUER 14000 0 FOR 14000 FOR THE CIGNA GROUP 125523100 US1255231003 04/22/2026 Election of Directors: George Kurian DIRECTOR ELECTIONS ISSUER 14000 0 FOR 14000 FOR THE CIGNA GROUP 125523100 US1255231003 04/22/2026 Election of Directors: Kathleen M. Mazzarella DIRECTOR ELECTIONS ISSUER 14000 0 FOR 14000 FOR THE CIGNA GROUP 125523100 US1255231003 04/22/2026 Election of Directors: Mark B. McClellan, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 14000 0 FOR 14000 FOR THE CIGNA GROUP 125523100 US1255231003 04/22/2026 Election of Directors: Philip O. Ozuah, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 14000 0 FOR 14000 FOR THE CIGNA GROUP 125523100 US1255231003 04/22/2026 Election of Directors: Kimberly A. Ross DIRECTOR ELECTIONS ISSUER 14000 0 FOR 14000 FOR THE CIGNA GROUP 125523100 US1255231003 04/22/2026 Election of Directors: Eric C. Wiseman DIRECTOR ELECTIONS ISSUER 14000 0 FOR 14000 FOR THE CIGNA GROUP 125523100 US1255231003 04/22/2026 Election of Directors: Donna F. Zarcone DIRECTOR ELECTIONS ISSUER 14000 0 FOR 14000 FOR THE CIGNA GROUP 125523100 US1255231003 04/22/2026 Advisory approval of executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 14000 0 FOR 14000 FOR THE CIGNA GROUP 125523100 US1255231003 04/22/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as The Cigna Group's independent registered public accounting firm for 2026 AUDIT-RELATED ISSUER 14000 0 FOR 14000 FOR THE CIGNA GROUP 125523100 US1255231003 04/22/2026 Shareholder Proposal - Shareholder Right to Act by Written Consent CORPORATE GOVERNANCE SECURITY HOLDER 14000 0 AGAINST 14000 FOR THE COOPER COMPANIES, INC. 216648501 US2166485019 04/07/2026 Election of Directors: Colleen E. Jay DIRECTOR ELECTIONS ISSUER 42700 0 FOR 42700 FOR THE COOPER COMPANIES, INC. 216648501 US2166485019 04/07/2026 Election of Directors: Barbara A. Carbone DIRECTOR ELECTIONS ISSUER 42700 0 FOR 42700 FOR THE COOPER COMPANIES, INC. 216648501 US2166485019 04/07/2026 Election of Directors: Lawrence E. Kurzius DIRECTOR ELECTIONS ISSUER 42700 0 FOR 42700 FOR THE COOPER COMPANIES, INC. 216648501 US2166485019 04/07/2026 Election of Directors: Cynthia L. Lucchese DIRECTOR ELECTIONS ISSUER 42700 0 FOR 42700 FOR THE COOPER COMPANIES, INC. 216648501 US2166485019 04/07/2026 Election of Directors: Teresa S. Madden DIRECTOR ELECTIONS ISSUER 42700 0 FOR 42700 FOR THE COOPER COMPANIES, INC. 216648501 US2166485019 04/07/2026 Election of Directors: Maria Rivas, M.D. DIRECTOR ELECTIONS ISSUER 42700 0 FOR 42700 FOR THE COOPER COMPANIES, INC. 216648501 US2166485019 04/07/2026 Election of Directors: Walter M Rosebrough, Jr. DIRECTOR ELECTIONS ISSUER 42700 0 FOR 42700 FOR THE COOPER COMPANIES, INC. 216648501 US2166485019 04/07/2026 Election of Directors: Robert S. Weiss DIRECTOR ELECTIONS ISSUER 42700 0 FOR 42700 FOR THE COOPER COMPANIES, INC. 216648501 US2166485019 04/07/2026 Election of Directors: Albert G. White III DIRECTOR ELECTIONS ISSUER 42700 0 FOR 42700 FOR THE COOPER COMPANIES, INC. 216648501 US2166485019 04/07/2026 Ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending October 31, 2026. AUDIT-RELATED ISSUER 42700 0 FOR 42700 FOR THE COOPER COMPANIES, INC. 216648501 US2166485019 04/07/2026 Approve, on a non-binding, advisory basis, the compensation of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 42700 0 FOR 42700 FOR THE J. M. SMUCKER COMPANY 832696405 US8326964058 08/13/2025 Election of Directors whose term of office will expire in 2026. Mercedes Abramo DIRECTOR ELECTIONS ISSUER 30000 0 FOR 30000 FOR THE J. M. SMUCKER COMPANY 832696405 US8326964058 08/13/2025 Election of Directors whose term of office will expire in 2026. Tarang Amin DIRECTOR ELECTIONS ISSUER 30000 0 FOR 30000 FOR THE J. M. SMUCKER COMPANY 832696405 US8326964058 08/13/2025 Election of Directors whose term of office will expire in 2026. Susan Chapman-Hughes DIRECTOR ELECTIONS ISSUER 30000 0 FOR 30000 FOR THE J. M. SMUCKER COMPANY 832696405 US8326964058 08/13/2025 Election of Directors whose term of office will expire in 2026. Jay Henderson DIRECTOR ELECTIONS ISSUER 30000 0 FOR 30000 FOR THE J. M. SMUCKER COMPANY 832696405 US8326964058 08/13/2025 Election of Directors whose term of office will expire in 2026. Jonathan Johnson III DIRECTOR ELECTIONS ISSUER 30000 0 FOR 30000 FOR THE J. M. SMUCKER COMPANY 832696405 US8326964058 08/13/2025 Election of Directors whose term of office will expire in 2026. Kirk Perry DIRECTOR ELECTIONS ISSUER 30000 0 FOR 30000 FOR THE J. M. SMUCKER COMPANY 832696405 US8326964058 08/13/2025 Election of Directors whose term of office will expire in 2026. Mark Smucker DIRECTOR ELECTIONS ISSUER 30000 0 FOR 30000 FOR THE J. M. SMUCKER COMPANY 832696405 US8326964058 08/13/2025 Election of Directors whose term of office will expire in 2026. Jodi Taylor DIRECTOR ELECTIONS ISSUER 30000 0 FOR 30000 FOR THE J. M. SMUCKER COMPANY 832696405 US8326964058 08/13/2025 Election of Directors whose term of office will expire in 2026. Dawn Willoughby DIRECTOR ELECTIONS ISSUER 30000 0 FOR 30000 FOR THE J. M. SMUCKER COMPANY 832696405 US8326964058 08/13/2025 Ratification of appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for the 2026 fiscal year. AUDIT-RELATED ISSUER 30000 0 FOR 30000 FOR THE J. M. SMUCKER COMPANY 832696405 US8326964058 08/13/2025 Advisory approval of the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 30000 0 FOR 30000 FOR THE KRAFT HEINZ COMPANY 500754106 US5007541064 05/14/2026 Election of Directors: John T. Cahill DIRECTOR ELECTIONS ISSUER 60000 0 FOR 60000 FOR THE KRAFT HEINZ COMPANY 500754106 US5007541064 05/14/2026 Election of Directors: Steve Cahillane DIRECTOR ELECTIONS ISSUER 60000 0 FOR 60000 FOR THE KRAFT HEINZ COMPANY 500754106 US5007541064 05/14/2026 Election of Directors: Humberto P. Alfonso DIRECTOR ELECTIONS ISSUER 60000 0 FOR 60000 FOR THE KRAFT HEINZ COMPANY 500754106 US5007541064 05/14/2026 Election of Directors: L. Kevin Cox DIRECTOR ELECTIONS ISSUER 60000 0 FOR 60000 FOR THE KRAFT HEINZ COMPANY 500754106 US5007541064 05/14/2026 Election of Directors: Lori Dickerson Fouche DIRECTOR ELECTIONS ISSUER 60000 0 FOR 60000 FOR THE KRAFT HEINZ COMPANY 500754106 US5007541064 05/14/2026 Election of Directors: Diane Gherson DIRECTOR ELECTIONS ISSUER 60000 0 FOR 60000 FOR THE KRAFT HEINZ COMPANY 500754106 US5007541064 05/14/2026 Election of Directors: Mary Lou Kelley DIRECTOR ELECTIONS ISSUER 60000 0 FOR 60000 FOR THE KRAFT HEINZ COMPANY 500754106 US5007541064 05/14/2026 Election of Directors: Elio Leoni Sceti DIRECTOR ELECTIONS ISSUER 60000 0 FOR 60000 FOR THE KRAFT HEINZ COMPANY 500754106 US5007541064 05/14/2026 Election of Directors: Tony Palmer DIRECTOR ELECTIONS ISSUER 60000 0 FOR 60000 FOR THE KRAFT HEINZ COMPANY 500754106 US5007541064 05/14/2026 Election of Directors: John C. Pope DIRECTOR ELECTIONS ISSUER 60000 0 FOR 60000 FOR THE KRAFT HEINZ COMPANY 500754106 US5007541064 05/14/2026 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 60000 0 FOR 60000 FOR THE KRAFT HEINZ COMPANY 500754106 US5007541064 05/14/2026 Approval of The Kraft Heinz Company Amended and Restated 2020 Omnibus Incentive Plan. COMPENSATION ISSUER 60000 0 FOR 60000 FOR THE KRAFT HEINZ COMPANY 500754106 US5007541064 05/14/2026 Ratification of the selection of PricewaterhouseCoopers LLP as our independent auditors for 2026. AUDIT-RELATED ISSUER 60000 0 FOR 60000 FOR THE KROGER CO. 501044101 US5010441013 06/25/2026 Election of Directors. Nora A. Aufreiter DIRECTOR ELECTIONS ISSUER 25000 0 FOR 25000 FOR THE KROGER CO. 501044101 US5010441013 06/25/2026 Election of Directors. Kevin M. Brown DIRECTOR ELECTIONS ISSUER 25000 0 FOR 25000 FOR THE KROGER CO. 501044101 US5010441013 06/25/2026 Election of Directors. Mitchell R. Butier DIRECTOR ELECTIONS ISSUER 25000 0 FOR 25000 FOR THE KROGER CO. 501044101 US5010441013 06/25/2026 Election of Directors. Gregory S. Foran DIRECTOR ELECTIONS ISSUER 25000 0 FOR 25000 FOR THE KROGER CO. 501044101 US5010441013 06/25/2026 Election of Directors. Anne Gates DIRECTOR ELECTIONS ISSUER 25000 0 FOR 25000 FOR THE KROGER CO. 501044101 US5010441013 06/25/2026 Election of Directors. Karen M. Hoguet DIRECTOR ELECTIONS ISSUER 25000 0 FOR 25000 FOR THE KROGER CO. 501044101 US5010441013 06/25/2026 Election of Directors. Ronald L. Sargent DIRECTOR ELECTIONS ISSUER 25000 0 FOR 25000 FOR THE KROGER CO. 501044101 US5010441013 06/25/2026 Election of Directors. J. Amanda Sourry Knox DIRECTOR ELECTIONS ISSUER 25000 0 FOR 25000 FOR THE KROGER CO. 501044101 US5010441013 06/25/2026 Election of Directors. Mark S. Sutton DIRECTOR ELECTIONS ISSUER 25000 0 FOR 25000 FOR THE KROGER CO. 501044101 US5010441013 06/25/2026 Election of Directors. Ashok Vemuri DIRECTOR ELECTIONS ISSUER 25000 0 FOR 25000 FOR THE KROGER CO. 501044101 US5010441013 06/25/2026 Approval, on an advisory basis, of Kroger's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 25000 0 FOR 25000 FOR THE KROGER CO. 501044101 US5010441013 06/25/2026 Ratification of PricewaterhouseCoopers LLP, as auditors. AUDIT-RELATED ISSUER 25000 0 FOR 25000 FOR THE KROGER CO. 501044101 US5010441013 06/25/2026 Approval of the 2019 Second Amended and Restated Long-Term Incentive Plan. COMPENSATION ISSUER 25000 0 AGAINST 25000 AGAINST THE KROGER CO. 501044101 US5010441013 06/25/2026 Report on GHG emissions reductions. ENVIRONMENT OR CLIMATE SECURITY HOLDER 25000 0 ABSTAIN 25000 AGAINST THE ONCOLOGY INSTITUTE, INC. 68236X100 US68236X1000 06/17/2026 Election of eight directors Brad Hively DIRECTOR ELECTIONS ISSUER 2300 0 FOR 2300 FOR THE ONCOLOGY INSTITUTE, INC. 68236X100 US68236X1000 06/17/2026 Election of eight directors Karen Johnson DIRECTOR ELECTIONS ISSUER 2300 0 FOR 2300 FOR THE ONCOLOGY INSTITUTE, INC. 68236X100 US68236X1000 06/17/2026 Election of eight directors Mohit Kaushal DIRECTOR ELECTIONS ISSUER 2300 0 FOR 2300 FOR THE ONCOLOGY INSTITUTE, INC. 68236X100 US68236X1000 06/17/2026 Election of eight directors Anne McGeorge DIRECTOR ELECTIONS ISSUER 2300 0 FOR 2300 FOR THE ONCOLOGY INSTITUTE, INC. 68236X100 US68236X1000 06/17/2026 Election of eight directors Mark Pacala DIRECTOR ELECTIONS ISSUER 2300 0 FOR 2300 FOR THE ONCOLOGY INSTITUTE, INC. 68236X100 US68236X1000 06/17/2026 Election of eight directors Mark Stolper DIRECTOR ELECTIONS ISSUER 2300 0 FOR 2300 FOR THE ONCOLOGY INSTITUTE, INC. 68236X100 US68236X1000 06/17/2026 Election of eight directors Kimberly Tzoumakas DIRECTOR ELECTIONS ISSUER 2300 0 FOR 2300 FOR THE ONCOLOGY INSTITUTE, INC. 68236X100 US68236X1000 06/17/2026 Election of eight directors Daniel Virnich DIRECTOR ELECTIONS ISSUER 2300 0 FOR 2300 FOR THE ONCOLOGY INSTITUTE, INC. 68236X100 US68236X1000 06/17/2026 Ratification of the appointment of BDO as the independent registered public accounting firm of the Company for 2026. AUDIT-RELATED ISSUER 2300 0 FOR 2300 FOR THE ONCOLOGY INSTITUTE, INC. 68236X100 US68236X1000 06/17/2026 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2300 0 FOR 2300 FOR THE ONCOLOGY INSTITUTE, INC. 68236X100 US68236X1000 06/17/2026 Approval, on a non-binding, advisory basis, of the preferred frequency of future advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2300 0 1 Year 2300 FOR THE PROCTER & GAMBLE COMPANY 742718109 US7427181091 10/14/2025 ELECTION OF DIRECTORS B. Marc Allen DIRECTOR ELECTIONS ISSUER 8000 0 FOR 8000 FOR THE PROCTER & GAMBLE COMPANY 742718109 US7427181091 10/14/2025 ELECTION OF DIRECTORS Craig Arnold DIRECTOR ELECTIONS ISSUER 8000 0 FOR 8000 FOR THE PROCTER & GAMBLE COMPANY 742718109 US7427181091 10/14/2025 ELECTION OF DIRECTORS Brett Biggs DIRECTOR ELECTIONS ISSUER 8000 0 FOR 8000 FOR THE PROCTER & GAMBLE COMPANY 742718109 US7427181091 10/14/2025 ELECTION OF DIRECTORS Sheila Bonini DIRECTOR ELECTIONS ISSUER 8000 0 FOR 8000 FOR THE PROCTER & GAMBLE COMPANY 742718109 US7427181091 10/14/2025 ELECTION OF DIRECTORS Amy L. Chang DIRECTOR ELECTIONS ISSUER 8000 0 FOR 8000 FOR THE PROCTER & GAMBLE COMPANY 742718109 US7427181091 10/14/2025 ELECTION OF DIRECTORS Shailesh Jejurikar DIRECTOR ELECTIONS ISSUER 8000 0 FOR 8000 FOR THE PROCTER & GAMBLE COMPANY 742718109 US7427181091 10/14/2025 ELECTION OF DIRECTORS Joseph Jimenez DIRECTOR ELECTIONS ISSUER 8000 0 FOR 8000 FOR THE PROCTER & GAMBLE COMPANY 742718109 US7427181091 10/14/2025 ELECTION OF DIRECTORS Christopher Kempczinski DIRECTOR ELECTIONS ISSUER 8000 0 FOR 8000 FOR THE PROCTER & GAMBLE COMPANY 742718109 US7427181091 10/14/2025 ELECTION OF DIRECTORS Debra L. Lee DIRECTOR ELECTIONS ISSUER 8000 0 FOR 8000 FOR THE PROCTER & GAMBLE COMPANY 742718109 US7427181091 10/14/2025 ELECTION OF DIRECTORS Christine M. McCarthy DIRECTOR ELECTIONS ISSUER 8000 0 FOR 8000 FOR THE PROCTER & GAMBLE COMPANY 742718109 US7427181091 10/14/2025 ELECTION OF DIRECTORS Ashley McEvoy DIRECTOR ELECTIONS ISSUER 8000 0 FOR 8000 FOR THE PROCTER & GAMBLE COMPANY 742718109 US7427181091 10/14/2025 ELECTION OF DIRECTORS Jon R. Moeller DIRECTOR ELECTIONS ISSUER 8000 0 FOR 8000 FOR THE PROCTER & GAMBLE COMPANY 742718109 US7427181091 10/14/2025 ELECTION OF DIRECTORS Robert J. Portman DIRECTOR ELECTIONS ISSUER 8000 0 FOR 8000 FOR THE PROCTER & GAMBLE COMPANY 742718109 US7427181091 10/14/2025 ELECTION OF DIRECTORS Rajesh Subramaniam DIRECTOR ELECTIONS ISSUER 8000 0 FOR 8000 FOR THE PROCTER & GAMBLE COMPANY 742718109 US7427181091 10/14/2025 Ratify Appointment of the Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 8000 0 FOR 8000 FOR THE PROCTER & GAMBLE COMPANY 742718109 US7427181091 10/14/2025 Advisory Vote to Approve the Company's Executive Compensation (the "Say on Pay" vote) SECTION 14A SAY-ON-PAY VOTES ISSUER 8000 0 FOR 8000 FOR THE PROCTER & GAMBLE COMPANY 742718109 US7427181091 10/14/2025 Approval of The Procter & Gamble 2025 Stock and Incentive Compensation Plan COMPENSATION ISSUER 8000 0 AGAINST 8000 AGAINST THE PROCTER & GAMBLE COMPANY 742718109 US7427181091 10/14/2025 Shareholder Proposal Requesting Additional Reporting on Plastic Packaging ENVIRONMENT OR CLIMATE SECURITY HOLDER 8000 0 ABSTAIN 8000 AGAINST THE SIMPLY GOOD FOODS COMPANY 82900L102 US82900L1026 01/28/2026 Election of the 11 director nominees Clayton C. Daley, Jr. DIRECTOR ELECTIONS ISSUER 60000 0 FOR 60000 FOR THE SIMPLY GOOD FOODS COMPANY 82900L102 US82900L1026 01/28/2026 Election of the 11 director nominees Michelle P. Goolsby DIRECTOR ELECTIONS ISSUER 60000 0 FOR 60000 FOR THE SIMPLY GOOD FOODS COMPANY 82900L102 US82900L1026 01/28/2026 Election of the 11 director nominees James M. Kilts DIRECTOR ELECTIONS ISSUER 60000 0 FOR 60000 FOR THE SIMPLY GOOD FOODS COMPANY 82900L102 US82900L1026 01/28/2026 Election of the 11 director nominees Romitha S. Mally DIRECTOR ELECTIONS ISSUER 60000 0 FOR 60000 FOR THE SIMPLY GOOD FOODS COMPANY 82900L102 US82900L1026 01/28/2026 Election of the 11 director nominees Robert G. Montgomery DIRECTOR ELECTIONS ISSUER 60000 0 FOR 60000 FOR THE SIMPLY GOOD FOODS COMPANY 82900L102 US82900L1026 01/28/2026 Election of the 11 director nominees Brian K. Ratzan DIRECTOR ELECTIONS ISSUER 60000 0 FOR 60000 FOR THE SIMPLY GOOD FOODS COMPANY 82900L102 US82900L1026 01/28/2026 Election of the 11 director nominees David W. Ritterbush DIRECTOR ELECTIONS ISSUER 60000 0 FOR 60000 FOR THE SIMPLY GOOD FOODS COMPANY 82900L102 US82900L1026 01/28/2026 Election of the 11 director nominees Joseph J. Schena DIRECTOR ELECTIONS ISSUER 60000 0 FOR 60000 FOR THE SIMPLY GOOD FOODS COMPANY 82900L102 US82900L1026 01/28/2026 Election of Director: Geoff E. Tanner DIRECTOR ELECTIONS ISSUER 60000 0 FOR 60000 FOR THE SIMPLY GOOD FOODS COMPANY 82900L102 US82900L1026 01/28/2026 Election of the 11 director nominees David J. West DIRECTOR ELECTIONS ISSUER 60000 0 FOR 60000 FOR THE SIMPLY GOOD FOODS COMPANY 82900L102 US82900L1026 01/28/2026 Election of the 11 director nominees James D. White DIRECTOR ELECTIONS ISSUER 60000 0 FOR 60000 FOR THE SIMPLY GOOD FOODS COMPANY 82900L102 US82900L1026 01/28/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for fiscal year 2026 AUDIT-RELATED ISSUER 60000 0 FOR 60000 FOR THE SIMPLY GOOD FOODS COMPANY 82900L102 US82900L1026 01/28/2026 To approve The Simply Good Foods Company Incentive Plan COMPENSATION ISSUER 60000 0 FOR 60000 FOR THE SIMPLY GOOD FOODS COMPANY 82900L102 US82900L1026 01/28/2026 To approve, by an advisory vote, the frequency of future advisory votes to approve the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 60000 0 1 Year 60000 FOR THE SIMPLY GOOD FOODS COMPANY 82900L102 US82900L1026 01/28/2026 To approve, by an advisory vote, the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 60000 0 FOR 60000 FOR THERMO FISHER SCIENTIFIC INC. 883556102 US8835561023 05/20/2026 Election of Directors Marc N. Casper DIRECTOR ELECTIONS ISSUER 2845 0 FOR 2845 FOR THERMO FISHER SCIENTIFIC INC. 883556102 US8835561023 05/20/2026 Election of Directors Nelson J. Chai DIRECTOR ELECTIONS ISSUER 2845 0 FOR 2845 FOR THERMO FISHER SCIENTIFIC INC. 883556102 US8835561023 05/20/2026 Election of Directors Ruby R. Chandy DIRECTOR ELECTIONS ISSUER 2845 0 FOR 2845 FOR THERMO FISHER SCIENTIFIC INC. 883556102 US8835561023 05/20/2026 Election of Directors C. Martin Harris DIRECTOR ELECTIONS ISSUER 2845 0 FOR 2845 FOR THERMO FISHER SCIENTIFIC INC. 883556102 US8835561023 05/20/2026 Election of Directors Tyler Jacks DIRECTOR ELECTIONS ISSUER 2845 0 FOR 2845 FOR THERMO FISHER SCIENTIFIC INC. 883556102 US8835561023 05/20/2026 Election of Directors Jennifer M. Johnson DIRECTOR ELECTIONS ISSUER 2845 0 FOR 2845 FOR THERMO FISHER SCIENTIFIC INC. 883556102 US8835561023 05/20/2026 Election of Directors R. Alexandra Keith DIRECTOR ELECTIONS ISSUER 2845 0 FOR 2845 FOR THERMO FISHER SCIENTIFIC INC. 883556102 US8835561023 05/20/2026 Election of Directors Karen S. Lynch DIRECTOR ELECTIONS ISSUER 2845 0 FOR 2845 FOR THERMO FISHER SCIENTIFIC INC. 883556102 US8835561023 05/20/2026 Election of Directors Debora L. Spar DIRECTOR ELECTIONS ISSUER 2845 0 FOR 2845 FOR THERMO FISHER SCIENTIFIC INC. 883556102 US8835561023 05/20/2026 Election of Directors Scott M. Sperling DIRECTOR ELECTIONS ISSUER 2845 0 FOR 2845 FOR THERMO FISHER SCIENTIFIC INC. 883556102 US8835561023 05/20/2026 Election of Directors Dion J. Weisler DIRECTOR ELECTIONS ISSUER 2845 0 FOR 2845 FOR THERMO FISHER SCIENTIFIC INC. 883556102 US8835561023 05/20/2026 An advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2845 0 FOR 2845 FOR THERMO FISHER SCIENTIFIC INC. 883556102 US8835561023 05/20/2026 Ratification of the Audit Committee's selection of PricewaterhouseCoopers LLP as the Company's independent auditors for 2026. AUDIT-RELATED ISSUER 2845 0 FOR 2845 FOR TINGYI (CAYMAN ISLANDS) HOLDING CORP G8878S103 KYG8878S1030 06/08/2026 TO RECEIVE AND CONSIDER THE AUDITED ACCOUNTS AND THE REPORTS OF THE DIRECTORS AND THE AUDITORS FOR THE YEAR ENDED 31 DECEMBER 2025; OTHER ISSUER 120000 0 FOR 120000 FOR TINGYI (CAYMAN ISLANDS) HOLDING CORP G8878S103 KYG8878S1030 06/08/2026 TO APPROVE THE PAYMENT OF A FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2025; CAPITAL STRUCTURE ISSUER 120000 0 FOR 120000 FOR TINGYI (CAYMAN ISLANDS) HOLDING CORP G8878S103 KYG8878S1030 06/08/2026 TO APPROVE THE PAYMENT OF A SPECIAL FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2025; CAPITAL STRUCTURE ISSUER 120000 0 FOR 120000 FOR TINGYI (CAYMAN ISLANDS) HOLDING CORP G8878S103 KYG8878S1030 06/08/2026 TO RE-ELECT MR. JUNICHIRO IDA AS AN EXECUTIVE DIRECTOR AND TO AUTHORIZE THE DIRECTORS TO FIX HIS REMUNERATION; COMPENSATION ISSUER 120000 0 FOR 120000 FOR TINGYI (CAYMAN ISLANDS) HOLDING CORP G8878S103 KYG8878S1030 06/08/2026 TO RE-ELECT MR. WEI HONG-CHEN AS AN EXECUTIVE DIRECTOR AND TO AUTHORIZE THE DIRECTORS TO FIX HIS REMUNERATION; COMPENSATION ISSUER 120000 0 FOR 120000 FOR TINGYI (CAYMAN ISLANDS) HOLDING CORP G8878S103 KYG8878S1030 06/08/2026 TO RE-ELECT MR. MASAYA TOCHIO AS AN INDEPENDENT NON-EXECUTIVE DIRECTOR AND TO AUTHORIZE THE DIRECTORS TO FIX HIS REMUNERATION; COMPENSATION ISSUER 120000 0 FOR 120000 FOR TINGYI (CAYMAN ISLANDS) HOLDING CORP G8878S103 KYG8878S1030 06/08/2026 TO RE-APPOINT FORVIS MAZARS CPA LIMITED AS AUDITOR OF THE COMPANY AND AUTHORIZE THE DIRECTORS TO FIX THEIR REMUNERATION; AUDIT-RELATED ISSUER 120000 0 FOR 120000 FOR TINGYI (CAYMAN ISLANDS) HOLDING CORP G8878S103 KYG8878S1030 06/08/2026 THAT THERE BE GRANTED TO THE DIRECTORS AN UNCONDITIONAL GENERAL MANDATE TO BUY-BACK SHARES OF THE COMPANY, AND THAT THE EXERCISE BY THE DIRECTORS OF ALL POWERS OF THE COMPANY TO BUY-BACK SHARES SUBJECT TO AND IN ACCORDANCE WITH ALL APPLICABLE LAWS, RULES AND REGULATIONS BE AND IS HEREBY GENERALLY AND UNCONDITIONALLY APPROVED, SUBJECT TO THE FOLLOWING CONDITIONS: (A) SUCH; MANDATE SHALL NOT EXTEND BEYOND THE RELEVANT PERIOD; (B) SUCH MANDATE SHALL AUTHORIZE THE DIRECTORS TO PROCURE THE COMPANY TO BUY-BACK SHARES AT SUCH PRICES AS THE DIRECTORS MAY AT THEIR DISCRETION DETERMINE; (C) THE TOTAL NUMBER OF SHARES REPURCHASED BY THE COMPANY PURSUANT TO PARAGRAPH (A) OF THIS RESOLUTION DURING THE RELEVANT PERIOD SHALL NOT EXCEED 10 PER CENT OF THE TOTAL NUMBER OF SHARES OF THE COMPANY IN ISSUE AS AT THE DATE OF PASSING OF THIS RESOLUTION; AND (D) FOR THE PURPOSES OF THIS RESOLUTION RELEVANT PERIOD MEANS THE PERIOD FROM THE PASSING OF THIS RESOLUTION UNTIL WHICHEVER IS THE EARLIER OF: (I) THE CONCLUSION OF THE NEXT ANNUAL GENERAL MEETING OF THE COMPANY; (II) THE EXPIRATION OF THE PERIOD WITHIN WHICH THE NEXT ANNUAL GENERAL MEETING OF THE COMPANY IS REQUIRED BY THE ARTICLES OF THE COMPANY OR ANY APPLICABLE LAW TO BE HELD; AND (III) THE REVOCATION OR VARIATION OF THIS RESOLUTION BY AN ORDINARY RESOLUTION OF THE SHAREHOLDERS OF THE COMPANY IN GENERAL MEETING CAPITAL STRUCTURE ISSUER 120000 0 FOR 120000 FOR TINGYI (CAYMAN ISLANDS) HOLDING CORP G8878S103 KYG8878S1030 06/08/2026 TO CONSIDER AND, IF THOUGHT FIT, PASS THE FOLLOWING RESOLUTION AS A SPECIAL RESOLUTION: THAT THE AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF THE COMPANY (THE NEW ARTICLES), A COPY OF WHICH HAS BEEN PRODUCED TO THE MEETING MARKED A AND FOR IDENTIFICATION PURPOSE SIGNED BY THE CHAIRMAN OF THE MEETING, BE AND ARE HEREBY APPROVED AND ADOPTED IN SUBSTITUTION FOR AND TO THE EXCLUSION OF THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION OF THE COMPANY WITH IMMEDIATE EFFECT AND THAT THE DIRECTORS OF THE COMPANY BE AND ARE HEREBY AUTHORISED TO DO ALL THINGS NECESSARY TO IMPLEMENT THE ADOPTION OF THE NEW ARTICLES, INCLUDING ATTENDING TO ANY REGISTRATION AND/OR FILING OF THE NEW ARTICLES AND ALL REQUISITE DOCUMENTS FOR AND ON BEHALF OF THE COMPANY CORPORATE GOVERNANCE ISSUER 120000 0 FOR 120000 FOR TRAVERE THERAPEUTICS, INC. 89422G107 US89422G1076 05/19/2026 Election of Director: 1. Roy Baynes DIRECTOR ELECTIONS ISSUER 4300 0 FOR 4300 FOR TRAVERE THERAPEUTICS, INC. 89422G107 US89422G1076 05/19/2026 Election of Director: 2. Suzanne Bruhn DIRECTOR ELECTIONS ISSUER 4300 0 FOR 4300 FOR TRAVERE THERAPEUTICS, INC. 89422G107 US89422G1076 05/19/2026 Election of Director: 3. Timothy Coughlin DIRECTOR ELECTIONS ISSUER 4300 0 FOR 4300 FOR TRAVERE THERAPEUTICS, INC. 89422G107 US89422G1076 05/19/2026 Election of Director: 4. Eric Dube DIRECTOR ELECTIONS ISSUER 4300 0 FOR 4300 FOR TRAVERE THERAPEUTICS, INC. 89422G107 US89422G1076 05/19/2026 Election of Director: 5. Gary Lyons DIRECTOR ELECTIONS ISSUER 4300 0 FOR 4300 FOR TRAVERE THERAPEUTICS, INC. 89422G107 US89422G1076 05/19/2026 Election of Director: 6. Jeffrey Meckler DIRECTOR ELECTIONS ISSUER 4300 0 FOR 4300 FOR TRAVERE THERAPEUTICS, INC. 89422G107 US89422G1076 05/19/2026 Election of Director: 7. John Orwin DIRECTOR ELECTIONS ISSUER 4300 0 FOR 4300 FOR TRAVERE THERAPEUTICS, INC. 89422G107 US89422G1076 05/19/2026 Election of Director: 8. Sandra Poole DIRECTOR ELECTIONS ISSUER 4300 0 FOR 4300 FOR TRAVERE THERAPEUTICS, INC. 89422G107 US89422G1076 05/19/2026 Election of Director: 9. Ron Squarer DIRECTOR ELECTIONS ISSUER 4300 0 FOR 4300 FOR TRAVERE THERAPEUTICS, INC. 89422G107 US89422G1076 05/19/2026 Election of Director: 10. Ruth Williams-Brinkley DIRECTOR ELECTIONS ISSUER 4300 0 FOR 4300 FOR TRAVERE THERAPEUTICS, INC. 89422G107 US89422G1076 05/19/2026 To approve the Company's 2018 Equity Incentive Plan, as amended, to increase the number of shares of common stock authorized for issuance thereunder by 3,000,000 shares. COMPENSATION ISSUER 4300 0 ABSTAIN 4300 AGAINST TRAVERE THERAPEUTICS, INC. 89422G107 US89422G1076 05/19/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 4300 0 FOR 4300 FOR TRAVERE THERAPEUTICS, INC. 89422G107 US89422G1076 05/19/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 4300 0 1 Year 4300 FOR TRAVERE THERAPEUTICS, INC. 89422G107 US89422G1076 05/19/2026 To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 4300 0 FOR 4300 FOR UNILEVER PLC 904767704 US9047677045 10/21/2025 To approve: (a) the Share Consolidation; and (b) the amendment to the Company's articles of association. CAPITAL STRUCTURE ISSUER 40000 0 FOR 40000 FOR UNILEVER PLC 904767704 US9047677045 10/21/2025 To approve the amendments to the Company's authority to purchase its own shares. CAPITAL STRUCTURE ISSUER 40000 0 FOR 40000 FOR UNILEVER PLC 904767803 US9047678035 05/13/2026 To receive the Report and Accounts for the year ended 31 December 2025 together with the Directors' Reports and the Auditor's Report OTHER ISSUER 31111 0 FOR 31111 FOR UNILEVER PLC 904767803 US9047678035 05/13/2026 To approve the Directors' Remuneration Report SECTION 14A SAY-ON-PAY VOTES ISSUER 31111 0 FOR 31111 FOR UNILEVER PLC 904767803 US9047678035 05/13/2026 To approve the Directors' Remuneration Policy CORPORATE GOVERNANCE ISSUER 31111 0 FOR 31111 FOR UNILEVER PLC 904767803 US9047678035 05/13/2026 To elect Srinivas Phatak as a Director DIRECTOR ELECTIONS ISSUER 31111 0 FOR 31111 FOR UNILEVER PLC 904767803 US9047678035 05/13/2026 To re-elect Fernando Fernandez as a Director DIRECTOR ELECTIONS ISSUER 31111 0 FOR 31111 FOR UNILEVER PLC 904767803 US9047678035 05/13/2026 To re-elect Adrian Hennah as a Director DIRECTOR ELECTIONS ISSUER 31111 0 FOR 31111 FOR UNILEVER PLC 904767803 US9047678035 05/13/2026 To re-elect Susan Kilsby as a Director DIRECTOR ELECTIONS ISSUER 31111 0 FOR 31111 FOR UNILEVER PLC 904767803 US9047678035 05/13/2026 To re-elect Ruby Lu as a Director DIRECTOR ELECTIONS ISSUER 31111 0 FOR 31111 FOR UNILEVER PLC 904767803 US9047678035 05/13/2026 To re-elect Judith McKenna as a Director DIRECTOR ELECTIONS ISSUER 31111 0 FOR 31111 FOR UNILEVER PLC 904767803 US9047678035 05/13/2026 To re-elect Ian Meakins as a Director DIRECTOR ELECTIONS ISSUER 31111 0 FOR 31111 FOR UNILEVER PLC 904767803 US9047678035 05/13/2026 To re-elect Benoit Potier as a Director DIRECTOR ELECTIONS ISSUER 31111 0 FOR 31111 FOR UNILEVER PLC 904767803 US9047678035 05/13/2026 To re-elect Nelson Peltz as a Director DIRECTOR ELECTIONS ISSUER 31111 0 FOR 31111 FOR UNILEVER PLC 904767803 US9047678035 05/13/2026 To re-elect Zoe Yujnovich as a Director DIRECTOR ELECTIONS ISSUER 31111 0 FOR 31111 FOR UNILEVER PLC 904767803 US9047678035 05/13/2026 To reappoint KPMG LLP as Auditor of the Company AUDIT-RELATED ISSUER 31111 0 FOR 31111 FOR UNILEVER PLC 904767803 US9047678035 05/13/2026 To authorise the Directors to fix the remuneration of the Auditor AUDIT-RELATED ISSUER 31111 0 FOR 31111 FOR UNILEVER PLC 904767803 US9047678035 05/13/2026 To authorise political donations and expenditure OTHER SOCIAL ISSUES ISSUER 31111 0 FOR 31111 FOR UNILEVER PLC 904767803 US9047678035 05/13/2026 To renew the authority to Directors to allot shares CAPITAL STRUCTURE ISSUER 31111 0 FOR 31111 FOR UNILEVER PLC 904767803 US9047678035 05/13/2026 To renew the authority to Directors to disapply pre-emption rights CAPITAL STRUCTURE ISSUER 31111 0 ABSTAIN 31111 AGAINST UNILEVER PLC 904767803 US9047678035 05/13/2026 To renew the authority to Directors to disapply pre-emption rights in connection with acquisitions or capital investments CAPITAL STRUCTURE ISSUER 31111 0 FOR 31111 FOR UNILEVER PLC 904767803 US9047678035 05/13/2026 To renew the authority to the Company to purchase its own shares CAPITAL STRUCTURE ISSUER 31111 0 FOR 31111 FOR UNILEVER PLC 904767803 US9047678035 05/13/2026 To shorten the notice period for General Meetings (other than Annual General Meetings) to 14 clear days' notice CORPORATE GOVERNANCE ISSUER 31111 0 FOR 31111 FOR UNIQURE N.V. N90064101 NL0010696654 06/10/2026 Adoption of the 2025 Dutch statutory annual accounts for the fiscal year ended December 31, 2025. OTHER ISSUER 3300 0 FOR 3300 FOR UNIQURE N.V. N90064101 NL0010696654 06/10/2026 Discharge of liability of the members of the Board for their management during the fiscal year ended December 31, 2025. CORPORATE GOVERNANCE ISSUER 3300 0 FOR 3300 FOR UNIQURE N.V. N90064101 NL0010696654 06/10/2026 Reappointment of Madhavan Balachandran as non-executive director. Madhavan Balachandran DIRECTOR ELECTIONS ISSUER 3300 0 FOR 3300 FOR UNIQURE N.V. N90064101 NL0010696654 06/10/2026 Reappointment of Jack Gage as non-executive director. Jack Kaye DIRECTOR ELECTIONS ISSUER 3300 0 FOR 3300 FOR UNIQURE N.V. N90064101 NL0010696654 06/10/2026 Reappointment of Leonard Post, Ph.D. as non-executive director. Leonard Post, Ph.D. DIRECTOR ELECTIONS ISSUER 3300 0 FOR 3300 FOR UNIQURE N.V. N90064101 NL0010696654 06/10/2026 Designation of the Board as the competent body to issue Ordinary Shares and grant rights to subscribe for Ordinary Shares. CAPITAL STRUCTURE ISSUER 3300 0 FOR 3300 FOR UNIQURE N.V. N90064101 NL0010696654 06/10/2026 Designation of the Board as the competent body to exclude or limit preemptive rights upon the issuance of Ordinary Shares. CAPITAL STRUCTURE ISSUER 3300 0 AGAINST 3300 AGAINST UNIQURE N.V. N90064101 NL0010696654 06/10/2026 Reauthorization of the Board to repurchase Ordinary Shares. CAPITAL STRUCTURE ISSUER 3300 0 FOR 3300 FOR UNIQURE N.V. N90064101 NL0010696654 06/10/2026 Appointment of KPMG Accountants N.V. as external auditor of the Company for the fiscal year 2026. AUDIT-RELATED ISSUER 3300 0 FOR 3300 FOR UNIQURE N.V. N90064101 NL0010696654 06/10/2026 Approval, on an advisory basis, of the compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES ISSUER 3300 0 FOR 3300 FOR UNIQURE N.V. N90064101 NL0010696654 06/10/2026 Approval, on an advisory basis, of the frequency of advisory votes on the compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES ISSUER 3300 0 1 Year 3300 FOR UNIQURE N.V. N90064101 NL0010696654 06/10/2026 Resolution to adopt the Amendment and Restatement of the 2014 Share Incentive Plan. COMPENSATION ISSUER 3300 0 AGAINST 3300 AGAINST UNIQURE N.V. N90064101 NL0010696654 06/10/2026 Resolution to adopt the amendment to the Articles of Association to reflect Dutch large company regime. CAPITAL STRUCTURE ISSUER 3300 0 FOR 3300 FOR UNIQURE N.V. N90064101 NL0010696654 06/10/2026 Resolution to adopt the amendment to the Articles of Association to increase the authorized share capital and number of Ordinary Shares. CAPITAL STRUCTURE ISSUER 3300 0 FOR 3300 FOR UNIQURE N.V. N90064101 NL0010696654 06/10/2026 Resolution to adopt the amendment to the Articles of Association to include a federal forum selection provision. CORPORATE GOVERNANCE ISSUER 3300 0 FOR 3300 FOR UNITEDHEALTH GROUP INCORPORATED 91324P102 US91324P1021 06/01/2026 Election of Directors. Charles Baker DIRECTOR ELECTIONS ISSUER 5105 0 FOR 5105 FOR UNITEDHEALTH GROUP INCORPORATED 91324P102 US91324P1021 06/01/2026 Election of Directors. Timothy Flynn DIRECTOR ELECTIONS ISSUER 5105 0 FOR 5105 FOR UNITEDHEALTH GROUP INCORPORATED 91324P102 US91324P1021 06/01/2026 Election of Directors. Paul Garcia DIRECTOR ELECTIONS ISSUER 5105 0 FOR 5105 FOR UNITEDHEALTH GROUP INCORPORATED 91324P102 US91324P1021 06/01/2026 Election of Directors. Kristen Gil DIRECTOR ELECTIONS ISSUER 5105 0 FOR 5105 FOR UNITEDHEALTH GROUP INCORPORATED 91324P102 US91324P1021 06/01/2026 Election of Directors. Scott Gottlieb, M.D. DIRECTOR ELECTIONS ISSUER 5105 0 FOR 5105 FOR UNITEDHEALTH GROUP INCORPORATED 91324P102 US91324P1021 06/01/2026 Election of Directors. Stephen Hemsley DIRECTOR ELECTIONS ISSUER 5105 0 FOR 5105 FOR UNITEDHEALTH GROUP INCORPORATED 91324P102 US91324P1021 06/01/2026 Election of Directors. F. William McNabb III DIRECTOR ELECTIONS ISSUER 5105 0 FOR 5105 FOR UNITEDHEALTH GROUP INCORPORATED 91324P102 US91324P1021 06/01/2026 Election of Directors. Valerie Montgomery Rice, M.D. DIRECTOR ELECTIONS ISSUER 5105 0 FOR 5105 FOR UNITEDHEALTH GROUP INCORPORATED 91324P102 US91324P1021 06/01/2026 Election of Directors. John Noseworthy, M.D. DIRECTOR ELECTIONS ISSUER 5105 0 FOR 5105 FOR UNITEDHEALTH GROUP INCORPORATED 91324P102 US91324P1021 06/01/2026 Advisory approval of the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 5105 0 FOR 5105 FOR UNITEDHEALTH GROUP INCORPORATED 91324P102 US91324P1021 06/01/2026 Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 5105 0 FOR 5105 FOR UNITEDHEALTH GROUP INCORPORATED 91324P102 US91324P1021 06/01/2026 If properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. CORPORATE GOVERNANCE SECURITY HOLDER 5105 0 AGAINST 5105 FOR UPSTREAM BIO, INC. 91678A107 US91678A1079 06/09/2026 Election of Director: 1. H. E. Fleming Jr., M.D. DIRECTOR ELECTIONS ISSUER 400 0 FOR 400 FOR UPSTREAM BIO, INC. 91678A107 US91678A1079 06/09/2026 Election of Director: 2. L. Ratcliffe,MBChB, PhD DIRECTOR ELECTIONS ISSUER 400 0 FOR 400 FOR UPSTREAM BIO, INC. 91678A107 US91678A1079 06/09/2026 To ratify the appointment of PricewaterhouseCoopers LLP as Upstream's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 400 0 FOR 400 FOR VERA THERAPEUTICS, INC. 92337R101 US92337R1014 05/21/2026 Election of Director: 1. Michael M Morrissey PhD DIRECTOR ELECTIONS ISSUER 2500 0 FOR 2500 FOR VERA THERAPEUTICS, INC. 92337R101 US92337R1014 05/21/2026 Election of Director: 2. Patrick G. Enright DIRECTOR ELECTIONS ISSUER 2500 0 FOR 2500 FOR VERA THERAPEUTICS, INC. 92337R101 US92337R1014 05/21/2026 Election of Director: 3. James R. Meyers DIRECTOR ELECTIONS ISSUER 2500 0 FOR 2500 FOR VERA THERAPEUTICS, INC. 92337R101 US92337R1014 05/21/2026 To ratify the selection by the Audit Committee of the Board of Directors of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2500 0 FOR 2500 FOR VERA THERAPEUTICS, INC. 92337R101 US92337R1014 05/21/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 2500 0 FOR 2500 FOR VERICEL CORPORATION 92346J108 US92346J1088 04/29/2026 Election of Director: 1. Robert L. Zerbe DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR VERICEL CORPORATION 92346J108 US92346J1088 04/29/2026 Election of Director: 2. Alan L. Rubino DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR VERICEL CORPORATION 92346J108 US92346J1088 04/29/2026 Election of Director: 3. Heidi Hagen DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR VERICEL CORPORATION 92346J108 US92346J1088 04/29/2026 Election of Director: 4. Kevin F. McLaughlin DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR VERICEL CORPORATION 92346J108 US92346J1088 04/29/2026 Election of Director: 5. Paul K. Wotton DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR VERICEL CORPORATION 92346J108 US92346J1088 04/29/2026 Election of Director: 6. Dominick C. Colangelo DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR VERICEL CORPORATION 92346J108 US92346J1088 04/29/2026 Election of Director: 7. Lisa Wright DIRECTOR ELECTIONS ISSUER 5000 0 FOR 5000 FOR VERICEL CORPORATION 92346J108 US92346J1088 04/29/2026 To approve, on an advisory basis, the compensation of Vericel Corporation's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 5000 0 FOR 5000 FOR VERICEL CORPORATION 92346J108 US92346J1088 04/29/2026 To ratify the appointment of PricewaterhouseCoopers LLP as Vericel Corporation's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 5000 0 FOR 5000 FOR VERONA PHARMA PLC 925050106 US9250501064 09/24/2025 To approve the proposed scheme of arrangement pursuant to Part 26 of the Companies Act 2006 (the "Scheme of Arrangement"). EXTRAORDINARY TRANSACTIONS ISSUER 400 0 FOR 400 FOR VERONA PHARMA PLC 925050106 US9250501064 09/24/2025 To (i) authorize the Company's board of directors to take all action necessary or appropriate for carrying the Scheme of Arrangement into effect and (ii) make certain amendments to the Company's Articles of Association in order to facilitate the Scheme of Arrangement, including provisions to ensure that any ordinary shares that are issued or transferred at or after the Voting Record Time will either be subject to the terms of the Scheme of Arrangement or will be acquired by Vol Holdings LLC ...(due to space limits, see proxy material for full proposal). CORPORATE GOVERNANCE ISSUER 400 0 FOR 400 FOR VERONA PHARMA PLC 925050106 US9250501064 09/24/2025 To approve, on an advisory, non-binding basis, the compensation that may be paid or become payable to the Company's named executive officers in connection with the Transaction, as disclosed in the table entitled "Potential Payments to Named Executive Officers" beginning on page 70 of the proxy statement, including the associated narrative discussion, and the agreements or understandings pursuant to which such compensation may be paid or become payable. SECTION 14A SAY-ON-PAY VOTES ISSUER 400 0 FOR 400 FOR VERTEX PHARMACEUTICALS INCORPORATED 92532F100 US92532F1003 05/13/2026 Election of Directors: Sangeeta Bhatia DIRECTOR ELECTIONS ISSUER 3200 0 FOR 3200 FOR VERTEX PHARMACEUTICALS INCORPORATED 92532F100 US92532F1003 05/13/2026 Election of Directors: Lloyd Carney DIRECTOR ELECTIONS ISSUER 3200 0 FOR 3200 FOR VERTEX PHARMACEUTICALS INCORPORATED 92532F100 US92532F1003 05/13/2026 Election of Directors: Alan Garber DIRECTOR ELECTIONS ISSUER 3200 0 FOR 3200 FOR VERTEX PHARMACEUTICALS INCORPORATED 92532F100 US92532F1003 05/13/2026 Election of Directors: Reshma Kewalramani DIRECTOR ELECTIONS ISSUER 3200 0 FOR 3200 FOR VERTEX PHARMACEUTICALS INCORPORATED 92532F100 US92532F1003 05/13/2026 Election of Directors: Michel Lagarde DIRECTOR ELECTIONS ISSUER 3200 0 FOR 3200 FOR VERTEX PHARMACEUTICALS INCORPORATED 92532F100 US92532F1003 05/13/2026 Election of Directors: Jeffrey Leiden DIRECTOR ELECTIONS ISSUER 3200 0 FOR 3200 FOR VERTEX PHARMACEUTICALS INCORPORATED 92532F100 US92532F1003 05/13/2026 Election of Directors: Diana McKenzie DIRECTOR ELECTIONS ISSUER 3200 0 FOR 3200 FOR VERTEX PHARMACEUTICALS INCORPORATED 92532F100 US92532F1003 05/13/2026 Election of Directors: Bruce Sachs DIRECTOR ELECTIONS ISSUER 3200 0 FOR 3200 FOR VERTEX PHARMACEUTICALS INCORPORATED 92532F100 US92532F1003 05/13/2026 Election of Directors: Jennifer Schneider DIRECTOR ELECTIONS ISSUER 3200 0 FOR 3200 FOR VERTEX PHARMACEUTICALS INCORPORATED 92532F100 US92532F1003 05/13/2026 Election of Directors: Nancy Thornberry DIRECTOR ELECTIONS ISSUER 3200 0 FOR 3200 FOR VERTEX PHARMACEUTICALS INCORPORATED 92532F100 US92532F1003 05/13/2026 Election of Directors: Suketu Upadhyay DIRECTOR ELECTIONS ISSUER 3200 0 FOR 3200 FOR VERTEX PHARMACEUTICALS INCORPORATED 92532F100 US92532F1003 05/13/2026 Ratification of Ernst & Young LLP as independent Registered Public Accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 3200 0 FOR 3200 FOR VERTEX PHARMACEUTICALS INCORPORATED 92532F100 US92532F1003 05/13/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 3200 0 FOR 3200 FOR VERTEX PHARMACEUTICALS INCORPORATED 92532F100 US92532F1003 05/13/2026 Approval of 2026 Stock and Option Plan. COMPENSATION ISSUER 3200 0 FOR 3200 FOR VERTEX PHARMACEUTICALS INCORPORATED 92532F100 US92532F1003 05/13/2026 Shareholder Proposal, if properly presented at the meeting, regarding shareholder right to act by written consent. CORPORATE GOVERNANCE SECURITY HOLDER 3200 0 AGAINST 3200 FOR VIATRIS INC. 92556V106 US92556V1061 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders. W. Don Cornwell DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR VIATRIS INC. 92556V106 US92556V1061 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders. Frank D'Amelio DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR VIATRIS INC. 92556V106 US92556V1061 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders. JoEllen Lyons Dillon DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR VIATRIS INC. 92556V106 US92556V1061 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders. Elisha Finney DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR VIATRIS INC. 92556V106 US92556V1061 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders. Leo Groothuis DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR VIATRIS INC. 92556V106 US92556V1061 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders. Melina Higgins DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR VIATRIS INC. 92556V106 US92556V1061 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders. James M. Kilts DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR VIATRIS INC. 92556V106 US92556V1061 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders. Richard Mark DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR VIATRIS INC. 92556V106 US92556V1061 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders. Mark Parrish DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR VIATRIS INC. 92556V106 US92556V1061 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders. Michael Severino DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR VIATRIS INC. 92556V106 US92556V1061 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders. David Simmons DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR VIATRIS INC. 92556V106 US92556V1061 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders. Scott A. Smith DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR VIATRIS INC. 92556V106 US92556V1061 05/15/2026 Election of 13 director nominees, each to hold office until the 2027annual meeting of shareholders. Rogerio Vivaldi Coelho DIRECTOR ELECTIONS ISSUER 10000 0 FOR 10000 FOR VIATRIS INC. 92556V106 US92556V1061 05/15/2026 Approval of, on a non-binding advisory basis, the 2025 compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES ISSUER 10000 0 FOR 10000 FOR VIATRIS INC. 92556V106 US92556V1061 05/15/2026 Ratification of the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 10000 0 FOR 10000 FOR VIEMED HEALTHCARE, INC. 92663R105 CA92663R1055 06/04/2026 Election of Director: 1. Casey Hoyt DIRECTOR ELECTIONS ISSUER 85000 0 FOR 85000 FOR VIEMED HEALTHCARE, INC. 92663R105 CA92663R1055 06/04/2026 Election of Director: 2. W. Todd Zehnder DIRECTOR ELECTIONS ISSUER 85000 0 FOR 85000 FOR VIEMED HEALTHCARE, INC. 92663R105 CA92663R1055 06/04/2026 Election of Director: 3. Randy Dobbs DIRECTOR ELECTIONS ISSUER 85000 0 FOR 85000 FOR VIEMED HEALTHCARE, INC. 92663R105 CA92663R1055 06/04/2026 Election of Director: 4. William Frazier DIRECTOR ELECTIONS ISSUER 85000 0 FOR 85000 FOR VIEMED HEALTHCARE, INC. 92663R105 CA92663R1055 06/04/2026 Election of Director: 5. Nitin Kaushal DIRECTOR ELECTIONS ISSUER 85000 0 FOR 85000 FOR VIEMED HEALTHCARE, INC. 92663R105 CA92663R1055 06/04/2026 Election of Director: 6. Timothy Smokoff DIRECTOR ELECTIONS ISSUER 85000 0 FOR 85000 FOR VIEMED HEALTHCARE, INC. 92663R105 CA92663R1055 06/04/2026 Election of Director: 7. Sabrina Heltz DIRECTOR ELECTIONS ISSUER 85000 0 FOR 85000 FOR VIEMED HEALTHCARE, INC. 92663R105 CA92663R1055 06/04/2026 Appointment of Auditors - Re-appointment of Ernst & Young LLP as Auditors of the Corporation for the fiscal year ending December 31, 2026 and authorizing the Board of Directors of to fix their remuneration. AUDIT-RELATED ISSUER 85000 0 FOR 85000 FOR VIEMED HEALTHCARE, INC. 92663R105 CA92663R1055 06/04/2026 Amendments to Security Based Compensation Plan - To consider and, if thought appropriate, to pass an ordinary resolution (the text of which is disclosed in Section 10(iv) of the Management Information and Proxy Circular) to ratify, confirm, and approve the Second Amendment to 2024 Omnibus Plan Resolution, as more particularly described in the Management Information and Proxy Circular. COMPENSATION ISSUER 85000 0 ABSTAIN 85000 AGAINST VIEMED HEALTHCARE, INC. 92663R105 CA92663R1055 06/04/2026 Advisory Vote on Executive Compensation - To consider and, if thought appropriate, to pass an ordinary resolution (the text of which is disclosed in Section 10(v) of the Management Information and Proxy Circular) to approve, in a non-binding advisory vote, the Say-on-Pay Resolution, as more particularly described in the Management Information and Proxy Circular. SECTION 14A SAY-ON-PAY VOTES ISSUER 85000 0 FOR 85000 FOR VIKING THERAPEUTICS INC 92686J106 US92686J1060 05/19/2026 Election of Director: 1. J. Matthew Singleton DIRECTOR ELECTIONS ISSUER 4400 0 FOR 4400 FOR VIKING THERAPEUTICS INC 92686J106 US92686J1060 05/19/2026 Election of Director: 2. S. Kathryn Rouan, Ph D DIRECTOR ELECTIONS ISSUER 4400 0 FOR 4400 FOR VIKING THERAPEUTICS INC 92686J106 US92686J1060 05/19/2026 TO RATIFY THE SELECTION OF CBIZ CPAS P.C. AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2026. AUDIT-RELATED ISSUER 4400 0 FOR 4400 FOR VIKING THERAPEUTICS INC 92686J106 US92686J1060 05/19/2026 TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 4400 0 FOR 4400 FOR VITASOY INTERNATIONAL HOLDINGS LTD Y93794108 HK0345001611 08/25/2025 TO RECEIVE AND ADOPT THE AUDITED FINANCIAL STATEMENTS AND THE REPORTS OF THE DIRECTORS AND AUDITORS FOR THE YEAR ENDED 31ST MARCH, 2025 OTHER ISSUER 424000 0 FOR 424000 FOR VITASOY INTERNATIONAL HOLDINGS LTD Y93794108 HK0345001611 08/25/2025 TO APPROVE THE PAYMENT OF A FINAL DIVIDEND IN RESPECT OF THE YEAR ENDED 31ST MARCH, 2025 CAPITAL STRUCTURE ISSUER 424000 0 FOR 424000 FOR VITASOY INTERNATIONAL HOLDINGS LTD Y93794108 HK0345001611 08/25/2025 TO RE-ELECT MR. WINSTON YAU-LAI LO AS AN EXECUTIVE DIRECTOR DIRECTOR ELECTIONS ISSUER 424000 0 FOR 424000 FOR VITASOY INTERNATIONAL HOLDINGS LTD Y93794108 HK0345001611 08/25/2025 TO RE-ELECT MR. PAUL JEREMY BROUGH AS AN INDEPENDENT NON-EXECUTIVE DIRECTOR DIRECTOR ELECTIONS ISSUER 424000 0 FOR 424000 FOR VITASOY INTERNATIONAL HOLDINGS LTD Y93794108 HK0345001611 08/25/2025 TO RE-ELECT DR. ROY CHI-PING CHUNG AS AN INDEPENDENT NON-EXECUTIVE DIRECTOR DIRECTOR ELECTIONS ISSUER 424000 0 FOR 424000 FOR VITASOY INTERNATIONAL HOLDINGS LTD Y93794108 HK0345001611 08/25/2025 TO RE-ELECT MS. WENDY WEN-YEE YUNG AS AN INDEPENDENT NON-EXECUTIVE DIRECTOR DIRECTOR ELECTIONS ISSUER 424000 0 FOR 424000 FOR VITASOY INTERNATIONAL HOLDINGS LTD Y93794108 HK0345001611 08/25/2025 TO DETERMINE THE REMUNERATION OF THE DIRECTORS COMPENSATION ISSUER 424000 0 FOR 424000 FOR VITASOY INTERNATIONAL HOLDINGS LTD Y93794108 HK0345001611 08/25/2025 TO APPOINT AUDITORS AND AUTHORISE THE DIRECTORS TO FIX THEIR REMUNERATION AUDIT-RELATED ISSUER 424000 0 FOR 424000 FOR VITASOY INTERNATIONAL HOLDINGS LTD Y93794108 HK0345001611 08/25/2025 TO GRANT A GENERAL MANDATE TO THE DIRECTORS TO ISSUE, ALLOT AND DEAL WITH ADDITIONAL SHARES OF THE COMPANY, NOT EXCEEDING 10% OF THE TOTAL NUMBER OF ISSUED SHARES OF THE COMPANY AS AT THE DATE OF PASSING THIS RESOLUTION CAPITAL STRUCTURE ISSUER 424000 0 AGAINST 424000 AGAINST VITASOY INTERNATIONAL HOLDINGS LTD Y93794108 HK0345001611 08/25/2025 TO GRANT A GENERAL MANDATE TO THE DIRECTORS TO BUY-BACK SHARES OF THE COMPANY, NOT EXCEEDING 10% OF THE TOTAL NUMBER OF ISSUED SHARES OF THE COMPANY AS AT THE DATE OF PASSING THIS RESOLUTION CAPITAL STRUCTURE ISSUER 424000 0 FOR 424000 FOR VITASOY INTERNATIONAL HOLDINGS LTD Y93794108 HK0345001611 08/25/2025 TO ADD THE NUMBER OF SHARES BOUGHT-BACK PURSUANT TO RESOLUTION 5B TO THE NUMBER OF SHARES AVAILABLE PURSUANT TO RESOLUTION 5A CAPITAL STRUCTURE ISSUER 424000 0 AGAINST 424000 AGAINST VITASOY INTERNATIONAL HOLDINGS LTD Y93794108 HK0345001611 08/25/2025 TO APPROVE THE GRANT OF SHARE OPTIONS TO MR. WINSTON YAU-LAI LO UNDER THE SHARE OPTION SCHEME ADOPTED BY THE COMPANY COMPENSATION ISSUER 424000 0 AGAINST 424000 AGAINST VITASOY INTERNATIONAL HOLDINGS LTD Y93794108 HK0345001611 08/25/2025 TO APPROVE THE AMENDMENTS TO THE ARTICLES OF ASSOCIATION OF THE COMPANY AND THE ADOPTION OF THE NEW ARTICLES OF ASSOCIATION CORPORATE GOVERNANCE ISSUER 424000 0 FOR 424000 FOR VIVOSIM LABS, INC. 68620A302 US68620A3023 12/16/2025 To elect each of Douglas Jay Cohen and David Gobel as a Class II director to hold office until the 2028 Annual Meeting of Stockholders and until his respective successor is elected and qualified; Douglas Jay Cohen DIRECTOR ELECTIONS ISSUER 3333 0 FOR 3333 FOR VIVOSIM LABS, INC. 68620A302 US68620A3023 12/16/2025 To elect each of Douglas Jay Cohen and David Gobel as a Class II director to hold office until the 2028 Annual Meeting of Stockholders and until his respective successor is elected and qualified; David Gobel DIRECTOR ELECTIONS ISSUER 3333 0 FOR 3333 FOR VIVOSIM LABS, INC. 68620A302 US68620A3023 12/16/2025 To ratify the appointment of Rosenberg Rich Baker Berman P.A. as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2026. AUDIT-RELATED ISSUER 3333 0 FOR 3333 FOR VIVOSIM LABS, INC. 68620A302 US68620A3023 12/16/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3333 0 FOR 3333 FOR VIVOSIM LABS, INC. 68620A302 US68620A3023 12/16/2025 To approve, on an advisory basis, the frequency of the advisory vote on the Company's executive compensation of one, two or three years. SECTION 14A SAY-ON-PAY VOTES ISSUER 3333 0 1 Year 3333 FOR WALGREENS BOOTS ALLIANCE, INC. 931427108 US9314271084 07/11/2025 To adopt and approve the Agreement and Plan of Merger, dated as of March 6, 2025 (as it may be amended from time to time, the "Merger Agreement"), by and among the Walgreens Boots Alliance, Inc. (the "Company"), Blazing Star Parent, LLC, a Delaware limited liability company ("Parent"), Blazing Star Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), and the other affiliates of Parent named therein, pursuant to which, subject to the terms and conditions ...(due to space limits, see proxy material for full proposal). CORPORATE GOVERNANCE ISSUER 4000 0 FOR 4000 FOR WALGREENS BOOTS ALLIANCE, INC. 931427108 US9314271084 07/11/2025 To adjourn the Special Meeting, from time to time, to a later date or dates if necessary or appropriate, including adjournments to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to approve the Merger Agreement Proposal (the "Adjournment Proposal"). CORPORATE GOVERNANCE ISSUER 4000 0 FOR 4000 FOR WALGREENS BOOTS ALLIANCE, INC. 931427108 US9314271084 07/11/2025 To approve, by nonbinding, advisory vote, certain compensation arrangements for the Company's named executive officers in connection with the Merger (the "Merger-Related Compensation Proposal"). SECTION 14A SAY-ON-PAY VOTES ISSUER 4000 0 FOR 4000 FOR WATERS CORPORATION 941848103 US9418481035 01/27/2026 To approve the issuance of shares of common stock, par value $0.01 per share, of the Company (the "Waters Common Stock"), pursuant to the Agreement and Plan of Merger, dated as of July 13, 2025, by and among the Company, Becton, Dickinson and Company, Augusta SpinCo Corporation and Beta Merger Sub, Inc., as amended from time to time (the "Share Issuance Proposal"). CAPITAL STRUCTURE ISSUER 400 0 FOR 400 FOR WATERS CORPORATION 941848103 US9418481035 01/27/2026 Approve adjourning the Special Meeting, if necessary, (a) to solicit additional proxies if there are insufficient votes to approve the Share Issuance Proposal, (b) if insufficient shares of Waters Common Stock are represented (online or by proxy) to conduct business at the Special Meeting, and (c) to allow time to file or mail any supplemental or amended legal disclosures required by law, and to give shareholders sufficient time to receive and review such disclosures before the Special Meeting. CORPORATE GOVERNANCE ISSUER 400 0 FOR 400 FOR WATERS CORPORATION 941848103 US9418481035 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected; Dr. Flemming Ornskov, M.D., M.P.H. DIRECTOR ELECTIONS ISSUER 1577 0 FOR 1577 FOR WATERS CORPORATION 941848103 US9418481035 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected; Linda Baddour DIRECTOR ELECTIONS ISSUER 1577 0 FOR 1577 FOR WATERS CORPORATION 941848103 US9418481035 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected; Udit Batra, Ph.D. DIRECTOR ELECTIONS ISSUER 1577 0 FOR 1577 FOR WATERS CORPORATION 941848103 US9418481035 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected; Dan Brennan DIRECTOR ELECTIONS ISSUER 1577 0 FOR 1577 FOR WATERS CORPORATION 941848103 US9418481035 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected; Richard Fearon DIRECTOR ELECTIONS ISSUER 1577 0 FOR 1577 FOR WATERS CORPORATION 941848103 US9418481035 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected; Claire M. Fraser, Ph.D. DIRECTOR ELECTIONS ISSUER 1577 0 FOR 1577 FOR WATERS CORPORATION 941848103 US9418481035 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected; Pearl S. Huang, Ph.D. DIRECTOR ELECTIONS ISSUER 1577 0 FOR 1577 FOR WATERS CORPORATION 941848103 US9418481035 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected; Wei Jiang DIRECTOR ELECTIONS ISSUER 1577 0 FOR 1577 FOR WATERS CORPORATION 941848103 US9418481035 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected; Heather Knight DIRECTOR ELECTIONS ISSUER 1577 0 FOR 1577 FOR WATERS CORPORATION 941848103 US9418481035 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected; Christopher A. Kuebler DIRECTOR ELECTIONS ISSUER 1577 0 FOR 1577 FOR WATERS CORPORATION 941848103 US9418481035 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected; Mark Vergnano DIRECTOR ELECTIONS ISSUER 1577 0 FOR 1577 FOR WATERS CORPORATION 941848103 US9418481035 05/21/2026 To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026; and AUDIT-RELATED ISSUER 1577 0 FOR 1577 FOR WATERS CORPORATION 941848103 US9418481035 05/21/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1577 0 FOR 1577 FOR WAVE LIFE SCIENCES LTD. Y95308105 SG9999014716 06/22/2026 To approve the scheme of arrangement under Singapore law among Wave Life Sciences Ltd., a public company limited by shares incorporated under the laws of the Republic of Singapore ("Wave-Singapore"), the shareholders of Wave-Singapore and Wave Life Sciences, Inc., a Delaware corporation, subject to approval of the High Court of the Republic of Singapore, as set forth in Wave-Singapore's notice of, and proxy statement relating to, the Special Meeting of Wave-Singapore shareholders. CORPORATE GOVERNANCE ISSUER 17500 0 FOR 17500 FOR WAYSTAR HOLDING CORP 946784105 US9467841055 06/01/2026 Election of Director: 1. Robert A. DeMichiei DIRECTOR ELECTIONS ISSUER 15000 0 FOR 15000 FOR WAYSTAR HOLDING CORP 946784105 US9467841055 06/01/2026 Election of Director: 2. John Driscoll DIRECTOR ELECTIONS ISSUER 15000 0 FOR 15000 FOR WAYSTAR HOLDING CORP 946784105 US9467841055 06/01/2026 Election of Director: 3. Paul G. Moskowitz DIRECTOR ELECTIONS ISSUER 15000 0 FOR 15000 FOR WAYSTAR HOLDING CORP 946784105 US9467841055 06/01/2026 Election of Director: 4. Lauren Young DIRECTOR ELECTIONS ISSUER 15000 0 FOR 15000 FOR WAYSTAR HOLDING CORP 946784105 US9467841055 06/01/2026 Ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 15000 0 FOR 15000 FOR WAYSTAR HOLDING CORP 946784105 US9467841055 06/01/2026 Indicate, on a non-binding advisory basis, the frequency of future advisory votes to approve the compensation of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 15000 0 1 Year 15000 FOR WK KELLOGG CO 92942W107 US92942W1071 09/19/2025 The Merger Proposal - To adopt and approve the Agreement and Plan of Merger, dated as of July 10, 2025 (as it may be amended, supplemented or otherwise modified in accordance with its terms, the "Merger Agreement"), by and among WK Kellogg Co, a Delaware corporation ("WK Kellogg"), Ferrero International S.A., a Luxembourg public limited company ("Parent"), and Frosty Merger Sub, Inc., a Delaware corporation and a wholly owned indirect subsidiary of Parent ("Merger Sub"), pursuant to which, among other things, Merger Sub will merge with and into WK Kellogg, with WK Kellogg surviving as a wholly owned indirect subsidiary of Parent (the "Merger"). CORPORATE GOVERNANCE ISSUER 5000 0 FOR 5000 FOR WK KELLOGG CO 92942W107 US92942W1071 09/19/2025 The Advisory Compensation Proposal - To approve, on an advisory, non-binding basis, the compensation that may be paid or become payable to WK Kellogg's named executive officers that is based on or otherwise relates to the Merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 5000 0 FOR 5000 FOR WK KELLOGG CO 92942W107 US92942W1071 09/19/2025 The Adjournment Proposal - To approve one or more adjournments of the special meeting, if necessary, to solicit additional proxies if a quorum is not present or there are not sufficient votes cast at the special meeting to approve the Merger Proposal. CORPORATE GOVERNANCE ISSUER 5000 0 FOR 5000 FOR XENON PHARMACEUTICALS INC 98420N105 CA98420N1050 06/02/2026 To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected; Dawn Svoronos DIRECTOR ELECTIONS ISSUER 3000 0 FOR 3000 FOR XENON PHARMACEUTICALS INC 98420N105 CA98420N1050 06/02/2026 To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected; Gillian Cannon DIRECTOR ELECTIONS ISSUER 3000 0 FOR 3000 FOR XENON PHARMACEUTICALS INC 98420N105 CA98420N1050 06/02/2026 To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected; Steven Gannon DIRECTOR ELECTIONS ISSUER 3000 0 FOR 3000 FOR XENON PHARMACEUTICALS INC 98420N105 CA98420N1050 06/02/2026 To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected; Elizabeth Garofalo DIRECTOR ELECTIONS ISSUER 3000 0 FOR 3000 FOR XENON PHARMACEUTICALS INC 98420N105 CA98420N1050 06/02/2026 To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected; Justin Gover DIRECTOR ELECTIONS ISSUER 3000 0 FOR 3000 FOR XENON PHARMACEUTICALS INC 98420N105 CA98420N1050 06/02/2026 To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected; Patrick Machado DIRECTOR ELECTIONS ISSUER 3000 0 FOR 3000 FOR XENON PHARMACEUTICALS INC 98420N105 CA98420N1050 06/02/2026 To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected; Ian Mortimer DIRECTOR ELECTIONS ISSUER 3000 0 FOR 3000 FOR XENON PHARMACEUTICALS INC 98420N105 CA98420N1050 06/02/2026 To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected; Gary Patou DIRECTOR ELECTIONS ISSUER 3000 0 FOR 3000 FOR XENON PHARMACEUTICALS INC 98420N105 CA98420N1050 06/02/2026 To approve, on an advisory basis, the compensation of the Corporation's named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 3000 0 FOR 3000 FOR XENON PHARMACEUTICALS INC 98420N105 CA98420N1050 06/02/2026 To approve, on an advisory basis, the frequency of future shareholder advisory votes to approve the compensation of the Corporation's named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 3000 0 1 Year 3000 FOR XENON PHARMACEUTICALS INC 98420N105 CA98420N1050 06/02/2026 To approve the Corporation's 2026 Equity Incentive Plan; COMPENSATION ISSUER 3000 0 ABSTAIN 3000 AGAINST XENON PHARMACEUTICALS INC 98420N105 CA98420N1050 06/02/2026 To appoint PricewaterhouseCoopers LLP as the Corporation's auditor to hold office until the next annual meeting of the Corporation; AUDIT-RELATED ISSUER 3000 0 FOR 3000 FOR XENON PHARMACEUTICALS INC 98420N105 CA98420N1050 06/02/2026 To authorize the Audit Committee of the board of directors of the Corporation to fix the remuneration to be paid to the auditors of the Corporation; AUDIT-RELATED ISSUER 3000 0 FOR 3000 FOR XERIS BIOPHARMA HOLDINGS, INC. 98422E103 US98422E1038 06/04/2026 To elect two Class II directors to our board of directors to serve until the 2029 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Dawn Halkuff DIRECTOR ELECTIONS ISSUER 25000 0 FOR 25000 FOR XERIS BIOPHARMA HOLDINGS, INC. 98422E103 US98422E1038 06/04/2026 To elect two Class II directors to our board of directors to serve until the 2029 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: John Johnson DIRECTOR ELECTIONS ISSUER 25000 0 FOR 25000 FOR XERIS BIOPHARMA HOLDINGS, INC. 98422E103 US98422E1038 06/04/2026 To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 25000 0 FOR 25000 FOR XERIS BIOPHARMA HOLDINGS, INC. 98422E103 US98422E1038 06/04/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 25000 0 FOR 25000 FOR YAKULT HONSHA CO.,LTD. J95468120 JP3931600005 06/24/2026 Appoint a Director Narita, Hiroshi DIRECTOR ELECTIONS ISSUER 106000 0 FOR 106000 FOR YAKULT HONSHA CO.,LTD. J95468120 JP3931600005 06/24/2026 Appoint a Director Hoshiko, Hideaki DIRECTOR ELECTIONS ISSUER 106000 0 FOR 106000 FOR YAKULT HONSHA CO.,LTD. J95468120 JP3931600005 06/24/2026 Appoint a Director Shimada, Junichi DIRECTOR ELECTIONS ISSUER 106000 0 FOR 106000 FOR YAKULT HONSHA CO.,LTD. J95468120 JP3931600005 06/24/2026 Appoint a Director Kawabata, Hiroyuki DIRECTOR ELECTIONS ISSUER 106000 0 FOR 106000 FOR YAKULT HONSHA CO.,LTD. J95468120 JP3931600005 06/24/2026 Appoint a Director Watanabe, Shuichi DIRECTOR ELECTIONS ISSUER 106000 0 FOR 106000 FOR YAKULT HONSHA CO.,LTD. J95468120 JP3931600005 06/24/2026 Appoint a Director Kishimoto, Akira DIRECTOR ELECTIONS ISSUER 106000 0 FOR 106000 FOR YAKULT HONSHA CO.,LTD. J95468120 JP3931600005 06/24/2026 Appoint a Director Tobe, Naoko DIRECTOR ELECTIONS ISSUER 106000 0 FOR 106000 FOR YAKULT HONSHA CO.,LTD. J95468120 JP3931600005 06/24/2026 Appoint a Director Nagasawa, Yumiko DIRECTOR ELECTIONS ISSUER 106000 0 FOR 106000 FOR YAKULT HONSHA CO.,LTD. J95468120 JP3931600005 06/24/2026 Appoint a Director Akutsu, Satoshi DIRECTOR ELECTIONS ISSUER 106000 0 FOR 106000 FOR YAKULT HONSHA CO.,LTD. J95468120 JP3931600005 06/24/2026 Appoint a Director Matthew Digby DIRECTOR ELECTIONS ISSUER 106000 0 FOR 106000 FOR YAKULT HONSHA CO.,LTD. J95468120 JP3931600005 06/24/2026 Appoint a Director Fukuzawa, Toshihiko DIRECTOR ELECTIONS ISSUER 106000 0 FOR 106000 FOR YAKULT HONSHA CO.,LTD. J95468120 JP3931600005 06/24/2026 Appoint a Director Osumi, Takeshi DIRECTOR ELECTIONS ISSUER 106000 0 FOR 106000 FOR YAKULT HONSHA CO.,LTD. J95468120 JP3931600005 06/24/2026 Appoint a Director Naito, Manabu DIRECTOR ELECTIONS ISSUER 106000 0 FOR 106000 FOR YAKULT HONSHA CO.,LTD. J95468120 JP3931600005 06/24/2026 Approve Details of the Stock Compensation to be received by Directors (Excluding Outside Directors and Part-time Directors) COMPENSATION ISSUER 106000 0 FOR 106000 FOR YAKULT HONSHA CO.,LTD. J95468120 JP3931600005 06/24/2026 Shareholder Proposal: Appoint a Director James B. Rosenwald III DIRECTOR ELECTIONS SECURITY HOLDER 106000 0 ABSTAIN 106000 AGAINST YAKULT HONSHA CO.,LTD. J95468120 JP3931600005 06/24/2026 Shareholder Proposal: Appoint a Director Isogai, Kota DIRECTOR ELECTIONS SECURITY HOLDER 106000 0 ABSTAIN 106000 AGAINST YAKULT HONSHA CO.,LTD. J95468120 JP3931600005 06/24/2026 Shareholder Proposal: Approve Details of the Restricted-Stock Compensation to be received by Corporate Officers COMPENSATION SECURITY HOLDER 106000 0 ABSTAIN 106000 AGAINST YAKULT HONSHA CO.,LTD. J95468120 JP3931600005 06/24/2026 Shareholder Proposal: Amend Articles of Incorporation (Change Record Date of Annual General Meeting of Shareholders) CORPORATE GOVERNANCE SECURITY HOLDER 106000 0 ABSTAIN 106000 AGAINST ZIMMER BIOMET HOLDINGS, INC. 98956P102 US98956P1021 05/22/2026 Election of Directors: Betsy J. Bernard DIRECTOR ELECTIONS ISSUER 26500 0 FOR 26500 FOR ZIMMER BIOMET HOLDINGS, INC. 98956P102 US98956P1021 05/22/2026 Election of Directors: Michael J. Farrell DIRECTOR ELECTIONS ISSUER 26500 0 FOR 26500 FOR ZIMMER BIOMET HOLDINGS, INC. 98956P102 US98956P1021 05/22/2026 Election of Directors: Robert A. Hagemann DIRECTOR ELECTIONS ISSUER 26500 0 FOR 26500 FOR ZIMMER BIOMET HOLDINGS, INC. 98956P102 US98956P1021 05/22/2026 Election of Directors: Arthur J. Higgins DIRECTOR ELECTIONS ISSUER 26500 0 FOR 26500 FOR ZIMMER BIOMET HOLDINGS, INC. 98956P102 US98956P1021 05/22/2026 Election of Directors: Maria Teresa Hilado DIRECTOR ELECTIONS ISSUER 26500 0 FOR 26500 FOR ZIMMER BIOMET HOLDINGS, INC. 98956P102 US98956P1021 05/22/2026 Election of Directors: Syed Jafry DIRECTOR ELECTIONS ISSUER 26500 0 FOR 26500 FOR ZIMMER BIOMET HOLDINGS, INC. 98956P102 US98956P1021 05/22/2026 Election of Directors: Sreelakshmi Kolli DIRECTOR ELECTIONS ISSUER 26500 0 FOR 26500 FOR ZIMMER BIOMET HOLDINGS, INC. 98956P102 US98956P1021 05/22/2026 Election of Directors: Devdatt Kurdikar DIRECTOR ELECTIONS ISSUER 26500 0 FOR 26500 FOR ZIMMER BIOMET HOLDINGS, INC. 98956P102 US98956P1021 05/22/2026 Election of Directors: Louis A. Shapiro DIRECTOR ELECTIONS ISSUER 26500 0 FOR 26500 FOR ZIMMER BIOMET HOLDINGS, INC. 98956P102 US98956P1021 05/22/2026 Election of Directors: Ivan Tornos DIRECTOR ELECTIONS ISSUER 26500 0 FOR 26500 FOR ZIMMER BIOMET HOLDINGS, INC. 98956P102 US98956P1021 05/22/2026 Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 26500 0 FOR 26500 FOR ZIMMER BIOMET HOLDINGS, INC. 98956P102 US98956P1021 05/22/2026 Approve, on a non-binding advisory basis, named executive officer compensation ("Say on Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 26500 0 FOR 26500 FOR ZIMMER BIOMET HOLDINGS, INC. 98956P102 US98956P1021 05/22/2026 Shareholder Proposal on Independent Board Chairman. CORPORATE GOVERNANCE SECURITY HOLDER 26500 0 AGAINST 26500 FOR ZIMVIE INC. 98888T107 US98888T1079 10/10/2025 A proposal to adopt the Agreement and Plan of Merger, dated as of July 20, 2025 (the ''merger agreement''), by and among ZimVie Inc, (the ''Company''), Zamboni Parent Inc, (''Parent''), and Zamboni MergerCo Inc, (''MergerCo''), pursuant to which and subject to the terms and conditions thereof, MergerCo will be merged with and into the Company (the ''merger''), with the Company surviving the merger as a wholly owned subsidiary of Parent. CORPORATE GOVERNANCE ISSUER 9900 0 FOR 9900 FOR ZIMVIE INC. 98888T107 US98888T1079 10/10/2025 A proposal to approve, by advisory (non-binding) vote, the compensation that may be paid or become payable to the Company's named executive officers in connection with the consummation of the merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 9900 0 FOR 9900 FOR ZIMVIE INC. 98888T107 US98888T1079 10/10/2025 A proposal to approve any adjournment of the special meeting for the purpose of soliciting additional proxies if there are insufficient votes at the special meeting to approve Proposal 1. CORPORATE GOVERNANCE ISSUER 9900 0 FOR 9900 FOR ZYMEWORKS INC. 98985Y108 US98985Y1082 12/30/2025 Election of Director: 1. Carlos Campoy DIRECTOR ELECTIONS ISSUER 2500 0 FOR 2500 FOR ZYMEWORKS INC. 98985Y108 US98985Y1082 12/30/2025 Election of Director: 2. Alessandra Cesano DIRECTOR ELECTIONS ISSUER 2500 0 FOR 2500 FOR ZYMEWORKS INC. 98985Y108 US98985Y1082 12/30/2025 Election of Director: 3. Robert E. Landry DIRECTOR ELECTIONS ISSUER 2500 0 FOR 2500 FOR ZYMEWORKS INC. 98985Y108 US98985Y1082 12/30/2025 Advisory vote on the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 2500 0 FOR 2500 FOR ZYMEWORKS INC. 98985Y108 US98985Y1082 12/30/2025 Ratification of the appointment of KPMG LLP, chartered professional accountants, as auditors for the year ending December 31, 2025 AUDIT-RELATED ISSUER 2500 0 FOR 2500 FOR